Olprinone hydrochloride
type: Concept
broader: organic molecular entity

SO3-3beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

KFP-HG2L2479-6
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-)
broader: organic molecular entity

Calcitonin receptor-stimulating peptide 1
type: Concept
broader: organic molecular entity

Rifamycin S
type: Concept
broader: organic molecular entity

KFP-L8LJ45N6-0
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

Hydroxylamine hydrochloride
type: Concept
broader: organic molecular entity

magnocurarine trifluoroacetate, rac-
type: Concept
broader: organic molecular entity

KFP-GVWNG47D-J
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

(-)-Epigallocatechin-3-(3-O-methyl) gallate
type: Concept
broader: organic molecular entity

trans-Dodec-2-enoyl-[acp]
type: Concept
broader: organic molecular entity

bkas#36(1-)
type: Concept
broader: organic molecular entity

KFP-TB8N2SRS-V
type: Concept
preferred label: N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

Tiron
type: Concept
broader: organic molecular entity

an aldopyranose
type: Concept
broader: organic molecular entity

alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1)-N-acylsphinganine
type: Concept
broader: organic molecular entity

Antimony trioxide
type: Concept
broader: organic molecular entity

bkos#22-CoA(4-)
type: Concept
broader: organic molecular entity

KFP-W3KN99J1-R
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

KFP-M66W7N3R-7
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

2-oleoyl-sn-glycero-3-phospho-(1'-sn-glycerol)
type: Concept
broader: organic molecular entity

KFP-FSKZKJVC-M
type: Concept
preferred label: beta-D-galactosyl-(1->4)-N-acetyl-beta-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

beta-D-Glucuronosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosylproteoglycan
type: Concept
broader: organic molecular entity

bioconjugate
type: Concept
broader: organic molecular entity

Relaxin-1
type: Concept
broader: organic molecular entity

Obestatin
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
type: Concept
broader: organic molecular entity

2-Chlorophenylhydrazine hydrochloride
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

bkos#36(1-)
type: Concept
broader: organic molecular entity

Oxprenolol hydrochloride
type: Concept
broader: organic molecular entity

mbas#3(1-)
type: Concept
broader: organic molecular entity

bhas#20(1-)
type: Concept
broader: organic molecular entity

Enocitabine
type: Concept
broader: organic molecular entity

alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

3-O-sulfo-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
type: Concept
broader: organic molecular entity

4-[2-(diphenylmethoxy)ethyl]-1-[(4-azidophenyl)-methyl]-piperidine
type: Concept
broader: organic molecular entity

Sulfamethoxazole sodium
type: Concept
broader: organic molecular entity

Aflatoxin B1 endo-cysteinylglycine conjugate
type: Concept
broader: organic molecular entity

zinc-66(2+)
type: Concept
broader: organic molecular entity

25-O-Deacetylrifabutin
type: Concept
broader: organic molecular entity

5'''-methyl chlorobiocin-like antibiotic
type: Concept
broader: organic molecular entity

1-O-(1Z-hexadecenyl)-2-(5-oxovaleroyl)-sn-glycero-3-phosphocholine
type: Concept
broader: organic molecular entity

KFP-XLC3CNX7-V
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(5-)
broader: organic molecular entity

alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(3-)
type: Concept
broader: organic molecular entity

PB1-F2
type: Concept
broader: organic molecular entity

KFP-XSLT0FSW-2
type: Concept
preferred label: N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

3-O-sulfo-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(3-O-sulfo)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-)
type: Concept
broader: organic molecular entity

ascr#8(1-)
type: Concept
broader: organic molecular entity

nociceptin
type: Concept
broader: organic molecular entity

Cer(d16:0(15Me)/22:0)
type: Concept
broader: organic molecular entity

Suvanine
type: Concept
broader: organic molecular entity

Humanin
type: Concept
broader: organic molecular entity

CI Acid Orange 20
type: Concept
broader: organic molecular entity

3,5,7,9,11,13,15,17,19-Nonaoxo-henicosanoyl-[acp]
type: Concept
broader: organic molecular entity

Iron sorbitex
type: Concept
broader: organic molecular entity

organic hydroxy compound
type: Concept
broader: organic molecular entity

Lafutidine
type: Concept
broader: organic molecular entity

petrobactin(1+)
type: Concept
broader: organic molecular entity

loracarbef monohydrate
type: Concept
broader: organic molecular entity

KFP-DP52Z786-8
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

KFP-FRKKVSNX-6
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
broader: organic molecular entity

bhas#1-CoA(4-)
type: Concept
broader: organic molecular entity

Corticotropin-like intermediary peptide
type: Concept
broader: organic molecular entity

Glucagon hydrochloride
type: Concept
broader: organic molecular entity

cornusiin E(2-)
type: Concept
broader: organic molecular entity

Gluten exorphin A5
type: Concept
broader: organic molecular entity

demethylluteothin(1-)
type: Concept
broader: organic molecular entity

Etizolam
type: Concept
broader: organic molecular entity

L-Tyrosyl-[pcp]
type: Concept
broader: organic molecular entity

3,4-Dihydroxy-L-phenylalanyl-[pcp]
type: Concept
broader: organic molecular entity

KFP-PTHH1SP1-0
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(3-)
broader: organic molecular entity

KFP-C06GXRXX-3
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

KFP-P321ZVJH-0
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

Sodium salicylate
type: Concept
broader: organic molecular entity

KFP-M4JTZDC6-7
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

Dexchlorpheniramine maleate
type: Concept
broader: organic molecular entity

azidoglyburide
type: Concept
broader: organic molecular entity

KFP-B7T1S92C-M
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

Guanylin
type: Concept
broader: organic molecular entity

ascr#16-CoA
type: Concept
broader: organic molecular entity

alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[alpha-N-acetylneuraminosyl-(2->6)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
type: Concept
broader: organic molecular entity

rac-1,9,10-trihydroxy-2-methoxy-6-methylaporphinium trifluoroacetate
type: Concept
broader: organic molecular entity

icas#3(1-)
type: Concept
broader: organic molecular entity

NDP-N-methyl-L-glucosamine
type: Concept
broader: organic molecular entity

ungeremine
type: Concept
broader: organic molecular entity

manganese-55(7+)
type: Concept
broader: organic molecular entity

Lonijaposide J
type: Concept
broader: organic molecular entity

KFP-FGVX0HR4-4
type: Concept
preferred label: beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(3-)
broader: organic molecular entity

heteroorganic entity
type: Concept
broader: organic molecular entity

ascr#14(1-)
type: Concept
broader: organic molecular entity

GJ1012 C
type: Concept
broader: organic molecular entity

alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

enzyme bound BLM intermediate
type: Concept
broader: organic molecular entity

protein binder
type: Concept
broader: organic molecular entity

bhas#20-CoA(4-)
type: Concept
broader: organic molecular entity

KFP-L6WT7NTM-3
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

disialyl-Lewis A antigen
type: Concept
broader: organic molecular entity

bkas#24-CoA
type: Concept
broader: organic molecular entity

all-trans-retro-retinol
type: Concept
broader: organic molecular entity

Copper hydroxide
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
type: Concept
broader: organic molecular entity

Glucose-dependent insulinotropic peptide
type: Concept
broader: organic molecular entity

bkos#16(1-)
type: Concept
broader: organic molecular entity

Protein Cys-Cys
type: Concept
broader: organic molecular entity

(5Z)-7-{(1R,2R,3R,5S)-3,5-DIHYDROXY-2-[(1E,3S)-3-HYDROXY-5-PHENYLPENT-1-ENYL]CYCLOPENTYL}-N-ETHYLHEPT-5-ENAMIDE
type: Concept
broader: organic molecular entity

Semicarbazide hydrochloride
type: Concept
broader: organic molecular entity

KFP-ZW23WGC6-T
type: Concept
preferred label: 6-phosphoethanolamine-D-mannose-(alpha1->2)-6-phosphoethanolamine-D-mannose-(alpha1->6)-2-phosphoethanolamine-D-mannose-(alpha1->4)-D-glucosaminyl-(alpha1->6)-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-2-acyl-inositol zwitterion
broader: organic molecular entity

Goserelin
type: Concept
broader: organic molecular entity

Peptide(-Trp)
type: Concept
broader: organic molecular entity

KFP-PMLV70T8-C
type: Concept
preferred label: alpha-N-acetyl-9-O-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-)
broader: organic molecular entity

KFP-X8FDGGP9-S
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-galactosaminyl-(1->4)-[alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(3-)
broader: organic molecular entity

Mas8
type: Concept
broader: organic molecular entity

KFP-S064PKQF-F
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(4-)
broader: organic molecular entity

Afloqualone
type: Concept
broader: organic molecular entity

S 1033
type: Concept
broader: organic molecular entity

KFP-D1GFNQSF-D
type: Concept
preferred label: beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(3-)
broader: organic molecular entity

KFP-JH6HWHTB-4
type: Concept
preferred label: N-acetyl-alpha-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

bhos#14(1-)
type: Concept
broader: organic molecular entity

1-palmitoyl-2-(9,10-epoxyoctadecanoyl)-sn-glycero-3-phospho-L-serine(1-)
type: Concept
broader: organic molecular entity

KFP-D25P9NT9-K
type: Concept
preferred label: N-acetyl-alpha-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

bkos#30-CoA
type: Concept
broader: organic molecular entity

Iotalamic acid
type: Concept
broader: organic molecular entity

alpha-D-Gal-(1->3)-(alpha-L-Fuc-(1->2))-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

II2Xylbeta-Ml4Cer
type: Concept
broader: organic molecular entity

ascr#13-CoA(4-)
type: Concept
broader: organic molecular entity

N(delta)-methyl-L-argininium
type: Concept
broader: organic molecular entity

KFP-K5WHVHMV-9
type: Concept
preferred label: N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

hydropyrene
type: Concept
broader: organic molecular entity

KFP-TN1JW2Z4-4
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0) (1-)
type: Concept
broader: organic molecular entity

BRL 32872
type: Concept
broader: organic molecular entity

Mannogen
type: Concept
broader: organic molecular entity

Bacterio-chlorophyll c
type: Concept
broader: organic molecular entity

2,4-DIoxo acid
type: Concept
broader: organic molecular entity

3,5,7,9,11,13,15,17,19-Nonaoxo-docosanoyl-[acp]
type: Concept
broader: organic molecular entity

alpha-NeuAc-(2->6)-[alpha-NeuAc-(2->3)]-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

suvanine's sodium salt
type: Concept
broader: organic molecular entity

KFP-VMKPH7LS-4
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

Bombesin
type: Concept
broader: organic molecular entity

halisulfate 1, (rel)-
type: Concept
broader: organic molecular entity

Radium-224
type: Concept
broader: organic molecular entity

bkas#28-CoA(4-)
type: Concept
broader: organic molecular entity

N-acyl-S-1,2-diacyl-sn-glyceryl-L-cysteine residue
type: Concept
broader: organic molecular entity

bkas#14-CoA
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
type: Concept
broader: organic molecular entity

1-(10Z)-heptadecenoyl-2-arachidonoyl-sn-glycero-3-phospho-1D-myo-inositol(1-)
type: Concept
broader: organic molecular entity

alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
type: Concept
broader: organic molecular entity

KFP-RSL982W4-G
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(5-)
broader: organic molecular entity

Sodium 2-O-L-rhamnopyranosyl-4-deoxy-alpha-L-threo-hex-4-eno-pyranosiduronate
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
type: Concept
broader: organic molecular entity

arsenic-75(5+)
type: Concept
broader: organic molecular entity

KFP-LZF9CQ67-J
type: Concept
preferred label: N-acetyl-alpha-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

KFP-Z0HJJGT7-R
type: Concept
preferred label: alpha-L-fucosyl-(1->3)-[beta-D-galactosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

DNA 3'-a,b-unsaturated aldehyde
type: Concept
broader: organic molecular entity

KFP-MMK2L4GB-L
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

KFP-Q8L8Z4N4-H
type: Concept
preferred label: beta-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

bkas#12(1-)
type: Concept
broader: organic molecular entity

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
type: Concept
broader: organic molecular entity

KFP-B76D7L3H-G
type: Concept
preferred label: N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

bkos#22(1-)
type: Concept
broader: organic molecular entity

bhas#20-CoA
type: Concept
broader: organic molecular entity

KFP-BDR17VJP-8
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

organosilicon compound
type: Concept
broader: organic molecular entity

beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-(1->6)-[beta-D-Gal-(1->3)]-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine
type: Concept
broader: organic molecular entity

KFP-R6N372S3-J
type: Concept
preferred label: N-acetyl-alpha-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-alpha-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-(d18:1(4E))
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1<->1')-ceramide(d20:0) (1-)
type: Concept
broader: organic molecular entity

Azaspiracid-2
type: Concept
broader: organic molecular entity

trans-Dec-2-enoyl-[acp]
type: Concept
broader: organic molecular entity

Lipoyl-[acp]
type: Concept
broader: organic molecular entity

Jamaicamide
type: Concept
broader: organic molecular entity

Galactose oligosaccharide
type: Concept
broader: organic molecular entity

bhas#24-CoA
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
type: Concept
broader: organic molecular entity

bkos#36-CoA(4-)
type: Concept
broader: organic molecular entity

medium-chain fatty acyl-AMP(1-)
type: Concept
broader: organic molecular entity

N-acetyl-alpha-D-glucosaminyl-(1->6)-(phosphatidyl)-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol(1-)
type: Concept
broader: organic molecular entity

bhas#24(1-)
type: Concept
broader: organic molecular entity

beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

4'-hydroxyasperentin
type: Concept
broader: organic molecular entity

isowighteone hydrate
type: Concept
broader: organic molecular entity

ascr#18-CoA(4-)
type: Concept
broader: organic molecular entity

Protein serine
type: Concept
broader: organic molecular entity

Fudosteine
type: Concept
broader: organic molecular entity

osas#1
type: Concept
broader: organic molecular entity

Lankacidin C
type: Concept
broader: organic molecular entity

chetoseminudin C
type: Concept
broader: organic molecular entity

bkas#20-CoA
type: Concept
broader: organic molecular entity

KFP-MVDF0F4X-9
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

R-S-Alanylglycine
type: Concept
broader: organic molecular entity

Cerebellin
type: Concept
broader: organic molecular entity

alpha-NeuGc-(2->8)-alpha-NeuGc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E))
type: Concept
broader: organic molecular entity

N7-Methyl-Gpppa
type: Concept
broader: organic molecular entity

KFP-G038MQ0F-V
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

ascr#24-CoA
type: Concept
broader: organic molecular entity

cis-11,12-methyleneoctadecanoic acid
type: Concept
broader: organic molecular entity

Ranitidine bismuth citrate
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
type: Concept
broader: organic molecular entity

Levamisole hydrochloride
type: Concept
broader: organic molecular entity

MB0-002
type: Concept
broader: organic molecular entity

Methylsulfomycin I
type: Concept
broader: organic molecular entity

beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

KFP-PL444JZ5-S
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

bkas#16-CoA(4-)
type: Concept
broader: organic molecular entity

S-arachidonoyl-L-cysteine group
type: Concept
broader: organic molecular entity

N-methyldopaminechrome
type: Concept
broader: organic molecular entity

KFP-HKT3WGRP-S
type: Concept
preferred label: beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

7,9,12-Decaketide intermediate 1
type: Concept
broader: organic molecular entity

KFP-NZVQJN5H-Z
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

Cer(d16:0(15Me)/21:0)
type: Concept
broader: organic molecular entity

KFP-CXWZ2BLZ-2
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)
broader: organic molecular entity

bkas#9(1-)
type: Concept
broader: organic molecular entity

carbon group molecular entity
type: Concept
narrower: organic molecular entity

KFP-SNMHN6N4-9
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

Acetyl-[pcp]
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
type: Concept
broader: organic molecular entity

Benzyl violet 4B
type: Concept
broader: organic molecular entity

KFP-Q4TG49LM-3
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

KFP-ZWQ1H3WF-Z
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

KFP-X08HB2RX-M
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

lupeol acetate
type: Concept
broader: organic molecular entity

methoxymycolate type-1 (VI')
type: Concept
broader: organic molecular entity

strontium-88(2+)
type: Concept
broader: organic molecular entity

maritinamine Trifluoroacetic acid
type: Concept
broader: organic molecular entity

herquline A(1+)
type: Concept
broader: organic molecular entity

Nbeta-acetylstreptothricin E
type: Concept
broader: organic molecular entity

ascr#26-CoA(4-)
type: Concept
broader: organic molecular entity

ascr#3(1-)
type: Concept
broader: organic molecular entity

aluminum-27(3+)
type: Concept
broader: organic molecular entity

KFP-X3C43B6D-V
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(2-)
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
type: Concept
broader: organic molecular entity

SO3-3-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

alpha-L-Fuc-(1->2)-[alpha-D-Gal-(1->3)]-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E))
type: Concept
broader: organic molecular entity

ascr#26-CoA
type: Concept
broader: organic molecular entity

dBET6
type: Concept
broader: organic molecular entity

1-palmitoyl-2-(10-hydroxyoctadecanoyl)-sn-glycero-3-phospho-L-serine(1-)
type: Concept
broader: organic molecular entity

Magnesium dipropionate
type: Concept
broader: organic molecular entity

Ethyl selenac
type: Concept
broader: organic molecular entity

bkos#14-CoA(4-)
type: Concept
broader: organic molecular entity

KFP-MLZXBKT4-F
type: Concept
preferred label: alpha-N-acetyl-9-O-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
broader: organic molecular entity

KFP-BFNPS4G8-6
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

Methyprylon
type: Concept
broader: organic molecular entity

KFP-LFMNSGV0-W
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

4-{[4-({4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile
type: Concept
broader: organic molecular entity

KFP-F5CCGDD8-0
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

Bacillomycin D
type: Concept
broader: organic molecular entity

alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
type: Concept
broader: organic molecular entity

KFP-SJ4MQPK4-P
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(4-)
broader: organic molecular entity

Kisspeptin-10
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
type: Concept
broader: organic molecular entity

N-stearoyl-sphingoid base
type: Concept
broader: organic molecular entity

Pituitary adenylate cyclase-activating peptide-27
type: Concept
broader: organic molecular entity

sulfur-34(2-)
type: Concept
broader: organic molecular entity

9-O-adenylylspectinomycin zwitterion
type: Concept
broader: organic molecular entity

alpha-N-glycoloylneuraminosyl-(2->8)-alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)
type: Concept
broader: organic molecular entity

KFP-MCDVJN98-X
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
broader: organic molecular entity

bhas#22(1-)
type: Concept
broader: organic molecular entity

Ritipenem acoxil hydrate
type: Concept
broader: organic molecular entity

KFP-VPVT533B-0
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(4-)
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
type: Concept
broader: organic molecular entity

Neuropeptide FF
type: Concept
broader: organic molecular entity

bkos#16-CoA
type: Concept
broader: organic molecular entity

Cefuroxime sodium
type: Concept
broader: organic molecular entity

ascr#14-CoA
type: Concept
broader: organic molecular entity

octane-1-thiol
type: Concept
broader: organic molecular entity

Acetylkitasamycin
type: Concept
broader: organic molecular entity

boron-11(3-)
type: Concept
broader: organic molecular entity

KFP-RLRN3HJS-K
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
type: Concept
broader: organic molecular entity

Mono-(alk-1-enyl)-glycerol
type: Concept
broader: organic molecular entity

Erythropoietin
type: Concept
broader: organic molecular entity

Fenuron-TCA
type: Concept
broader: organic molecular entity

Endokinin D
type: Concept
broader: organic molecular entity

Cer(d16:0(15Me)/24:0)
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
type: Concept
broader: organic molecular entity

Cocaine- and Amphetamine- regulated transcript (1-39)
type: Concept
broader: organic molecular entity

alpha-D-Ribose 5-phosphate(2-)
type: Concept
broader: organic molecular entity

Atrial natriuretic peptide
type: Concept
broader: organic molecular entity

Flurbiprofen axetil
type: Concept
broader: organic molecular entity

Aliphatic hydroxy acid
type: Concept
broader: organic molecular entity

KFP-GDXS9DLX-T
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

S-palmitoleoyl-L-cysteine group
type: Concept
broader: organic molecular entity

[Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(2-methylpropanoyl)dihydrolipoyllysine
type: Concept
broader: organic molecular entity

bkos#20(1-)
type: Concept
broader: organic molecular entity

aspergiltriene A
type: Concept
broader: organic molecular entity

3,5,7,9,11,13,15,17-Octaoxo-nonadecanoyl-[acp]
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
type: Concept
broader: organic molecular entity

ascr#36-CoA(4-)
type: Concept
broader: organic molecular entity

KFP-LN7Q66N2-Z
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

Hydrocotarnine hydrochloride
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

Cys-Tyr thioether
type: Concept
broader: organic molecular entity

bhos#16-CoA
type: Concept
broader: organic molecular entity

Fe(III)-{di[N-(2,3-dihydroxybenzoyl)-L-seryl]-N-(C-5-[deoxy-beta-D-glucosyl]-2,3-dihydroxybenzoyl)-L-serinate}(4-)
type: Concept
broader: organic molecular entity

Bitumens
type: Concept
broader: organic molecular entity

alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[alpha-N-acetylneuraminosyl-(2->6)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)
type: Concept
broader: organic molecular entity

Opipramol hydrochloride
type: Concept
broader: organic molecular entity

KFP-GV6F0HB0-V
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(2-)
broader: organic molecular entity

1-radyl,2-acyl-sn-glycero-3-phospho-(1D-myo-2-acyl-inositol)(1-)
type: Concept
broader: organic molecular entity

Iotroxic acid
type: Concept
broader: organic molecular entity

stavudine
type: Concept
broader: organic molecular entity

N-PROPARGYL-1(R)-AMINONDAN
type: Concept
broader: organic molecular entity

bkas#28-CoA
type: Concept
broader: organic molecular entity

bhas#16(1-)
type: Concept
broader: organic molecular entity

bkas#1-CoA
type: Concept
broader: organic molecular entity

KFP-TGN2VJM0-0
type: Concept
preferred label: alpha-N-acetyl-9-O-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(2-)
broader: organic molecular entity

ascr#26(1-)
type: Concept
broader: organic molecular entity

KFP-CGGFSPH2-N
type: Concept
preferred label: N-acetyl-alpha-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

poly-beta-1,6-N-acetyl-D-glucosamine
type: Concept
broader: organic molecular entity

HexCer(d16:1(4E,15Me)/22:0(OH))
type: Concept
broader: organic molecular entity

bkos#30(1-)
type: Concept
broader: organic molecular entity

S-(15-deoxy-Delta(12,14)-prostaglandin J2-9-yl)cysteine residue(1-)
type: Concept
broader: organic molecular entity

oteseconazole
type: Concept
broader: organic molecular entity

1-O-octadecyl-sn-glycero-3-phosphocholine
type: Concept
broader: organic molecular entity

KFP-H5BX5ML9-S
type: Concept
preferred label: beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(3-)
broader: organic molecular entity

Protein aspartate
type: Concept
broader: organic molecular entity

Sodium diethyldithiocarbamate
type: Concept
broader: organic molecular entity

bkas#20-CoA(4-)
type: Concept
broader: organic molecular entity

N(4)-{beta-D-GlcNAc-(1->2)-[beta-D-GlcNAc-(1->4)]-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->2)-{beta-D-GlcNAc-(1->6)}-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc}-Asn residue
type: Concept
broader: organic molecular entity

KFP-VC3DPMMP-T
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

7,9,12-Octaketide intermediate 2
type: Concept
broader: organic molecular entity

Parathyroid hormone-related peptide (1-36)
type: Concept
broader: organic molecular entity

BT1583
type: Concept
broader: organic molecular entity

KFP-M5XBLWVX-1
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

Glucagon-like peptide 1
type: Concept
broader: organic molecular entity

selenium-82(6+)
type: Concept
broader: organic molecular entity

Sda antigen
type: Concept
broader: organic molecular entity

KFP-J3T3R8HS-Z
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

KFP-BBVCHN6N-9
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(5-)
broader: organic molecular entity

Oxabolone cipionate
type: Concept
broader: organic molecular entity

bkas#24(1-)
type: Concept
broader: organic molecular entity

6 thiodeoxyguanosine monophosphate (2-)
type: Concept
broader: organic molecular entity

Monanchocidin B, rel-
type: Concept
broader: organic molecular entity

Colestilan
type: Concept
broader: organic molecular entity

Mycosubtilin
type: Concept
broader: organic molecular entity

longiborneol
type: Concept
broader: organic molecular entity

cumulene
type: Concept
broader: organic molecular entity

[Pyruvate formate-lyase]-glycine radical
type: Concept
broader: organic molecular entity

Neuropeptide B-23
type: Concept
broader: organic molecular entity

KFP-CFCTJF9G-R
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(5-)
broader: organic molecular entity

ascr#38-CoA(4-)
type: Concept
broader: organic molecular entity

3-O-sulfo-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(3-O-sulfo)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)
type: Concept
broader: organic molecular entity

bhas#1-CoA
type: Concept
broader: organic molecular entity

Prolactin-releasing peptide-20
type: Concept
broader: organic molecular entity

3-Oxodecanoyl-[acp]
type: Concept
broader: organic molecular entity

1-((2S)-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}propanoyl)-L-proline
type: Concept
broader: organic molecular entity

alpha-D-Man-(1->6)-alpha-D-Man-(1->4)-alpha-D-glucosaminyl-(1->6)-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-2-acyl-inositol zwitterion
type: Concept
broader: organic molecular entity

KFP-XW9S6GVV-M
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

KFP-D9TKJWPK-8
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

an aldono-1,5-lactone
type: Concept
broader: organic molecular entity

[Pyruvate formate-lyase]-glycine
type: Concept
broader: organic molecular entity

3-O-sulfo-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
type: Concept
broader: organic molecular entity

(3S)-3-Hydroxyacyl-hydrolipoate
type: Concept
broader: organic molecular entity

KFP-Q97QNPLF-5
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

KFP-MKK8PPV0-9
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

Duplicate orsellinic acid
type: Concept
broader: organic molecular entity

Cys-Ser thioether
type: Concept
broader: organic molecular entity

UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-L-glutamate(4-)
type: Concept
broader: organic molecular entity

KFP-K4WD2ZRQ-H
type: Concept
preferred label: beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

Oxeladin citrate
type: Concept
broader: organic molecular entity

KFP-VXTX7HVV-4
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

cycloguanil hydrochloride
type: Concept
broader: organic molecular entity

KFP-DKWRDX3V-J
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

lipid
type: Concept
broader: organic molecular entity

echinuline
type: Concept
broader: organic molecular entity

KFP-NF5PNZ16-S
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

(+)-malbrancheamide B(1+)
type: Concept
broader: organic molecular entity

KFP-H6ZVDLS7-B
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(2-)
broader: organic molecular entity

KFP-PZJVF9VG-G
type: Concept
preferred label: beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

Heparin binding peptide
type: Concept
broader: organic molecular entity

Mazindol
type: Concept
broader: organic molecular entity

bkos#10(1-)
type: Concept
broader: organic molecular entity

Iodine aqueous
type: Concept
broader: organic molecular entity

Neuromedin B
type: Concept
broader: organic molecular entity

KFP-XV6TKBKM-G
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

N-(acyl)-sphingosylphosphoethanolamine zwitterion
type: Concept
broader: organic molecular entity

1D-myo-Inositol bisdiphosphate tetrakisphosphate
type: Concept
broader: organic molecular entity

Sulfametomidine
type: Concept
broader: organic molecular entity

KFP-MCV20SZN-4
type: Concept
preferred label: alpha-N-acetylneuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

bkas#12-CoA(4-)
type: Concept
broader: organic molecular entity

alpha-Linolenoyl-ACP
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(2-)
type: Concept
broader: organic molecular entity

S-(diphytanylglyceryl)-L-cysteine residue
type: Concept
broader: organic molecular entity

Cefpimizole sodium
type: Concept
broader: organic molecular entity

bkos#1(1-)
type: Concept
broader: organic molecular entity

Xaa-ornithine
type: Concept
broader: organic molecular entity

(beta-D-glucosyl)-O-mycofactocinol
type: Concept
broader: organic molecular entity

opacaline B
type: Concept
broader: organic molecular entity

ascr#16(1-)
type: Concept
broader: organic molecular entity

(4E,8E)-10-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4,8-dimethyldeca-4,8-dienoate
type: Concept
broader: organic molecular entity

sodium(2R,3R,E)-9-(2,5-dihydroxyphenyl)-3,7-dimethyl-1-((1S,4aS,8aS)-5,5,8a-trimethyl-2-methylenedecahydronaphthalen-1-yl)non-7-en-2-yl sulfate
type: Concept
broader: organic molecular entity

Alprostadil alfadex
type: Concept
broader: organic molecular entity

Brilliant Blue
type: Concept
broader: organic molecular entity

S-stearoyl-L-cysteine group
type: Concept
broader: organic molecular entity

Activin B
type: Concept
broader: organic molecular entity

KFP-KCFRL2MB-5
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

C26-CoA
type: Concept
broader: organic molecular entity

VM 44864
type: Concept
broader: organic molecular entity

Clinofibrate
type: Concept
broader: organic molecular entity

Meprobamate
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
type: Concept
broader: organic molecular entity

Gefarnate
type: Concept
broader: organic molecular entity

KFP-JTD9MRN4-3
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(3-)
broader: organic molecular entity

bkos#20-CoA
type: Concept
broader: organic molecular entity

Strobane
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1<->1')-ceramide(d20:1(4E))(1-)
type: Concept
broader: organic molecular entity

alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
type: Concept
broader: organic molecular entity

bhas#22-CoA
type: Concept
broader: organic molecular entity

organic ion
type: Concept
broader: organic molecular entity

alpha-D-Gal-(1->3)-(alpha-L-Fuc-(1->2))-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E))
type: Concept
broader: organic molecular entity

Urotensin II
type: Concept
broader: organic molecular entity

bhas#28(1-)
type: Concept
broader: organic molecular entity

KFP-LHSZHSN5-5
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
broader: organic molecular entity

Neuromedin U
type: Concept
broader: organic molecular entity

Cocaine- and Amphetamine- regulated transcript (42-89)
type: Concept
broader: organic molecular entity

manganese-55(2+)
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(1-)
type: Concept
broader: organic molecular entity

organophosphonate(2-)
type: Concept
broader: organic molecular entity

p-Aminobenzamidine dihydrochloride
type: Concept
broader: organic molecular entity

Duplicate eugenitin
type: Concept
broader: organic molecular entity

phosphoethanolamine-glycosyl-inositol-phosphoceramide zwitterion
type: Concept
broader: organic molecular entity

bkos#26(1-)
type: Concept
broader: organic molecular entity

bkos#24
type: Concept
broader: organic molecular entity

flavipin
type: Concept
broader: organic molecular entity

KFP-Z9Z71CSL-5
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
broader: organic molecular entity

Thiogalactoside
type: Concept
broader: organic molecular entity

KFP-G26JTFKL-V
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

Rhodoquinone-9
type: Concept
broader: organic molecular entity

KFP-B67P9S3R-C
type: Concept
preferred label: N-acetyl-alpha-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
type: Concept
broader: organic molecular entity

Lichenysin D
type: Concept
broader: organic molecular entity

AC-55541
type: Concept
broader: organic molecular entity

dimethyl-hexadecanoic acid
type: Concept
broader: organic molecular entity

bkas#22(1-)
type: Concept
broader: organic molecular entity

bhos#32-CoA(4-)
type: Concept
broader: organic molecular entity

KFP-NZ2BK75W-Q
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

KFP-B16R4HRG-T
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

Arylhydroxamate
type: Concept
broader: organic molecular entity

KFP-TMMZ3V2C-Z
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

Formylisoglutamine(1-)
type: Concept
broader: organic molecular entity

bkas#14(1-)
type: Concept
broader: organic molecular entity

Fe(III)-{N-(2,3-dihydroxybenzoyl)-L-seryl-N-(C-5-[deoxy-beta-D-glucosyl]-2,3-dihydroxybenzoyl)-L-serinate}(2-)
type: Concept
broader: organic molecular entity

isopentadecanoyl carnitine
type: Concept
broader: organic molecular entity

Aceglatone
type: Concept
broader: organic molecular entity

Propamocarb hydrochloride
type: Concept
broader: organic molecular entity

DNA 8-oxoguanine
type: Concept
broader: organic molecular entity

KFP-NLQLPJP8-6
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(3-)
broader: organic molecular entity

Resistin
type: Concept
broader: organic molecular entity

[Myeline basic protein] L-arginine
type: Concept
broader: organic molecular entity

KFP-G4B7TSPD-Q
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-ceramide(d18:0)
broader: organic molecular entity

KFP-KW2ZWDVP-0
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

KFP-M5L88Q0K-3
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-galactosaminyl-(1->4)-[alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(3-)
broader: organic molecular entity

Glycyrrhizinate dipotassium
type: Concept
broader: organic molecular entity

Cyclic secondary alcohol
type: Concept
broader: organic molecular entity

KFP-ZMNLK23L-C
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

Oxine-copper
type: Concept
broader: organic molecular entity

KFP-GJKQZ1HT-C
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
type: Concept
broader: organic molecular entity

Chrysoidine
type: Concept
broader: organic molecular entity

KFP-BHLKGJ10-5
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

Iodosulfuron-methyl-sodium
type: Concept
broader: organic molecular entity

7-methyloctanoyl carnitine
type: Concept
broader: organic molecular entity

2-Alkylmalic acid
type: Concept
broader: organic molecular entity

KFP-BQ5F52JW-6
type: Concept
preferred label: alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

urea herbicide
type: Concept
broader: organic molecular entity

beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

Peptide(N-Glu, Asp, Cystine)
type: Concept
broader: organic molecular entity

diphenylpyraline teoclate
type: Concept
broader: organic molecular entity

boron-11(3+)
type: Concept
broader: organic molecular entity

7,9,12-Decaketide intermediate 5
type: Concept
broader: organic molecular entity

3-Amino-3-(5-chloro-3,4-dihydroxyphenyl)propanoyl-[pcp]
type: Concept
broader: organic molecular entity

flavonoids
type: Concept
broader: organic molecular entity

Apelin-36
type: Concept
broader: organic molecular entity

KFP-HHQ36HVD-C
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

KFP-M9BBM3TF-M
type: Concept
preferred label: N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(1-)
type: Concept
broader: organic molecular entity

Dihydroxyaluminum
type: Concept
broader: organic molecular entity

KFP-QBK2SSQ1-K
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(3-)
type: Concept
broader: organic molecular entity

Adiponectin
type: Concept
broader: organic molecular entity

Erionite
type: Concept
broader: organic molecular entity

Tazanolast
type: Concept
broader: organic molecular entity

KFP-XX3ZRLPZ-1
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(3-)
broader: organic molecular entity

alpha-L-Fuc-(1->2)-[alpha-D-Gal-(1->3)]-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

alpha-N-Acetyl-D-glucosaminyl-(1->4)-beta-D-glucuronosyl-(1->3)-beta-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-xylosylproteoglycan
type: Concept
broader: organic molecular entity

Cer(d16:0(15Me)/22:0(OH))
type: Concept
broader: organic molecular entity

Panipenem
type: Concept
broader: organic molecular entity

Neuropeptide B-29
type: Concept
broader: organic molecular entity

alpha-D-Gal-(1->3)-alpha-D-Gal-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphingosine
type: Concept
broader: organic molecular entity

KFP-N67B4V91-B
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-)
broader: organic molecular entity

Cefsulodin sodium
type: Concept
broader: organic molecular entity

alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
type: Concept
broader: organic molecular entity

Valacyclovir hydrochloride
type: Concept
broader: organic molecular entity

Gla protein
type: Concept
broader: organic molecular entity

seractide
type: Concept
broader: organic molecular entity

bkas#18-CoA(4-)
type: Concept
broader: organic molecular entity

KFP-VPRBDGHD-D
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
type: Concept
broader: organic molecular entity

2-O-[6-O-octanoyl-alpha-D-glucopyranosyl-(1->6)-alpha-D-glucopyranosyl]-D-glycerate
type: Concept
broader: organic molecular entity

18-Carbamoyl-3,5,7,9,11,13,15,17-octaoxo-octadecanoyl-[acp]
type: Concept
broader: organic molecular entity

GP369
type: Concept
broader: organic molecular entity

graphite oxide
type: Concept
broader: organic molecular entity

E-Halidrysone A
type: Concept
broader: organic molecular entity

ROOH
type: Concept
broader: organic molecular entity

Aflatoxin B1 exo-cysteinylglycine conjugate
type: Concept
broader: organic molecular entity

KFP-DRK8C3R1-R
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(2-)
broader: organic molecular entity

Neuropeptide Y
type: Concept
broader: organic molecular entity

D and C Red No. 9
type: Concept
broader: organic molecular entity

gamma-Lipotropin
type: Concept
broader: organic molecular entity

KFP-C7744S98-R
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

KFP-FZ5Q1TT9-6
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

bkas#16(1-)
type: Concept
broader: organic molecular entity

(5R)-5,6-dihydro-5-(thymidin-7-yl)thymidine (in double-helical DNA)
type: Concept
broader: organic molecular entity

KFP-BDWNRHT7-1
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
broader: organic molecular entity

bhas#36(1-)
type: Concept
broader: organic molecular entity

bhos#38(1-)
type: Concept
broader: organic molecular entity

Clofenamide
type: Concept
broader: organic molecular entity

alpha-N-acetylneuraminosyl-(2->6)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
type: Concept
broader: organic molecular entity

bhos#18-CoA
type: Concept
broader: organic molecular entity

Adenosine 5'-phosphate disodium
type: Concept
broader: organic molecular entity

carbocyclic thromboxane A2(1-)
type: Concept
broader: organic molecular entity

C15815
type: Concept
broader: organic molecular entity

KFP-BZBD85FB-W
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(2-)
broader: organic molecular entity

inositol-1-phospho-N-(2-hydroxy-very-long-chain fatty acyl)-4R-hydroxysphingoid base(1-)
type: Concept
broader: organic molecular entity

bhas#1(1-)
type: Concept
broader: organic molecular entity

Tetrahydrobiopterin-4a-carbinolamine
type: Concept
broader: organic molecular entity

beta-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine
type: Concept
broader: organic molecular entity

bhos#34(1-)
type: Concept
broader: organic molecular entity

Bisbentiamine
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

4-pentynoyl-Coenzyme A
type: Concept
broader: organic molecular entity

acid anhydride
type: Concept
broader: organic molecular entity

7MeG5'-ppp5'ACCCCC
type: Concept
broader: organic molecular entity

Nicarbazin
type: Concept
broader: organic molecular entity

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
type: Concept
broader: organic molecular entity

1-myristoyl-sn-glycero-2,3-cyclic-phosphate(1-)
type: Concept
broader: organic molecular entity

magnesium-25(2+)
type: Concept
broader: organic molecular entity

Fursultiamine hydrochloride
type: Concept
broader: organic molecular entity

DPLA
type: Concept
broader: organic molecular entity

KFP-CGHB1W4F-3
type: Concept
preferred label: beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(3-)
broader: organic molecular entity

bhos#28(1-)
type: Concept
broader: organic molecular entity

KFP-GHXGZHDP-C
type: Concept
preferred label: beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(3-)
broader: organic molecular entity

3'-hydroxyflavone
type: Concept
broader: organic molecular entity

bhos#20-CoA
type: Concept
broader: organic molecular entity

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N- glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(1-)
type: Concept
broader: organic molecular entity

N-(4-Aminobutylidene)-[eIF5A-precursor]-lysine
type: Concept
broader: organic molecular entity

Fluocinonide
type: Concept
broader: organic molecular entity

prochaetoglobosin III
type: Concept
broader: organic molecular entity

KFP-JM9TRFS4-4
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

Met-Xaa
type: Concept
broader: organic molecular entity

KFP-MTK56XJ6-L
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
broader: organic molecular entity

Ranatensin
type: Concept
broader: organic molecular entity

KFP-NXTL8MJL-3
type: Concept
preferred label: alpha-N-acetylneuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

C-terminal amino acid- phosphatidylserine amidated glycine residue(2-)
type: Concept
broader: organic molecular entity

Buserelin acetate
type: Concept
broader: organic molecular entity

Cer(d16:1(4E)(1OH,3OH)(15Me)/17:0(2OH[R]))
type: Concept
broader: organic molecular entity

Lewis A antigen
type: Concept
broader: organic molecular entity

GlcNAc-beta1,3-Gal-R
type: Concept
broader: organic molecular entity

(-)-variculatriene B
type: Concept
broader: organic molecular entity

KFP-B6L76J19-9
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

Calcium formate
type: Concept
broader: organic molecular entity

KFP-QRL55JCG-2
type: Concept
preferred label: beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(3-)
broader: organic molecular entity

Calcium iodide
type: Concept
broader: organic molecular entity

Endokinin C
type: Concept
broader: organic molecular entity

beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)-[beta-D-Gal-(1->3)]-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine
type: Concept
broader: organic molecular entity

KFP-DDQ1CF87-P
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

6-Thioguanosine diphosphate(3-)
type: Concept
broader: organic molecular entity

phosphoethanolamine-glycosyl-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-2-acyl-inositol zwitterion
type: Concept
broader: organic molecular entity

bhos#34-CoA(4-)
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-beta-D-galactosyldiacylglycerol
type: Concept
broader: organic molecular entity

rubidium-85(1+)
type: Concept
broader: organic molecular entity

dPreQ0
type: Concept
broader: organic molecular entity

1-salicylate O-glucuronide(1-)
type: Concept
broader: organic molecular entity

KFP-JBJG81P3-W
type: Concept
preferred label: alpha-N-acetylneuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

tetracosanoyl carnitine
type: Concept
broader: organic molecular entity

1-radyl-2-acyl-sn-glycerolipid
type: Concept
broader: organic molecular entity

alpha-N-acetylneuraminosyl-(2->6)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
type: Concept
broader: organic molecular entity

Proadrenomedullin N-terminal 20 peptide
type: Concept
broader: organic molecular entity

bhas#28-CoA(4-)
type: Concept
broader: organic molecular entity

KFP-KSLHR8G3-G
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

Penflutizide
type: Concept
broader: organic molecular entity

Sepiolite
type: Concept
broader: organic molecular entity

5-BROMOVINYLDEOXYURIDINE
type: Concept
broader: organic molecular entity

KFP-MVBSRRVC-0
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
broader: organic molecular entity

Type 1 monosialylgalactosylgloboside
type: Concept
broader: organic molecular entity

Ponceau SX
type: Concept
broader: organic molecular entity

(R)-3-Hydroxyhexanoyl-[acp]
type: Concept
broader: organic molecular entity

KFP-VHS08X2V-L
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

KFP-WD622N5J-B
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
broader: organic molecular entity

lithocholate-3-O-beta-D-glucoside(1-)
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

N(1)-(3,4-dihydroxybenzoyl)-N(8)-citryl-spermidine (1-)
type: Concept
broader: organic molecular entity

SO3-3-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

alpha-D-Gal-(1->3)-alpha-D-Gal-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine
type: Concept
broader: organic molecular entity

organic molecule
type: Concept
broader: organic molecular entity

BPC
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
type: Concept
broader: organic molecular entity

Kemptide
type: Concept
broader: organic molecular entity

KFP-XTR513T5-H
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

aspergildiene B
type: Concept
broader: organic molecular entity

9-Hydroxy-3,5,7,11,13,15,17,19-nonaoxo-eicosanoyl-[acp]
type: Concept
broader: organic molecular entity

ascr#32-CoA
type: Concept
broader: organic molecular entity

2,2',2''-((2R,5R,8S,11R)-11-((2R,4S,5E,7E,9E)-2,4-dihydroxypentadeca-5,7,9-trien-1-yl)-3,6,9,13,17-pentaoxo-1,4,7,10,14-pentaazacycloheptadecane-2,5,8-triyl)triacetamide
type: Concept
broader: organic molecular entity

methylated enzyme bound BLM intermediate
type: Concept
broader: organic molecular entity

alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphingosine
type: Concept
broader: organic molecular entity

bhas#10-CoA
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
type: Concept
broader: organic molecular entity

4-(N-Maleimido)benzyltrimethylammonium iodide
type: Concept
broader: organic molecular entity

KFP-JTKS3KX3-B
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

Sulfuric monoester
type: Concept
broader: organic molecular entity

cochliodinol
type: Concept
broader: organic molecular entity

syringylglycerol
type: Concept
broader: organic molecular entity

KFP-J2S3MG0D-M
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

Cyclofenil
type: Concept
broader: organic molecular entity

Cer(d16:1(4E)(1OH,3OH)(15Me)/28:0(2OH[R]))
type: Concept
broader: organic molecular entity

Potassium bis(2-hydroxyethyl)dithiocarbamate
type: Concept
broader: organic molecular entity

KFP-CVNNTP14-F
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

bkos#26-CoA(4-)
type: Concept
broader: organic molecular entity

ascr#18-CoA
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
type: Concept
broader: organic molecular entity

bhos#18-CoA(4-)
type: Concept
broader: organic molecular entity

KFP-H3DCX1C3-L
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(4-)
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
type: Concept
broader: organic molecular entity

Cortistatin-29
type: Concept
broader: organic molecular entity

D-mannose-(alpha1->2)-D-mannose-(alpha1->6)-D-mannose-(alpha1->4)-D-glucosaminyl-(alpha1->6)-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-2-acyl-inositol zwitterion
type: Concept
broader: organic molecular entity

Kisspeptin-13
type: Concept
broader: organic molecular entity

olefinic compound
type: Concept
broader: organic molecular entity

Morfamquat
type: Concept
broader: organic molecular entity

N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

KFP-ZZR6C4CM-8
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(4-)
broader: organic molecular entity

KFP-PL883CF9-W
type: Concept
preferred label: N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

alpha-D-GalNAc-(1->3)-(alpha-L-Fuc-(1->2))-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1)-N-acylsphinganine
type: Concept
broader: organic molecular entity

KFP-MG30T6JN-9
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
type: Concept
broader: organic molecular entity

[Cytochrome c] S-methionine
type: Concept
broader: organic molecular entity

bkas#26-CoA(4-)
type: Concept
broader: organic molecular entity

Diacylglycerylhomoserine
type: Concept
broader: organic molecular entity

bhos#30-CoA(4-)
type: Concept
broader: organic molecular entity

Thyroglobulin L-tyrosine
type: Concept
broader: organic molecular entity

C8 beta-D-glucosyl N-acylsphingosine
type: Concept
broader: organic molecular entity

galanthamine Trifluoroacetic acid
type: Concept
broader: organic molecular entity

3-mercaptolactic acid-cysteine disulfide
type: Concept
broader: organic molecular entity

alpha-D-Gal-(1->3)-(alpha-L-Fuc-(1->2))-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphingosine
type: Concept
broader: organic molecular entity

Rokitamycin
type: Concept
broader: organic molecular entity

Sodium chondroitin sulfate
type: Concept
broader: organic molecular entity

pestalodiol
type: Concept
broader: organic molecular entity

Cefoxitin sodium
type: Concept
broader: organic molecular entity

HexCer(d16:1(4E,15Me)/24:0(OH))
type: Concept
broader: organic molecular entity

beta-Hydroxy-L-tyrosyl-[pcp]
type: Concept
broader: organic molecular entity

bkas#9
type: Concept
broader: organic molecular entity

perlolyrine
type: Concept
broader: organic molecular entity

Urotensin I
type: Concept
broader: organic molecular entity

4-Substituted anilide
type: Concept
broader: organic molecular entity

KFP-N6XFK974-X
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

N(5)-[(S)-citryl]-D-ornithine(2-)
type: Concept
broader: organic molecular entity

Ricin
type: Concept
broader: organic molecular entity

Kisspeptin-14
type: Concept
broader: organic molecular entity

6-Benzyl-4-isopropyl-1-hydroxypyridin-2(1H)-one
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)
type: Concept
broader: organic molecular entity

bkos#22-CoA
type: Concept
broader: organic molecular entity

PC (O-16:0/4:1)
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
type: Concept
broader: organic molecular entity

Nec-1s
type: Concept
broader: organic molecular entity

Dinoprost tromethamine
type: Concept
broader: organic molecular entity

alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(1-)
type: Concept
broader: organic molecular entity

icas#10(1-)
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
type: Concept
broader: organic molecular entity

KFP-KTB0MV8D-N
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(3-)
broader: organic molecular entity

N-[12-[(7-Nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-ceramide
type: Concept
broader: organic molecular entity

aspergildiene A
type: Concept
broader: organic molecular entity

KFP-SN7XXCXH-Z
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

KFP-FB2HL9P4-2
type: Concept
preferred label: beta-D-galactosyl-(1->4)-N-acetyl-beta-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

Mercuric oxide
type: Concept
broader: organic molecular entity

Protein L-selenocysteine
type: Concept
broader: organic molecular entity

sodium(E)-((1R,4aS,4bS,8aS,10aS)-4b,8,8,10a-tetramethyl-1-(2-(2-oxo-2,5-dihydro-1H-pyrrol-3-yl)ethyl)decahydrophenanthren-2(1H,3H,4bH)-ylidene)methyl sulfate
type: Concept
broader: organic molecular entity

RI
type: Concept
broader: organic molecular entity

bkas#20
type: Concept
broader: organic molecular entity

bhas#32-CoA(4-)
type: Concept
broader: organic molecular entity

KFP-R77VSZB5-V
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

alpha-D-glucosaminyl-(1->6)-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-2-acyl-inositol zwitterion
type: Concept
broader: organic molecular entity

5-Hydroxy-guaiacyl lignin
type: Concept
broader: organic molecular entity

ascr#30(1-)
type: Concept
broader: organic molecular entity

variculatriene A
type: Concept
broader: organic molecular entity

N-acyl-1-O-alkyl-2-acyl-sn-glycero-3-phosphoethanolamine(1-)
type: Concept
broader: organic molecular entity

KFP-LLX6G86S-4
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-galactosaminyl-(1->4)-[alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(3-)
broader: organic molecular entity

KFP-T4LH9NF4-H
type: Concept
preferred label: beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(2-)
broader: organic molecular entity

Ophiopogonin C
type: Concept
broader: organic molecular entity

1-octanoyl-sn-glycero-2,3-cyclic-phosphate(1-)
type: Concept
broader: organic molecular entity

Neuromedin N
type: Concept
broader: organic molecular entity

3,5,7,11,13,15-Heptaoxo-9-hydroxy-octadecanoyl-[acp]
type: Concept
broader: organic molecular entity

KFP-H98J3K65-N
type: Concept
preferred label: alpha-N-acetylneuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

variediene
type: Concept
broader: organic molecular entity

sodium(E)-((1R,4aS,4bS,8aS,10aS)-1-(2-((S)-5-methoxy-2-oxo-2,5-dihydrofuran-3-yl)ethyl)-4b,8,8,10a-tetramethyldecahydrophenanthren-2(1H,3H,4bH)-ylidene)methyl sulfate
type: Concept
broader: organic molecular entity

1,2-dihexanoyl-3-oleoyl-sn-glycerol
type: Concept
broader: organic molecular entity

KFP-L1P3JRW9-4
type: Concept
preferred label: alpha-L-fucosyl-(1->3)-[beta-D-galactosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

4-deoxy-6-O-methyl-L-threo-hex-4-enopyranuronate
type: Concept
broader: organic molecular entity

KFP-NZT8SB5W-J
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

3,5,7,11,13,15-Heptaoxo-9-hydroxy-hexadecanoyl-[acp]
type: Concept
broader: organic molecular entity

Protein N6-(octanoyl)lysine
type: Concept
broader: organic molecular entity

ascr#30-CoA(4-)
type: Concept
broader: organic molecular entity

cis-9,10-methylenehexadecanoic acid
type: Concept
broader: organic molecular entity

Cer(d16:1(4E)(1OH,3OH)(15Me)/20:0(2OH[R]))
type: Concept
broader: organic molecular entity

KFP-SG18QR8Q-W
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

glucosylceramide (d18:1/24:0)
type: Concept
broader: organic molecular entity

2-azelaoyl-sn-glycero-3-phosphocholine(1-)
type: Concept
broader: organic molecular entity

N-arachidonoylethanolamine phosphate(2-)
type: Concept
broader: organic molecular entity

KFP-SH9ZK1FR-R
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

bhos#30-CoA
type: Concept
broader: organic molecular entity

(1S,8aS)-octahydroindolizin-1-ol(1+)
type: Concept
broader: organic molecular entity

beta-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N- glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
type: Concept
broader: organic molecular entity

(14E,18E)-lycopadiene
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

33-Deoxy-33-hydroperoxyfurohyperforin
type: Concept
broader: organic molecular entity

Floctafenine
type: Concept
broader: organic molecular entity

KFP-FSD7D0W1-Q
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

KFP-LKZCJC6T-1
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
type: Concept
broader: organic molecular entity

KFP-NFVRS6B4-S
type: Concept
preferred label: beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

KFP-CJNJD563-R
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

Thyroglobulin 3,5-diiodotyrosine
type: Concept
broader: organic molecular entity

KFP-ZC86MB8T-0
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

dl-Methylephedrine hydrochloride
type: Concept
broader: organic molecular entity

ascr#19-CoA
type: Concept
broader: organic molecular entity

KFP-X6V4XJPN-K
type: Concept
preferred label: N-acetyl-alpha-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-alpha-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

Pyrantel pamoate
type: Concept
broader: organic molecular entity

C-terminal amide O-palmitoyl-L-threonine residue
type: Concept
broader: organic molecular entity

3-O-sulfo-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(3-O-sulfo)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
type: Concept
broader: organic molecular entity

Sucralfate
type: Concept
broader: organic molecular entity

BRD proteins degrader
type: Concept
broader: organic molecular entity

Fibrinogen binding inhibitor peptide
type: Concept
broader: organic molecular entity

KFP-XVXWNJLX-8
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
broader: organic molecular entity

KFP-B1X0C0P7-S
type: Concept
preferred label: alpha-D-galactosyl-(1->4)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine
broader: organic molecular entity

Pamicogrel
type: Concept
broader: organic molecular entity

N,N-Diethyl-2-[4-[6-methoxy-2-(4-methoxyphenyl)-1H-inden-3-yl]phenoxy]ethanamine hydrochloride
type: Concept
broader: organic molecular entity

teicoplanin A3
type: Concept
broader: organic molecular entity

KFP-T76HQ7ZM-S
type: Concept
preferred label: beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
broader: organic molecular entity

Nocistatin
type: Concept
broader: organic molecular entity

ECO 02301
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
type: Concept
broader: organic molecular entity

Feprazone
type: Concept
broader: organic molecular entity

Monocyte locomotion inhibitory factor
type: Concept
broader: organic molecular entity

alpha-L-Fuc-(1->2)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
type: Concept
broader: organic molecular entity

(3AS,4R,5S,6S,8R,9R,9AR,10R)-5-HYDROXY-4,6,9,10-TETRAMETHYL-1-OXO-6-VINYLDECAHYDRO-3A,9-PROPANOCYCLOPENTA[8]ANNULEN-8-YL {[(3-EXO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL]THIO}ACETATE
type: Concept
broader: organic molecular entity

melinacidin IV
type: Concept
broader: organic molecular entity

beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)-[beta-D-Gal-(1->3)]-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

m-Benzenesulfonium diazonium chloride
type: Concept
broader: organic molecular entity

Nicomol
type: Concept
broader: organic molecular entity

Cytochrome cL
type: Concept
broader: organic molecular entity

N2-Acylated Arg-CH2Cl
type: Concept
broader: organic molecular entity

Epitiostanol
type: Concept
broader: organic molecular entity

Acid amide
type: Concept
broader: organic molecular entity

bhas#14-CoA
type: Concept
broader: organic molecular entity

alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(3-)
type: Concept
broader: organic molecular entity

ascr#28-CoA(4-)
type: Concept
broader: organic molecular entity

bkos#18-CoA(4-)
type: Concept
broader: organic molecular entity

Procaine hydrochloride
type: Concept
broader: organic molecular entity

KFP-W8GBX6DN-5
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

rac-3'-hydroxy-N,N-dimethylcoclaurinium trifluoroacetate
type: Concept
broader: organic molecular entity

alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
type: Concept
broader: organic molecular entity

ascr#12-CoA(4-)
type: Concept
broader: organic molecular entity

crinamabine Trifluoroacetic acid
type: Concept
broader: organic molecular entity

Serine protease NS3
type: Concept
broader: organic molecular entity

linoleoyl containing 1,2,3-triacyl-sn-glycerol
type: Concept
broader: organic molecular entity

Big endothelin
type: Concept
broader: organic molecular entity

Phenylpropanol
type: Concept
broader: organic molecular entity

KFP-DV66R7WR-6
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-)
broader: organic molecular entity

KFP-H7PB17L3-Z
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
broader: organic molecular entity

cobalt-59(3+)
type: Concept
broader: organic molecular entity

Dynorphin B
type: Concept
broader: organic molecular entity

KFP-R0CW2XXV-V
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-Fuc-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

trimethyl(octadecyl)silane
type: Concept
broader: organic molecular entity

(8E,10E,12E)-3,5,7-trihydroxyoctadeca-8,10,12-trienal
type: Concept
broader: organic molecular entity

methylthiourea
type: Concept
broader: organic molecular entity

KFP-CQJ7Q3J8-H
type: Concept
preferred label: beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

1-oleoyl-2-acyl-sn-glycero-3-phosphoglycerol(1-)
type: Concept
broader: organic molecular entity

beta-D-GlcNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

ascr#18(1-)
type: Concept
broader: organic molecular entity

bkas#34(1-)
type: Concept
broader: organic molecular entity

KFP-FPVHSNNQ-Z
type: Concept
preferred label: alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-[alpha-N-acetylneuraminosyl-(2->6)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)
broader: organic molecular entity

N,N-Bis(2-chloroethyl)-DL-alanine hydrochloride
type: Concept
broader: organic molecular entity

Di-2,5-cyclohexadien-1-ylsilane
type: Concept
broader: organic molecular entity

ascr#24(1-)
type: Concept
broader: organic molecular entity

KFP-TF3JS86H-4
type: Concept
preferred label: beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

KFP-XZ20RH0Q-R
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

bkas#22-CoA
type: Concept
broader: organic molecular entity

nickel-60(2+)
type: Concept
broader: organic molecular entity

6 thioguanosine triphosphate(4-)
type: Concept
broader: organic molecular entity

Tenatoprazole
type: Concept
broader: organic molecular entity

bhas#1
type: Concept
broader: organic molecular entity

Ethyl icosapentate
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

Naphazoline
type: Concept
broader: organic molecular entity

KFP-NF3G148M-L
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

Iocarmic acid
type: Concept
broader: organic molecular entity

Cer(d16:1(4E)(1OH,3OH)(15Me)/19:0(2OH[R]))
type: Concept
broader: organic molecular entity

salicylic acyl beta-D-glucuronide (1-)
type: Concept
broader: organic molecular entity

1,5-Dicaffeoylquinic acid
type: Concept
broader: organic molecular entity

KFP-PBNHWRV0-J
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(4-)
broader: organic molecular entity

beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-(1->6)-[beta-D-Gal-(1->3)]-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

ascr#13-CoA
type: Concept
broader: organic molecular entity

Met-enkephalin-Arg-Gly-Leu
type: Concept
broader: organic molecular entity

S-Alkyl-thiohydroximate
type: Concept
broader: organic molecular entity

HA Peptide
type: Concept
broader: organic molecular entity

ascr#7(1-)
type: Concept
broader: organic molecular entity

dehydroprobetaenone I
type: Concept
broader: organic molecular entity

1,2-DIACYL-SN-GLYCERO-3-PHOSHOCHOLINE
type: Concept
broader: organic molecular entity

1,2-didodecanoyl-sn-glycero-3-phosphoethanolamine
type: Concept
broader: organic molecular entity

KFP-S7KCCVQB-8
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

bhas#28-CoA
type: Concept
broader: organic molecular entity

aliphatic compound
type: Concept
broader: organic molecular entity

KFP-HF04RB8G-B
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)
broader: organic molecular entity

pseudopaline(2-)
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
type: Concept
broader: organic molecular entity

Nonaketamide tricyclic intermediate
type: Concept
broader: organic molecular entity

molybdenum-98(6+)
type: Concept
broader: organic molecular entity

Enzyme bound ZBM intermediate
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

Translation Initiation Targets
type: Concept
broader: organic molecular entity

penochalasin A
type: Concept
broader: organic molecular entity

KFP-B9QV3PV5-P
type: Concept
preferred label: N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

Long-chain ester
type: Concept
broader: organic molecular entity

MPLA
type: Concept
broader: organic molecular entity

organic fundamental parent
type: Concept
broader: organic molecular entity

KFP-Q6NP1VBS-1
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

5,10-methylenetetrahydrosulfopterin
type: Concept
broader: organic molecular entity

3-Oxooctanoyl-[acp]
type: Concept
broader: organic molecular entity

Fenaminosulf
type: Concept
broader: organic molecular entity

H3K27Me3
type: Concept
broader: organic molecular entity

dG+ monophosphate
type: Concept
broader: organic molecular entity

bhas#10-CoA(4-)
type: Concept
broader: organic molecular entity

KFP-XSW5X9MK-B
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

bhos#12
type: Concept
broader: organic molecular entity

beta-Neoendorphin
type: Concept
broader: organic molecular entity

bkas#30-CoA(4-)
type: Concept
broader: organic molecular entity

Protizinic acid
type: Concept
broader: organic molecular entity

sodium(E)-((1R,4aS,4bS,8aS,10aS)-1-(2-((2S,5R)-2,5-dimethoxy-2,5-dihydrofuran-3-yl)ethyl)-4b,8,8,10a-tetramethyldecahydrophenanthren-2(1H,3H,4bH)-ylidene)methyl sulfate
type: Concept
broader: organic molecular entity

pentaglutamyl folate
type: Concept
broader: organic molecular entity

Non-structural protein 4A
type: Concept
broader: organic molecular entity

Adrenomedullin 2
type: Concept
broader: organic molecular entity

F420(ox.)
type: Concept
broader: organic molecular entity

Trichlormethine
type: Concept
broader: organic molecular entity

KFP-MV34882J-V
type: Concept
preferred label: alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-(alpha-L-fucosyl-(1->3))-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

pentyl dodecanoate
type: Concept
broader: organic molecular entity

Protein Nomega-Methyl-L-arginine
type: Concept
broader: organic molecular entity

Enzyme N6-(dihydrolipoyl)lysine
type: Concept
broader: organic molecular entity

Interferon gamma-1b
type: Concept
broader: organic molecular entity

13(R)-HODE(1-)
type: Concept
broader: organic molecular entity

quercetin 3-O-(6"malonyl)-B-D-glucoside
type: Concept
broader: organic molecular entity

4-amino-5-hydroxy-3-all-trans-hexaprenylbenzoate
type: Concept
broader: organic molecular entity

(3-((3R,5R,7S,8E,10E,12E)-3-amino-5-hydroxy-7-methoxyoctadeca-8,10,12-trienamido)propanoyl)-D-asparaginyl-D-asparagine
type: Concept
broader: organic molecular entity

N7-meGpppG
type: Concept
broader: organic molecular entity

KFP-HGPJRRC1-X
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-)
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
type: Concept
broader: organic molecular entity

1-palmitoyl-sn-glycero-2,3-cyclic-phosphate(1-)
type: Concept
broader: organic molecular entity

KFP-K3KX9ZBX-9
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

KFP-D1L0JCQQ-4
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)
broader: organic molecular entity

Vasoactive intestinal peptide
type: Concept
broader: organic molecular entity

ascr#33-CoA
type: Concept
broader: organic molecular entity

N-Acyl-O-acetylneuraminate
type: Concept
broader: organic molecular entity

cis-9,10-methylenehexadecanoyl-CoA(4-)
type: Concept
broader: organic molecular entity

C-peptide
type: Concept
broader: organic molecular entity

Proscillaridin
type: Concept
broader: organic molecular entity

Neuropeptide GE
type: Concept
broader: organic molecular entity

Cys-Met thioether
type: Concept
broader: organic molecular entity

KFP-ZFKKD2M9-1
type: Concept
preferred label: alpha-L-fucosyl-(1->3)-[beta-D-galactosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

N-(ultra-long-chain-acyl)-sphingoid base
type: Concept
broader: organic molecular entity

Lipomannan
type: Concept
broader: organic molecular entity

7(S)-hydroperoxy-17(S)-hydroxydocosahexaenoic acid
type: Concept
broader: organic molecular entity

(Z)-2-((N-methylformamido)methylene)-5-hydroxybutanolactone
type: Concept
broader: organic molecular entity

(1S,10aS)-3-(CONH2)-1-(Me2N)-3,3a,4,6-(HO)4-2,5-dioxo-1H,10aH,11H,11aH-cyclopenta[b]anthracene
type: Concept
broader: organic molecular entity

N-Formylderivatives
type: Concept
broader: organic molecular entity

KFP-Z8XDS0M3-4
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

DL-epinastine hydrochloride
type: Concept
broader: organic molecular entity

ascr#35-CoA
type: Concept
broader: organic molecular entity

isoheptadecanoyl carnitine
type: Concept
broader: organic molecular entity

bkas#36-CoA
type: Concept
broader: organic molecular entity

alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-[alpha-NeuAc-(2->6)]-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine
type: Concept
broader: organic molecular entity

alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
type: Concept
broader: organic molecular entity

alpha-NeuAc-(2->6)-(alpha-NeuAc-(2->3))-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphingosine
type: Concept
broader: organic molecular entity

Calcium sulfide
type: Concept
broader: organic molecular entity

6-thiodeoxyguanosine triphosphate (4-)
type: Concept
broader: organic molecular entity

Pentetreotide
type: Concept
broader: organic molecular entity

(+)-8-O-demethylmaritidine Trifluoroacetic acid
type: Concept
broader: organic molecular entity

Aflatoxin B1 exo-N-acetylcysteine conjugate
type: Concept
broader: organic molecular entity

[Myeline basic protein] N-methyl-L-arginine
type: Concept
broader: organic molecular entity

Paracetamol-Cys-Gly conjugate
type: Concept
broader: organic molecular entity

(+)-premalbrancheamide(1+)
type: Concept
broader: organic molecular entity

Granuliberin R
type: Concept
broader: organic molecular entity

Gla protein precursor
type: Concept
broader: organic molecular entity

3-Oxostearoyl-[acp]
type: Concept
broader: organic molecular entity

1-O-(1Z-hexadecenyl)-2-(5-hydroxyvaleroyl)-sn-glycero-3-phosphocholine
type: Concept
broader: organic molecular entity

KFP-C4MJPVM3-L
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(3-)
broader: organic molecular entity

ascr#35(1-)
type: Concept
broader: organic molecular entity

chetracin A
type: Concept
broader: organic molecular entity

amicoumacin A 2-phosphate(1-)
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
type: Concept
broader: organic molecular entity

Hydroxymalonyl-[acp]
type: Concept
broader: organic molecular entity

Magnesium L-ascorbic acid-2-phosphate
type: Concept
broader: organic molecular entity

Ternatin 4 (DA3)
type: Concept
broader: organic molecular entity

ascr#21(1-)
type: Concept
broader: organic molecular entity

SRA12
type: Concept
broader: organic molecular entity

bkos#30-CoA(4-)
type: Concept
broader: organic molecular entity

Cer(d16:1(4E)(1OH,3OH)(15Me)/16:0(2OH[R]))
type: Concept
broader: organic molecular entity

Carmoisine
type: Concept
broader: organic molecular entity

Thrombin
type: Concept
broader: organic molecular entity

KFP-PPQB25M5-Q
type: Concept
preferred label: N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine
type: Concept
broader: organic molecular entity

(2S)-3-(1H-indol-3-yl)-2-isocyanopropanoate
type: Concept
broader: organic molecular entity

a ring-opened 7-methylguanine in DNA
type: Concept
broader: organic molecular entity

Benexate hydrochloride
type: Concept
broader: organic molecular entity

Radium-226
type: Concept
broader: organic molecular entity

Isometamidium chloride
type: Concept
broader: organic molecular entity

Timnodonyl carnitine
type: Concept
broader: organic molecular entity

Perlapine
type: Concept
broader: organic molecular entity

KFP-PM476MSK-7
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)-[beta-D-Gal-(1->3)]-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphingosine
type: Concept
broader: organic molecular entity

Substance P
type: Concept
broader: organic molecular entity

KFP-RNM5SJD6-8
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

ascr#36(1-)
type: Concept
broader: organic molecular entity

bhas#30-CoA
type: Concept
broader: organic molecular entity

Lewis B antigen
type: Concept
broader: organic molecular entity

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N- glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
type: Concept
broader: organic molecular entity

Polyurethane foam
type: Concept
broader: organic molecular entity

Tofisopam
type: Concept
broader: organic molecular entity

bkos#16
type: Concept
broader: organic molecular entity

Phenanthroviridone aglycon
type: Concept
broader: organic molecular entity

KFP-TJZDWQ7B-L
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

ascr#32(1-)
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
type: Concept
broader: organic molecular entity

KFP-H302MVD9-J
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
broader: organic molecular entity

Blonanserin
type: Concept
broader: organic molecular entity

HexCer(d16:1(4E,15Me)/25:0(OH))
type: Concept
broader: organic molecular entity

bkas#34
type: Concept
broader: organic molecular entity

KFP-KVM7LDHV-Z
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->8)-alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

(3R,5R,7S,8E,10E,12E)-3-amino-5,7-dihydroxyoctadeca-8,10,12-trienoic acid
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

Berberine chloride (TN)
type: Concept
broader: organic molecular entity

bkos#24-CoA
type: Concept
broader: organic molecular entity

cyclo(1, 12)-Pen-K34-I-D-D-I30-T88-D-Y-I-S84-C-OH
type: Concept
broader: organic molecular entity

ethenzamide
type: Concept
broader: organic molecular entity

sulfur-34(4+)
type: Concept
broader: organic molecular entity

KFP-CD8F2J5V-B
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

SO3-3-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
type: Concept
broader: organic molecular entity

[N-(2,3-dihydroxybenzoyl)-L-seryl]2-N-(C-5-[deoxy-beta-D-glucosyl]-2,3-dihydroxybenzoyl)-L-serine
type: Concept
broader: organic molecular entity

Neuromedin S
type: Concept
broader: organic molecular entity

Iron-dextrin complex
type: Concept
broader: organic molecular entity

8-oxo-GMP(2-)
type: Concept
broader: organic molecular entity

KFP-ZGMNVV1Z-Z
type: Concept
preferred label: beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

Orexin A
type: Concept
broader: organic molecular entity

Endomorphin-2
type: Concept
broader: organic molecular entity

Prostaglandin A2-d4
type: Concept
broader: organic molecular entity

bkos#32
type: Concept
broader: organic molecular entity

bhos#12(1-)
type: Concept
broader: organic molecular entity

(2S)-2-ammonio-4-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]ammonio}butanoate
type: Concept
broader: organic molecular entity

alpha-L-Fuc-(1->2)-alpha-D-Gal-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphingosine
type: Concept
broader: organic molecular entity

norgalanthamine Trifluoroacetic acid
type: Concept
broader: organic molecular entity

monosodium urate
type: Concept
broader: organic molecular entity

KFP-GWVZ3P8J-K
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

Trichomycin
type: Concept
broader: organic molecular entity

Tripamide
type: Concept
broader: organic molecular entity

N-aryl-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine(1-)
type: Concept
broader: organic molecular entity

4,5-dihydro-6beta-hydroxy-20beta-dihydro-prednisolone
type: Concept
broader: organic molecular entity

KFP-XGV9RK93-S
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(3-)
broader: organic molecular entity

arsenic-75(3-)
type: Concept
broader: organic molecular entity

Leumorphin
type: Concept
broader: organic molecular entity

isoprenoid
type: Concept
broader: organic molecular entity

N(1)-(3,4-dihydroxybenzoyl)-N(8),N'(8)-citryl-bis(spermidine) (2+)
type: Concept
broader: organic molecular entity

KFP-VWF26CV2-1
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(3-)
broader: organic molecular entity

Phenbenzamine hydrochloride
type: Concept
broader: organic molecular entity

Dimetacrine tartrate
type: Concept
broader: organic molecular entity

4,9-anhydro-10-hemiketal-5-deoxyTTX
type: Concept
broader: organic molecular entity

Potassium 2,6-dihydroxytriazinecarboxylate
type: Concept
broader: organic molecular entity

2-PROPYLPENTANAMIDE
type: Concept
broader: organic molecular entity

SO3-6-O-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

KFP-HJLSFQDK-G
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(3-)
broader: organic molecular entity

(+)-malbrancheamide D(1+)
type: Concept
broader: organic molecular entity

IdoA2S-GlcNS6S trisaccharide
type: Concept
broader: organic molecular entity

KFP-RP9VZNWM-Q
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine
type: Concept
broader: organic molecular entity

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

2,6-Dichlorophenolindophenol sodium salt
type: Concept
broader: organic molecular entity

KFP-F38P9G8N-Q
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

bhos#9
type: Concept
broader: organic molecular entity

alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
type: Concept
broader: organic molecular entity

KFP-H4R8RN2T-3
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

KFP-QFN32ZG2-X
type: Concept
preferred label: beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(3-)
broader: organic molecular entity

alpha-N-Acetylneuraminyl-2,6-beta-D-galactosyl-1,4-N-acetyl-D-glucosaminyl-glycoprotein
type: Concept
broader: organic molecular entity

bhos#20(1-)
type: Concept
broader: organic molecular entity

alpha-N-glycoloylneuraminosyl-(2->8)-alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)
type: Concept
broader: organic molecular entity

KFP-S8VL9TP6-B
type: Concept
preferred label: N-acetyl-alpha-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

(+)-malbrancheamide(1+)
type: Concept
broader: organic molecular entity

KFP-N32H0QTJ-K
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

epivittatine Trifluoroacetic acid
type: Concept
broader: organic molecular entity

KFP-JN8M43DP-V
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
broader: organic molecular entity

4-(N-Maleimido)phenyltrimethylammonium iodide
type: Concept
broader: organic molecular entity

KFP-J86V1DMG-V
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(2-)
broader: organic molecular entity

Osutidine
type: Concept
broader: organic molecular entity

omega-linoleoyloxy-O-ultra-long chain acylceramide
type: Concept
broader: organic molecular entity

dTDP-6-deoxy-beta-L-talose(2-)
type: Concept
broader: organic molecular entity

SO3-3beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

Sodium iodate
type: Concept
broader: organic molecular entity

Propantheline chloride
type: Concept
broader: organic molecular entity

S-substituted L-cysteinylglycine zwitterion
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
type: Concept
broader: organic molecular entity

KFP-R7P6KN5D-B
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(2-)
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(1-)
type: Concept
broader: organic molecular entity

KFP-D3KC6ZD7-7
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

bkos#1
type: Concept
broader: organic molecular entity

hexadecadienoate
type: Concept
broader: organic molecular entity

E-Isohalidrysone A
type: Concept
broader: organic molecular entity

bkos#20-CoA(4-)
type: Concept
broader: organic molecular entity

Magainin 2
type: Concept
broader: organic molecular entity

Ml4Cer
type: Concept
broader: organic molecular entity

N6-Alkylaminopurine-9-beta-D-glucoside
type: Concept
broader: organic molecular entity

gamma-Endorphin
type: Concept
broader: organic molecular entity

chetoseminudin A
type: Concept
broader: organic molecular entity

Alkylnitrile
type: Concept
broader: organic molecular entity

cytidine 5'-{[hydroxy(2-hydroxyethyl)phosphonoyl]phosphate}(2-)
type: Concept
broader: organic molecular entity

S. pneumoniae serotype 18C CPS
type: Concept
broader: organic molecular entity

Oxendolone
type: Concept
broader: organic molecular entity

chaetocin B
type: Concept
broader: organic molecular entity

KFP-K5L5WPQN-J
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(3-)
broader: organic molecular entity

1-(4-METHOXYPHENYL)-7-OXO-6-[4-(2-OXOPIPERIDIN-1-YL)PHENYL]-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDINE-3-CARBOXAMIDE
type: Concept
broader: organic molecular entity

KFP-WL6MFSH2-7
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-Fuc-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

(4aR,10bS)-oxomaritidine(1+)
type: Concept
broader: organic molecular entity

KFP-S72B9TTK-N
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

beta-D-Glucuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminylproteoglycan
type: Concept
broader: organic molecular entity

3,5,7,9,11,13,15-Heptaoxo-hexadecanoyl-[acp]
type: Concept
broader: organic molecular entity

alpha-L-Fuc-(1->2)-[alpha-D-Gal-(1->3)]-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

Falecalcitriol
type: Concept
broader: organic molecular entity

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
type: Concept
broader: organic molecular entity

bhas#16-CoA
type: Concept
broader: organic molecular entity

4-HNEM
type: Concept
broader: organic molecular entity

KFP-MLCTPXN8-5
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(5-)
broader: organic molecular entity

Flupyrsulfuron-methyl sodium
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
type: Concept
broader: organic molecular entity

ascr#25(1-)
type: Concept
broader: organic molecular entity

vittatine Trifluoroacetic acid
type: Concept
broader: organic molecular entity

neoechinulin A
type: Concept
broader: organic molecular entity

Coal-tar pitch
type: Concept
broader: organic molecular entity

KFP-RZX2NCN3-R
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(1-)
broader: organic molecular entity

1'-Hydroxy-gamma-carotene glucoside ester
type: Concept
broader: organic molecular entity

KFP-H27J5Q07-K
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

Hexaflurate
type: Concept
broader: organic molecular entity

Phenelzine sulfate
type: Concept
broader: organic molecular entity

KFP-W6PMFPCV-S
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

KFP-MPFRXG5W-7
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

Caffeine-D9
type: Concept
broader: organic molecular entity

Medazepam
type: Concept
broader: organic molecular entity

1-[2-[4-(4-methoxyphenyl)piperazin-1-yl]ethyl]-N-methyl-3,4-dihydro-1H-isochromene-6-carboxamide
type: Concept
broader: organic molecular entity

Peptide 2-[3-carboxy-3-(dimethylammonio)propyl]-L-histidine
type: Concept
broader: organic molecular entity

imine
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
type: Concept
broader: organic molecular entity

Butylparaben
type: Concept
broader: organic molecular entity

Dexamethasone 17-propionate
type: Concept
broader: organic molecular entity

bhas#12(1-)
type: Concept
broader: organic molecular entity

dl-alpha-Tocopheryl sodium phosphate
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
type: Concept
broader: organic molecular entity

Mefruside
type: Concept
broader: organic molecular entity

RRR-ALPHA-TOCOPHERYLQUINONE
type: Concept
broader: organic molecular entity

Orexin B
type: Concept
broader: organic molecular entity

tellimagrandin II(1-)
type: Concept
broader: organic molecular entity

alpha-NeuAc-(2->6)-(alpha-NeuAc-(2->3))-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine
type: Concept
broader: organic molecular entity

Compound 77
type: Concept
broader: organic molecular entity

[Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(3-methylbutanoyl)dihydrolipoyllysine
type: Concept
broader: organic molecular entity

dotriacontatetraenoate
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(1-)
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)
type: Concept
broader: organic molecular entity

Ar4Cer
type: Concept
broader: organic molecular entity

N-aryl-1-palmitoyl-sn-glycero-3-phosphoethanolamine(1-)
type: Concept
broader: organic molecular entity

N-omega-hydroxyacylsphingosine
type: Concept
broader: organic molecular entity

Thioinosine
type: Concept
broader: organic molecular entity

KFP-C4WL60DB-6
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

6beta-hydroxy-20alpha-dihydro-prednisolone
type: Concept
broader: organic molecular entity

Methacycline hydrochloride
type: Concept
broader: organic molecular entity

Secretin
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

alpha-D-Gal-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N- acylsphingosine
type: Concept
broader: organic molecular entity

N-terminal trimethyl-alpha-amino-acid(1+) residue
type: Concept
broader: organic molecular entity

alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

KFP-SNHNFL20-J
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

KFP-NS9B1THS-K
type: Concept
preferred label: alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-(alpha-L-fucosyl-(1->3))-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

bhas#14
type: Concept
broader: organic molecular entity

Halazepam
type: Concept
broader: organic molecular entity

2'-DEOXYCOFORMYCIN
type: Concept
broader: organic molecular entity

cleisthantin derivative
type: Concept
broader: organic molecular entity

KFP-J18BG699-R
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

Motilin
type: Concept
broader: organic molecular entity

Fe(III)-{N-(2,3-dihydroxybenzoyl)-L-seryl-[N-(C-5-[deoxy-beta-D-glucosyl]-2,3-dihydroxybenzoyl)-L-serine]2}(4-)
type: Concept
broader: organic molecular entity

SO3-3beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

Protein glutamate methyl ester
type: Concept
broader: organic molecular entity

opacaline A
type: Concept
broader: organic molecular entity

KFP-R2R7C48M-P
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

Indolicidin
type: Concept
broader: organic molecular entity

bkos#28-CoA(4-)
type: Concept
broader: organic molecular entity

D-Ornithine hydrochloride
type: Concept
broader: organic molecular entity

KFP-B685RSXC-9
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

KFP-BH3PZZVK-N
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-alpha-[L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
type: Concept
broader: organic molecular entity

KFP-M7Q9WXF2-5
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide (d18:1(4E))(2-)
broader: organic molecular entity

Mas17
type: Concept
broader: organic molecular entity

KFP-WSW5V47V-K
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
broader: organic molecular entity

3-Decanoyl-[acyl-carrier protein]
type: Concept
broader: organic molecular entity

N(6)-[(2S,3R)-2-amino-8-carboxyoctan-3-yl]-L-lysine(1+) residue
type: Concept
broader: organic molecular entity

bkos#34(1-)
type: Concept
broader: organic molecular entity

betaenone B
type: Concept
broader: organic molecular entity

KFP-GHX118BL-9
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
broader: organic molecular entity

(S)-3-hydroxyhexacosanoyl-CoA(4-)
type: Concept
broader: organic molecular entity

phenylpropane
type: Concept
broader: organic molecular entity

bkos#38
type: Concept
broader: organic molecular entity

gamma-glutamyl-beta-cyanoalanine(1-)
type: Concept
broader: organic molecular entity

Relaxin-3
type: Concept
broader: organic molecular entity

Ester of phosphinic acid
type: Concept
broader: organic molecular entity

ascr#15-CoA
type: Concept
broader: organic molecular entity

KFP-JLZXGJ71-S
type: Concept
preferred label: N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-alpha-D-galactosaminyl-(1->3)-(alpha-L-fucosyl-(1->2))-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

2-glutaroyl-sn-glycero-3-phosphocholine(1-)
type: Concept
broader: organic molecular entity

KFP-DH7NH268-6
type: Concept
preferred label: alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

KFP-K9Q2415B-B
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

3-Oxotetradecanoyl-[acp]
type: Concept
broader: organic molecular entity

bhas#18(1-)
type: Concept
broader: organic molecular entity

KFP-GCDP6CV2-0
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

KFP-XWR02W3D-N
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
type: Concept
broader: organic molecular entity

alamethicin F50
type: Concept
broader: organic molecular entity

Cer(d16:1(4E)(1OH,3OH)(15Me)/27:0(2OH[R]))
type: Concept
broader: organic molecular entity

6 thiodeoxyguanosine diphosphate (3-)
type: Concept
broader: organic molecular entity

alpha-L-Fuc-(1->2)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E))
type: Concept
broader: organic molecular entity

INT-2
type: Concept
broader: organic molecular entity

alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-(beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4))-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E))
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

3-methyladenine DNA
type: Concept
broader: organic molecular entity

Guinea Green B
type: Concept
broader: organic molecular entity

KFP-H619NMGW-S
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

Mazaticol hydrochloride
type: Concept
broader: organic molecular entity

(S)-norcodamine(1+)
type: Concept
broader: organic molecular entity

Monanchocidin E, rel-
type: Concept
broader: organic molecular entity

KFP-PTJWCQQC-V
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
broader: organic molecular entity

Cadralazine
type: Concept
broader: organic molecular entity

KFP-T7VJ4T2L-Z
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

KFP-F2CL9L9Z-0
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

Cetrimide
type: Concept
broader: organic molecular entity

Methoxymalonyl-[acp]
type: Concept
broader: organic molecular entity

6-Thioinosine-5'-monophosphate(2-)
type: Concept
broader: organic molecular entity

CV 2961
type: Concept
broader: organic molecular entity

S-succinyl-L-cysteine(2-)
type: Concept
broader: organic molecular entity

KFP-JB7S27B4-7
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

Cyclamate
type: Concept
broader: organic molecular entity

Calcium L-aspartate
type: Concept
broader: organic molecular entity

chaetoglocin C
type: Concept
broader: organic molecular entity

N2-Acylated Lys-CH2Cl
type: Concept
broader: organic molecular entity

trans-Hex-2-enoyl-[acp]
type: Concept
broader: organic molecular entity

Ufenamate
type: Concept
broader: organic molecular entity

organic molecular entity
type: Concept
narrower: KFP-KCFRL2MB-5
narrower: Hypadil (TN)
narrower: bhas#9-CoA
narrower: Mannomustine dihydrochloride
narrower: KFP-SH9ZK1FR-R
narrower: Pronetalol hydrochloride
narrower: KFP-NLQLPJP8-6
narrower: Buccalin
narrower: beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
narrower: alpha-D-galactosyl-(1->4)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine
narrower: KFP-M4JTZDC6-7
narrower: alpha-N-acetylneuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
narrower: Sulfamethoxazole sodium
narrower: 5'-end (5'-triphosphoguanosine)-(2'-O-methyl-purine ribonucleoside)(3-) residue
narrower: KFP-FK6L6NNG-Z
narrower: Z-Isohalidrysone A
narrower: KFP-WSW5V47V-K
narrower: Opipramol hydrochloride
narrower: KFP-V0F9MQRH-9
narrower: ascr#32(1-)
narrower: bkos#16-CoA
narrower: KFP-MHTQ4LGW-S
narrower: KFP-C7744S98-R
narrower: bhas#24-CoA(4-)
narrower: (-)-latifolian A trifluoroacetate
narrower: (S)-norcodamine(1+)
narrower: KFP-DJVQ6WXF-D
narrower: bhos#1
narrower: ethenzamide
narrower: 2-glutaroyl-sn-glycero-3-phosphocholine(1-)
narrower: Hydroxymalonyl-[acp]
narrower: KFP-SN7XXCXH-Z
narrower: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
narrower: (S)-malyl alpha-D-glucosaminide(1-)
narrower: KFP-CNDTB2LN-T
narrower: (9R)-9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-9H,18H-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20-dione
narrower: D-glucosaminyl-(alpha1->6)-(1,2-diacyl-sn-glycero-3-phospho)-1D-myo-2-acyl-inositol zwitterion
narrower: sodium(E)-((1R,4aS,4bS,8aS,10aS)-1-(2-((2S,5R)-2,5-dimethoxy-2,5-dihydrofuran-3-yl)ethyl)-4b,8,8,10a-tetramethyldecahydrophenanthren-2(1H,3H,4bH)-ylidene)methyl sulfate
narrower: 4E2RCat
narrower: Interferon gamma-1b
narrower: Strobane
narrower: 7,9,12-Decaketide intermediate 3
narrower: N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine
narrower: ascr#25-CoA
narrower: 3-hydroxymonocarboxylic acid
narrower: Etizolam
narrower: KFP-D4X6KF8C-H
narrower: ascr#24(1-)
narrower: D-mannose-(alpha1->4)-D-glucosaminyl-(alpha1->6)-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-2-acyl-inositol zwitterion
narrower: KFP-BP527Q08-6
narrower: (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE
narrower: ascr#30-CoA
narrower: Calcitonin gene-related peptide 2
narrower: ECO 02301
narrower: KFP-H27J5Q07-K
narrower: 1,2-didodecanoyl-sn-glycero-3-phosphoethanolamine
narrower: Apafant
narrower: Pituitary adenylate cyclase-activating peptide-38
narrower: KFP-QKHHPBJ2-4
narrower: KFP-XF7T7BK7-T
narrower: KFP-BW12NBJ0-K
narrower: Tetracycline hydrochloride
narrower: KFP-TN1JW2Z4-4
narrower: alpha-L-Fuc-(1->2)-alpha-D-Gal-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine
narrower: S-myristoyl-L-cysteine group
narrower: KFP-N6XFK974-X
narrower: N-oleoylethanolamine phosphate(2-)
narrower: CHEBI:55478-chloramide
narrower: Sorivudine
narrower: Helospectin I
narrower: 1-salicylate O-glucuronide(1-)
narrower: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1<->1')-ceramide(d20:1(4E))(1-)
narrower: 3-Dimethylallyl-beta-hydroxy-L-tyrosyl-[pcp]
narrower: KFP-ZJHG0B12-5
narrower: cis-9,10-methylenehexadecanoyl-CoA(4-)
narrower: alpha-D-Gal-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine
narrower: Neuromedin C
narrower: ascr#12(1-)
narrower: alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)

Hypadil (TN)
type: Concept
broader: organic molecular entity

bhas#9-CoA
type: Concept
broader: organic molecular entity

Mannomustine dihydrochloride
type: Concept
broader: organic molecular entity

Pronetalol hydrochloride
type: Concept
broader: organic molecular entity

Buccalin
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->4)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine
type: Concept
broader: organic molecular entity

alpha-N-acetylneuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
type: Concept
broader: organic molecular entity

5'-end (5'-triphosphoguanosine)-(2'-O-methyl-purine ribonucleoside)(3-) residue
type: Concept
broader: organic molecular entity

KFP-FK6L6NNG-Z
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

Z-Isohalidrysone A
type: Concept
broader: organic molecular entity

KFP-V0F9MQRH-9
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

KFP-MHTQ4LGW-S
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

bhas#24-CoA(4-)
type: Concept
broader: organic molecular entity

(-)-latifolian A trifluoroacetate
type: Concept
broader: organic molecular entity

KFP-DJVQ6WXF-D
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-)
broader: organic molecular entity

bhos#1
type: Concept
broader: organic molecular entity

(S)-malyl alpha-D-glucosaminide(1-)
type: Concept
broader: organic molecular entity

KFP-CNDTB2LN-T
type: Concept
preferred label: beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

(9R)-9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-9H,18H-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20-dione
type: Concept
broader: organic molecular entity

D-glucosaminyl-(alpha1->6)-(1,2-diacyl-sn-glycero-3-phospho)-1D-myo-2-acyl-inositol zwitterion
type: Concept
broader: organic molecular entity

4E2RCat
type: Concept
broader: organic molecular entity

7,9,12-Decaketide intermediate 3
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine
type: Concept
broader: organic molecular entity

ascr#25-CoA
type: Concept
broader: organic molecular entity

3-hydroxymonocarboxylic acid
type: Concept
broader: organic molecular entity

KFP-D4X6KF8C-H
type: Concept
preferred label: beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(3-)
broader: organic molecular entity

D-mannose-(alpha1->4)-D-glucosaminyl-(alpha1->6)-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-2-acyl-inositol zwitterion
type: Concept
broader: organic molecular entity

KFP-BP527Q08-6
type: Concept
preferred label: beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(3-)
broader: organic molecular entity

(S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE
type: Concept
broader: organic molecular entity

ascr#30-CoA
type: Concept
broader: organic molecular entity

Calcitonin gene-related peptide 2
type: Concept
broader: organic molecular entity

Apafant
type: Concept
broader: organic molecular entity

Pituitary adenylate cyclase-activating peptide-38
type: Concept
broader: organic molecular entity

KFP-QKHHPBJ2-4
type: Concept
preferred label: beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(3-)
broader: organic molecular entity

KFP-XF7T7BK7-T
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(3-)
broader: organic molecular entity

KFP-BW12NBJ0-K
type: Concept
preferred label: beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

Tetracycline hydrochloride
type: Concept
broader: organic molecular entity

alpha-L-Fuc-(1->2)-alpha-D-Gal-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine
type: Concept
broader: organic molecular entity

S-myristoyl-L-cysteine group
type: Concept
broader: organic molecular entity

N-oleoylethanolamine phosphate(2-)
type: Concept
broader: organic molecular entity

CHEBI:55478-chloramide
type: Concept
broader: organic molecular entity

Sorivudine
type: Concept
broader: organic molecular entity

Helospectin I
type: Concept
broader: organic molecular entity

3-Dimethylallyl-beta-hydroxy-L-tyrosyl-[pcp]
type: Concept
broader: organic molecular entity

KFP-ZJHG0B12-5
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

alpha-D-Gal-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine
type: Concept
broader: organic molecular entity

Neuromedin C
type: Concept
broader: organic molecular entity

ascr#12(1-)
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

6'SLDN
type: Concept
broader: organic molecular entity

SP2509
type: Concept
broader: organic molecular entity

5S(6)-epoxy-18(R)-HEPE
type: Concept
broader: organic molecular entity

(N-Acetyl-beta-D-glucosaminyl-1,2)-alpha-D-mannosyl-1,3-(beta-N-acetyl-D-glucosaminyl-1,2-alpha-D-mannosyl-1,6)-beta-D-mannosyl-R
type: Concept
broader: organic molecular entity

mycofactocin
type: Concept
broader: organic molecular entity

Oxyntomodulin
type: Concept
broader: organic molecular entity

KFP-XF79X4LX-T
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-galactosaminyl-(1->4)-[alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(3-)
broader: organic molecular entity

KFP-C3JL3SR3-1
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

[Ribulose-1,5-bisphosphate-carboxylase]-N6-methyl-L-lysine
type: Concept
broader: organic molecular entity

alpha-D-Man-(1->6)-2-PEtn-alpha-D-Man-(1->4)-alpha-D-GlcN-(1->6)-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-2-acyl-inositol zwitterion
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

Talc
type: Concept
broader: organic molecular entity

KFP-HSBVTQWC-C
type: Concept
preferred label: D-mannose-(alpha1->2)-6-phosphoethanolamine-D-mannose-(alpha1->2)-D-mannose-(alpha1->6)-2-phosphoethanolamine-D-mannose-(alpha1->4)-D-glucosaminyl-(alpha1->6)-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-2-acyl-inositol zwitterion
broader: organic molecular entity

poly[(GA)]
type: Concept
broader: organic molecular entity

KFP-KG2TJNZM-J
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

Dimefline hydrochloride
type: Concept
broader: organic molecular entity

KFP-WV4HD193-4
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
broader: organic molecular entity

beta-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
type: Concept
broader: organic molecular entity

DNA without the base
type: Concept
broader: organic molecular entity

H3K27Ac
type: Concept
broader: organic molecular entity

L-Prolyl-[pcp]
type: Concept
broader: organic molecular entity

Methanetriol
type: Concept
broader: organic molecular entity

bhos#9-CoA(4-)
type: Concept
broader: organic molecular entity

inclisiran
type: Concept
broader: organic molecular entity

KFP-Z1X1HNXC-X
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(3-)
broader: organic molecular entity

Tryparedoxin
type: Concept
broader: organic molecular entity

CBS 113A
type: Concept
broader: organic molecular entity

KFP-MVWR187M-L
type: Concept
preferred label: beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(3-)
broader: organic molecular entity

Iodopsin
type: Concept
broader: organic molecular entity

cis-11,12-methyleneoctadecanoyl-CoA
type: Concept
broader: organic molecular entity

Iguratimod
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE
type: Concept
broader: organic molecular entity

Sulpyrine
type: Concept
broader: organic molecular entity

sulfur-34(6+)
type: Concept
broader: organic molecular entity

KFP-TMG65BXV-L
type: Concept
preferred label: beta-D-galactosyl-(1->4)-N-acetyl-beta-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

Urocortin II
type: Concept
broader: organic molecular entity

KFP-HHMWWVLG-M
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
broader: organic molecular entity

3-mercaptolactate-cysteine disulfide
type: Concept
broader: organic molecular entity

organometallic compound
type: Concept
broader: organic molecular entity

farrerol
type: Concept
broader: organic molecular entity

Cer(d16:1(4E)(1OH,3OH)(15Me)/18:0(2OH[R]))
type: Concept
broader: organic molecular entity

bhos#30(1-)
type: Concept
broader: organic molecular entity

10-deoxymethymycin(1+)
type: Concept
broader: organic molecular entity

Cer(d16:1(4E)(1OH,3OH)(15Me)/25:0(2OH[R]))
type: Concept
broader: organic molecular entity

SO3-3-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
type: Concept
broader: organic molecular entity

4-hydroxy-15-methylhexadecasphinganine-phosphocholine
type: Concept
broader: organic molecular entity

KFP-NDV4RW1B-Q
type: Concept
preferred label: alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-(alpha-L-fucosyl-(1->3))-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

HexCer(d16:1(4E,15Me)/21:0(OH))
type: Concept
broader: organic molecular entity

KFP-XTQ73S28-M
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

SO3-3beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

Hydroxychlorobactene glucoside ester
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
type: Concept
broader: organic molecular entity

Uroguanylin
type: Concept
broader: organic molecular entity

KFP-RLBR8M0V-3
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(2-)
broader: organic molecular entity

Arkin (TN)
type: Concept
broader: organic molecular entity

actinomycin X2
type: Concept
broader: organic molecular entity

KFP-TCSDSQJS-3
type: Concept
preferred label: alpha-N-acetylneuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

Phe-Trp-Asn
type: Concept
broader: organic molecular entity

Cellulose acetate phthalate
type: Concept
broader: organic molecular entity

Ranimustine
type: Concept
broader: organic molecular entity

KFP-MNWM5RC3-0
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(3-)
broader: organic molecular entity

Palmitoylphosphatidylcholine
type: Concept
broader: organic molecular entity

KFP-ST46KP2F-M
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

Cortistatin-17
type: Concept
broader: organic molecular entity

Leptin
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
type: Concept
broader: organic molecular entity

Pyrithiobac-sodium
type: Concept
broader: organic molecular entity

(3S)-3-Hydroxyacyl-N-acylthioethanolamine
type: Concept
broader: organic molecular entity

(5S)-hydroperoxy-(6E,8Z)-icosadienoate(1-)
type: Concept
broader: organic molecular entity

bkos#28
type: Concept
broader: organic molecular entity

Axenomycin
type: Concept
broader: organic molecular entity

alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-[alpha-NeuAc-(2->6)]-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

KFP-ZX61TXQS-V
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

KFP-V6WDHFDV-D
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
broader: organic molecular entity

Calcitonin gene-related peptide 1
type: Concept
broader: organic molecular entity

organic acid
type: Concept
broader: organic molecular entity

Loxiglumide
type: Concept
broader: organic molecular entity

KFP-M2CPQTFR-H
type: Concept
preferred label: beta-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

Cer(d16:0(15Me)/23:0)
type: Concept
broader: organic molecular entity

KFP-TK5K9483-P
type: Concept
preferred label: N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-alpha-D-galactosaminyl-(1->3)-(alpha-L-fucosyl-(1->2))-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

C-Protein
type: Concept
broader: organic molecular entity

bhos#9-CoA
type: Concept
broader: organic molecular entity

prostaglandin F2alpha-CoA(4-)
type: Concept
broader: organic molecular entity

Diacylglyceryl-N,N,N-trimethylhomoserine
type: Concept
broader: organic molecular entity

bhos#26-CoA
type: Concept
broader: organic molecular entity

Aminosalicylate sodium anhydrous
type: Concept
broader: organic molecular entity

KFP-F0NLRGNZ-V
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
broader: organic molecular entity

Wollastonite
type: Concept
broader: organic molecular entity

Thyroglobulin 3-Iodotyrosine
type: Concept
broader: organic molecular entity

Peroxidase
type: Concept
broader: organic molecular entity

SO3-3-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(1-)
type: Concept
broader: organic molecular entity

KFP-C8JF045J-G
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(1-)
broader: organic molecular entity

alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
type: Concept
broader: organic molecular entity

lipo-chitin oligosaccharide
type: Concept
broader: organic molecular entity

rac-N-methyllaudanosolinium trifluoroacetate
type: Concept
broader: organic molecular entity

RapaLink-1
type: Concept
broader: organic molecular entity

bkas#22-CoA(4-)
type: Concept
broader: organic molecular entity

beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E))
type: Concept
broader: organic molecular entity

Lewis X antigen
type: Concept
broader: organic molecular entity

osas#10(1-)
type: Concept
broader: organic molecular entity

ascr#5-CoA
type: Concept
broader: organic molecular entity

Aflatoxin B1 endo glutathione conjugate
type: Concept
broader: organic molecular entity

monocillin I
type: Concept
broader: organic molecular entity

Protein N6-(dihydrolipoyl)lysine
type: Concept
broader: organic molecular entity

KFP-FG13PNJD-9
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
broader: organic molecular entity

bhas#30-CoA(4-)
type: Concept
broader: organic molecular entity

alpha-D-Gal-(1->3)-alpha-D-Gal-(1->3)-alpha-D-Gal-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine
type: Concept
broader: organic molecular entity

KFP-NGGZN2WN-7
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

Carboxybiotinyl-[protein]
type: Concept
broader: organic molecular entity

bhas#34-CoA(4-)
type: Concept
broader: organic molecular entity

KFP-XHFN5XZX-K
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

Neuropeptide K
type: Concept
broader: organic molecular entity

sodium(2R,3R,Z)-9-(2,5-dihydroxyphenyl)-3,7-dimethyl-1-((1S,4aS,8aS)-2,5,5,8a-tetramethyl-1,4,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)non-7-en-2-yl sulfate
type: Concept
broader: organic molecular entity

3-Methyl-beta-keto-L-tyrosyl-[pcp]
type: Concept
broader: organic molecular entity

Ornoprostil
type: Concept
broader: organic molecular entity

KFP-ZMVQLPQ9-H
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

Coal tar creosote
type: Concept
broader: organic molecular entity

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N- glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
type: Concept
broader: organic molecular entity

dG+
type: Concept
broader: organic molecular entity

cadmium-111(2+)
type: Concept
broader: organic molecular entity

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)
type: Concept
broader: organic molecular entity

KFP-N4SX740H-1
type: Concept
preferred label: N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

bhas#9(1-)
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
type: Concept
broader: organic molecular entity

CholEsteryl BODIPY 542/563 C11
type: Concept
broader: organic molecular entity

Oxyfedrine hydrochloride
type: Concept
broader: organic molecular entity

KFP-BDX6NL8N-V
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
broader: organic molecular entity

KFP-KWSQF7X3-L
type: Concept
preferred label: beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

KFP-J0PXJH15-L
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(3-)
broader: organic molecular entity

Cer(d16:0(15Me)/25:0)
type: Concept
broader: organic molecular entity

4-hydroxy-15-methylhexadecasphinganine-phosphocholine(1+)
type: Concept
broader: organic molecular entity

Cer(d16:1(4E)(1OH,3OH)(15Me)/29:0(2OH[R]))
type: Concept
broader: organic molecular entity

KFP-N3CTT40T-X
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(3-)
broader: organic molecular entity

KFP-JMMLV8C2-4
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

prochaetoglobosin IV
type: Concept
broader: organic molecular entity

(1S,10S,10aS)-3-(CONH2)-9-Cl-1-(Me2N)-3,3a,4,10-(HO)4-10-Me-2,5-dioxo-1H,10aH,11H,11aH-cyclopenta[b]anthracen-6-olate
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
type: Concept
broader: organic molecular entity

3'-deoxy-3',4'-didehydro-CTP(4-)
type: Concept
broader: organic molecular entity

Clotiazepam
type: Concept
broader: organic molecular entity

Cholecystokinin-8
type: Concept
broader: organic molecular entity

iron dextran
type: Concept
broader: organic molecular entity

KFP-T4XJF275-K
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

9,14-Decaketide intermediate 1
type: Concept
broader: organic molecular entity

Reduced Vitamin K
type: Concept
broader: organic molecular entity

SO3-3beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1 (4E))
type: Concept
broader: organic molecular entity

SO3-3beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

KFP-L6HGB0R8-J
type: Concept
preferred label: beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

Prolactin-releasing peptide-31
type: Concept
broader: organic molecular entity

KFP-MFHJ5N8H-T
type: Concept
preferred label: N-acetyl-alpha-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

5'-end (5'-triphosphoguanosine)-(2'-O-methyl-guanosine)(3-) residue
type: Concept
broader: organic molecular entity

KFP-ZK6THGDT-S
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

[N-(C-5-[deoxy-beta-D-glucosyl]-2,3-dihydroxybenzoyl)-L-serine]3
type: Concept
broader: organic molecular entity

Krm 1657
type: Concept
broader: organic molecular entity

Oxapium iodide
type: Concept
broader: organic molecular entity

KFP-L5RJ8QH6-6
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

bhas#38-CoA(4-)
type: Concept
broader: organic molecular entity

chaetocin C
type: Concept
broader: organic molecular entity

KFP-J2ZX0V19-4
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

Flutoprazepam
type: Concept
broader: organic molecular entity

Aminomalonyl-[acp]
type: Concept
broader: organic molecular entity

9-Hydroxy-3,5,7,11,13,15,17,19-nonaoxo-docosanoyl-[acp]
type: Concept
broader: organic molecular entity

3-[(2S,9R,10R,11S,14R,15S)-14-Hydroxy-9-methoxycarbonyl-2,15-dimethyl-5-oxo-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadec-6-en-14-yl]propanoic acid
type: Concept
broader: organic molecular entity

Sarafotoxin S6b
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
type: Concept
broader: organic molecular entity

KFP-SGXVTN5K-V
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(2-)
broader: organic molecular entity

1-octanoyl-sn-glycero-3-phosphocholine zwitterion
type: Concept
broader: organic molecular entity

6-Benzyl-1-hydroxypyridin-2(1H)-one
type: Concept
broader: organic molecular entity

N-lauroyl-heptadecasphingosine-1-phosphoethanolamine zwitterion
type: Concept
broader: organic molecular entity

Bufferin
type: Concept
broader: organic molecular entity

alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

bhas#38-CoA
type: Concept
broader: organic molecular entity

KFP-QS10J7MP-J
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-)
broader: organic molecular entity

Histone-L-lysine
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
type: Concept
broader: organic molecular entity

KFP-LPJ9WFSB-5
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
broader: organic molecular entity

Saccharin sodium
type: Concept
broader: organic molecular entity

arsenic-75(3+)
type: Concept
broader: organic molecular entity

bhas#26-CoA(4-)
type: Concept
broader: organic molecular entity

hexanoyl-sn-glycero-3-phosphoethanolamine zwitterion
type: Concept
broader: organic molecular entity

C75
type: Concept
broader: organic molecular entity

bkos#14(1-)
type: Concept
broader: organic molecular entity

Aranidipine
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
type: Concept
broader: organic molecular entity

3-O-sulfo-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(2-)
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1<->1')-ceramide
type: Concept
broader: organic molecular entity

Entecavir triphosphate
type: Concept
broader: organic molecular entity

Cys-Ala thioether
type: Concept
broader: organic molecular entity

(+)-isomalbrancheamide B(1+)
type: Concept
broader: organic molecular entity

ascr#31-CoA
type: Concept
broader: organic molecular entity

Oxidized thiol-containing reductant
type: Concept
broader: organic molecular entity

bhas#22-CoA(4-)
type: Concept
broader: organic molecular entity

GIPC-anchor amidated glycine residue(1-)
type: Concept
broader: organic molecular entity

(3S,8S,9S,12S)-3,12-BIS(1,1-DIMETHYLETHYL)-8-HYDROXY-4,11-DIOXO-9-(PHENYLMETHYL)-6-[[4-(2-PYRIDINYL)PHENYL]METHYL]-2,5,6,10,13-PENTAAZATETRADECANEDIOIC ACID DIMETHYL ESTER
type: Concept
broader: organic molecular entity

4-Deoxy-alpha-L-erythro-hex-4-enopyranuronoside
type: Concept
broader: organic molecular entity

KFP-F3L4Z7SV-Q
type: Concept
preferred label: beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(3-)
broader: organic molecular entity

4-Substituted phenylacetonitrile
type: Concept
broader: organic molecular entity

bhos#22-CoA
type: Concept
broader: organic molecular entity

bhos#14-CoA(4-)
type: Concept
broader: organic molecular entity

angl#2
type: Concept
broader: organic molecular entity

alpha-D-Gal-(1->4)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)- beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine
type: Concept
broader: organic molecular entity

Ebastine
type: Concept
broader: organic molecular entity

gamma-Melanotropin
type: Concept
broader: organic molecular entity

KFP-M7KCW52R-C
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-galactosaminyl-(1->4)-[alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(3-)
broader: organic molecular entity

Fibrinogen binding peptide
type: Concept
broader: organic molecular entity

1-acyl-2-palmitoleoyl-sn-glycero-3-phosphoserine(1-)
type: Concept
broader: organic molecular entity

alpha-Aminoadipoyl-S-acyl enzyme
type: Concept
broader: organic molecular entity

KFP-B3ZL0KVM-C
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

Non-structural protein 5A
type: Concept
broader: organic molecular entity

Biotinyl-[protein]
type: Concept
broader: organic molecular entity

hamayne Trifluoroacetic acid
type: Concept
broader: organic molecular entity

KFP-WXQ18T28-1
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(5-)
broader: organic molecular entity

L-arginyl-L-glutamic acid monoacetate
type: Concept
broader: organic molecular entity

Bucillamine
type: Concept
broader: organic molecular entity

Amylin
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
type: Concept
broader: organic molecular entity

KFP-D7NKTLZ8-S
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-)
broader: organic molecular entity

Protein P
type: Concept
broader: organic molecular entity

Butyryl-[acp]
type: Concept
broader: organic molecular entity

Didecyldimethylammonium chloride
type: Concept
broader: organic molecular entity

1-palmitoyl-2-(10-hydroperoxy-8E-octadecenoyl)-sn-glycero-3-phosphocholine
type: Concept
broader: organic molecular entity

Aliphatic oxo acid
type: Concept
broader: organic molecular entity

KFP-G32B3Q31-2
type: Concept
preferred label: N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-alpha-D-galactosaminyl-(1->3)-(alpha-L-fucosyl-(1->2))-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

KFP-PWWKWWW7-J
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-)
broader: organic molecular entity

Carboquone
type: Concept
broader: organic molecular entity

bkas#1-CoA(4-)
type: Concept
broader: organic molecular entity

KFP-D4X6SP5T-9
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

Endothal-disodium
type: Concept
broader: organic molecular entity

beta-Substituted alpha-L-amino acid
type: Concept
broader: organic molecular entity

Ar5Cer
type: Concept
broader: organic molecular entity

Ceftiofur sodium
type: Concept
broader: organic molecular entity

bhas#26-CoA
type: Concept
broader: organic molecular entity

KFP-NP4M084F-0
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine
type: Concept
broader: organic molecular entity

semisynthetic derivative
type: Concept
broader: organic molecular entity

Lomotil
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
type: Concept
broader: organic molecular entity

Terguride
type: Concept
broader: organic molecular entity

Insulin-like 3
type: Concept
broader: organic molecular entity

Clobetasone butyrate
type: Concept
broader: organic molecular entity

Iobenzamic acid
type: Concept
broader: organic molecular entity

Rescimetol
type: Concept
broader: organic molecular entity

3,5,7,9,11,13,15,17,19-Nonaoxo-eicosanoyl-[acp]
type: Concept
broader: organic molecular entity

KFP-R2KQL0LF-6
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

KFP-T7B6KK7L-R
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(3-)
broader: organic molecular entity

alpha-D-Gal-(1->3)-alpha-D-Gal-(1->3)-alpha-D-Gal-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphingosine
type: Concept
broader: organic molecular entity

2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID
type: Concept
broader: organic molecular entity

Rebamipide
type: Concept
broader: organic molecular entity

bkos#28-CoA
type: Concept
broader: organic molecular entity

ascr#5-CoA(4-)
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E)/16:0)
type: Concept
broader: organic molecular entity

KFP-X1BR7WPS-X
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(4-)
broader: organic molecular entity

beta-D-GlcNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

Glicentin
type: Concept
broader: organic molecular entity

aucubin
type: Concept
broader: organic molecular entity

bhas#32(1-)
type: Concept
broader: organic molecular entity

Prolyl-peptide
type: Concept
broader: organic molecular entity

KFP-WL52KLB7-H
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

Timepidium bromide
type: Concept
broader: organic molecular entity

C15813
type: Concept
broader: organic molecular entity

Bleomycin B
type: Concept
broader: organic molecular entity

KFP-Z4CPCQCQ-S
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

DNA with 3-terminal trans-a,b-unsaturated sugar
type: Concept
broader: organic molecular entity

KFP-GQ03PFZN-J
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

5'-end (5'-triphosphoguanosine)-(2'-O-methyl-adenosine)(3-) residue
type: Concept
broader: organic molecular entity

bhas#12-CoA
type: Concept
broader: organic molecular entity

icas#9(1-)
type: Concept
broader: organic molecular entity

Sulfadimethoxine sodium
type: Concept
broader: organic molecular entity

beta-citryl-L-glutamyl-L-glutamate
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->8)-alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)
type: Concept
broader: organic molecular entity

alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
type: Concept
broader: organic molecular entity

KFP-WRM61540-7
type: Concept
preferred label: beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

Ergotamine tartrate
type: Concept
broader: organic molecular entity

Cys-Asn thioether
type: Concept
broader: organic molecular entity

Hyoscyamine methylbromide
type: Concept
broader: organic molecular entity

19-O-acetylchaetoglobosin B
type: Concept
broader: organic molecular entity

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
type: Concept
broader: organic molecular entity

probetaenone I
type: Concept
broader: organic molecular entity

cis-3-O-feruloylquinic acid
type: Concept
broader: organic molecular entity

CH3-R
type: Concept
broader: organic molecular entity

bkos#32(1-)
type: Concept
broader: organic molecular entity

Clidanac
type: Concept
broader: organic molecular entity

Sunset Yellow FCF
type: Concept
broader: organic molecular entity

ascr#27-CoA(4-)
type: Concept
broader: organic molecular entity

angl#1
type: Concept
broader: organic molecular entity

Thymosin beta-4
type: Concept
broader: organic molecular entity

bkas#26(1-)
type: Concept
broader: organic molecular entity

Placental lactogen
type: Concept
broader: organic molecular entity

(+)-isomalbrancheamide D(1+)
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
type: Concept
broader: organic molecular entity

Cyanoglycoside
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
type: Concept
broader: organic molecular entity

Homoamino acid
type: Concept
broader: organic molecular entity

[Dihydrolipoyllysine-residue succinyltransferase] S-succinyldihydrolipoyllysine
type: Concept
broader: organic molecular entity

Zinc phosphide
type: Concept
broader: organic molecular entity

5-Methyl-pyrrole-2-carboxyl-[pcp]
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

aspergildiene C
type: Concept
broader: organic molecular entity

bhos#36-CoA(4-)
type: Concept
broader: organic molecular entity

Urocortin III
type: Concept
broader: organic molecular entity

bhos#26-CoA(4-)
type: Concept
broader: organic molecular entity

NeuGc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

8-(6-aminohexylamino)-2'-O-methyl 3',5'-cyclic AMP
type: Concept
broader: organic molecular entity

alpha-D-Gal-(1->4)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine
type: Concept
broader: organic molecular entity

selenium-82(2-)
type: Concept
broader: organic molecular entity

KFP-DG5XT15L-W
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(3-)
broader: organic molecular entity

beta-D-Glucuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-(1->4)-beta-D-glucuronosylproteoglycan
type: Concept
broader: organic molecular entity

Allatostatin I
type: Concept
broader: organic molecular entity

KFP-Q3K0L82K-7
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

Trypsin
type: Concept
broader: organic molecular entity

bkos#14
type: Concept
broader: organic molecular entity

KFP-MHFVXW0J-Q
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

RFamide-related peptide 1
type: Concept
broader: organic molecular entity

sodium(E)-((1R,4aS,4bS,8aS,10aS)-1-(2-((R)-5-methoxy-2-oxo-2,5-dihydrofuran-3-yl)ethyl)-4b,8,8,10a-tetramethyldecahydrophenanthren-2(1H,3H,4bH)-ylidene)methyl sulfate
type: Concept
broader: organic molecular entity

bkos#30
type: Concept
broader: organic molecular entity

Gramicidin A
type: Concept
broader: organic molecular entity

alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-(alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4))-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

(ethanolamineP) mannose (a1-2) (ethanolamineP) mannose (a1-6) (ethanolamineP) mannose (a1-4) glucosaminyl-acyl-PI
type: Concept
broader: organic molecular entity

Polymethylene polyphenyl isocyanate
type: Concept
broader: organic molecular entity

3-acetylpyridine adenine dinucleotide
type: Concept
broader: organic molecular entity

bhas#26(1-)
type: Concept
broader: organic molecular entity

KFP-Z1B014PM-Z
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(3-)
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
type: Concept
broader: organic molecular entity

KFP-NJ1BGR4H-1
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)
broader: organic molecular entity

alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-(alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4))-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E))
type: Concept
broader: organic molecular entity

trans-Tetradec-2-enoyl-[acp]
type: Concept
broader: organic molecular entity

1-Naphthaleneacetic acid sodium salt
type: Concept
broader: organic molecular entity

dihomo-gamma-linolenyl carnitine
type: Concept
broader: organic molecular entity

SRA8
type: Concept
broader: organic molecular entity

KFP-XRPR4VRR-0
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->8)-alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

KFP-X137T402-Q
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(2-)
broader: organic molecular entity

KFP-HF1SJQJD-N
type: Concept
preferred label: beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(3-)
broader: organic molecular entity

KFP-J7RGLGL8-9
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

bkas#16-CoA
type: Concept
broader: organic molecular entity

Rhodoquinonol-9
type: Concept
broader: organic molecular entity

KFP-K3NK5C84-0
type: Concept
preferred label: beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

Melinamide
type: Concept
broader: organic molecular entity

bhos#16(1-)
type: Concept
broader: organic molecular entity

KFP-HQ942VTX-7
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
type: Concept
broader: organic molecular entity

Halisulfate 2
type: Concept
broader: organic molecular entity

aspergildiene D
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-D-galactosamine(1-)
type: Concept
broader: organic molecular entity

alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
type: Concept
broader: organic molecular entity

KFP-VX61MR8B-R
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-)
broader: organic molecular entity

nitrile herbicide
type: Concept
broader: organic molecular entity

Midecamycin acetate
type: Concept
broader: organic molecular entity

Galanin
type: Concept
broader: organic molecular entity

Fibronectin
type: Concept
broader: organic molecular entity

5-Benzyl-1-hydroxypyridin-2(1H)-one
type: Concept
broader: organic molecular entity

Gastrin-releasing peptide
type: Concept
broader: organic molecular entity

biomacromolecule
type: Concept
broader: organic molecular entity

Prifinium bromide
type: Concept
broader: organic molecular entity

ascr#11(1-)
type: Concept
broader: organic molecular entity

KFP-VM70K1Q3-S
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

Type H1 glycolipid
type: Concept
broader: organic molecular entity

KFP-BS54RWSZ-J
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

Adrenorphin
type: Concept
broader: organic molecular entity

beta-D-GlcNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E))
type: Concept
broader: organic molecular entity

(2R,3R)-nemonapride(1+)
type: Concept
broader: organic molecular entity

KFP-QTPV9M9B-1
type: Concept
preferred label: N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

beta-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphingosine
type: Concept
broader: organic molecular entity

3-O-sulfo-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(3-O-sulfo)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
type: Concept
broader: organic molecular entity

bhos#10-CoA(4-)
type: Concept
broader: organic molecular entity

ascr#28-CoA
type: Concept
broader: organic molecular entity

Cefacetrile sodium
type: Concept
broader: organic molecular entity

KFP-K9TWQNBL-2
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

bhos#38-CoA
type: Concept
broader: organic molecular entity

bhas#9
type: Concept
broader: organic molecular entity

(2E,6E,10E)-geranylgeranial
type: Concept
broader: organic molecular entity

bhos#10-CoA
type: Concept
broader: organic molecular entity

7,9,12-Decaketide intermediate 4
type: Concept
broader: organic molecular entity

KFP-TV6BLR1B-0
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

2'-Hydroxy-MDCA
type: Concept
broader: organic molecular entity

Propyliodone
type: Concept
broader: organic molecular entity

Endomorphin-1
type: Concept
broader: organic molecular entity

Cer(d16:1(4E)(1OH,3OH)(15Me)/23:0(2OH[R]))
type: Concept
broader: organic molecular entity

beta-D-Gal-(1->3)-[beta-D-GlcNAc-(1->6)]-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine
type: Concept
broader: organic molecular entity

Haloxazolam
type: Concept
broader: organic molecular entity

4,5-dihydro-6beta-hydroxy-20alpha-dihydro-prednisolone
type: Concept
broader: organic molecular entity

Simfibrate
type: Concept
broader: organic molecular entity

KFP-RM59699T-9
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(3-)
broader: organic molecular entity

Protein N6,N6,N6-trimethyl-L-lysine
type: Concept
broader: organic molecular entity

Helospectin II
type: Concept
broader: organic molecular entity

beta-galactosylceramide
type: Concept
broader: organic molecular entity

KFP-ZM1W5BZW-Q
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

bkos#26
type: Concept
broader: organic molecular entity

alpha-D-Mannosyl-1,3-(R1)-beta-D-mannosyl-R2
type: Concept
broader: organic molecular entity

KFP-GSPFXG11-V
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

KFP-V26VGK7X-W
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

bkos#38(1-)
type: Concept
broader: organic molecular entity

bkos#22
type: Concept
broader: organic molecular entity

Dexamethasone palmitate
type: Concept
broader: organic molecular entity

beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

(R)-Hemiketal
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

Insulin-like growth factor I
type: Concept
broader: organic molecular entity

palmarumycin C8
type: Concept
broader: organic molecular entity

7,9,12-Octaketide intermediate 1
type: Concept
broader: organic molecular entity

ascr#23-CoA(4-)
type: Concept
broader: organic molecular entity

Histone N-methyl-L-arginine
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
type: Concept
broader: organic molecular entity

ascr#17(1-)
type: Concept
broader: organic molecular entity

KFP-SQ4NRSV5-C
type: Concept
preferred label: beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

bkos#18-CoA
type: Concept
broader: organic molecular entity

Fidarestat
type: Concept
broader: organic molecular entity

SO3-6-O-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
type: Concept
broader: organic molecular entity

bkas#32-CoA
type: Concept
broader: organic molecular entity

5-Substituted dCMP
type: Concept
broader: organic molecular entity

Trepibutone
type: Concept
broader: organic molecular entity

Mebutamate
type: Concept
broader: organic molecular entity

SO3-3beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E))
type: Concept
broader: organic molecular entity

N-acetyl-alpha-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
type: Concept
broader: organic molecular entity

CI Acid red 114
type: Concept
broader: organic molecular entity

S-oleoyl-L-cysteine group
type: Concept
broader: organic molecular entity

aglycone
type: Concept
broader: organic molecular entity

HLo7
type: Concept
broader: organic molecular entity

bhas#12
type: Concept
broader: organic molecular entity

Phaeomelanin
type: Concept
broader: organic molecular entity

Endothelin-1
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
type: Concept
broader: organic molecular entity

Romurtide
type: Concept
broader: organic molecular entity

5-methylaminomethyl-2-(Se-phospho)selenouridine 5'-monophosphate(2-) residue
type: Concept
broader: organic molecular entity

Sulfur donor
type: Concept
broader: organic molecular entity

F420(red.)
type: Concept
broader: organic molecular entity

bkas#1(1-)
type: Concept
broader: organic molecular entity

alpha-NeuGc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

KFP-G7L078N6-R
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

bkos#38-CoA(4-)
type: Concept
broader: organic molecular entity

KFP-KC6FNJG1-P
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

KFP-XQJ5D9M6-H
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

Tuberoinfundibular peptide of 39 residues
type: Concept
broader: organic molecular entity

(1-HYDROXY-2-IMIDAZO[1,2-A]PYRIDIN-3-YLETHANE-1,1-DIYL)BIS(PHOSPHONIC ACID)
type: Concept
broader: organic molecular entity

Urethane dimethacrylate
type: Concept
broader: organic molecular entity

Oxidized reactive black 5
type: Concept
broader: organic molecular entity

alpha-D-Gal-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

desulfo-Glucosinolate
type: Concept
broader: organic molecular entity

KFP-SZGL8T3W-R
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

bkas#9-CoA(4-)
type: Concept
broader: organic molecular entity

Aflatoxin B1 endo-N-acetylcysteine conjugate
type: Concept
broader: organic molecular entity

1-palmitoyl-2-(5-hydroxyvaleroyl)-sn-glycero-3-phosphate(2-)
type: Concept
broader: organic molecular entity

Type 1 disialyl-paragloboside
type: Concept
broader: organic molecular entity

Iodoxamic acid
type: Concept
broader: organic molecular entity

modulator
type: Concept
broader: organic molecular entity

bkos#36-CoA
type: Concept
broader: organic molecular entity

Sultiame
type: Concept
broader: organic molecular entity

Fibrinopeptide B
type: Concept
broader: organic molecular entity

alpha-Endorphin
type: Concept
broader: organic molecular entity

Activin A
type: Concept
broader: organic molecular entity

KFP-BCBDSXRS-1
type: Concept
preferred label: N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

Arenomycin B
type: Concept
broader: organic molecular entity

Interferon alfa-2a
type: Concept
broader: organic molecular entity

docosenoate
type: Concept
broader: organic molecular entity

mbas#10(1-)
type: Concept
broader: organic molecular entity

Liver-expressed antimicrobial peptide 1
type: Concept
broader: organic molecular entity

alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-(alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4))-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-[alpha-N-acetylneuraminosyl-(2->6)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
type: Concept
broader: organic molecular entity

KFP-N06LD42P-J
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)
broader: organic molecular entity

3-hydroxy-3-phenylpropionitrile
type: Concept
broader: organic molecular entity

Duplicate orcinol
type: Concept
broader: organic molecular entity

bhos#1-CoA(4-)
type: Concept
broader: organic molecular entity

Tryparedoxin disulfide
type: Concept
broader: organic molecular entity

KFP-P3WTK7SK-9
type: Concept
preferred label: 6-phosphoethanolamine-D-mannose-(alpha1->2)-D-mannose-(alpha1->6)-2-phosphoethanolamine-D-mannose-(alpha1->4)-D-glucosaminyl-(alpha1->6)-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-2-acyl-inositol zwitterion
broader: organic molecular entity

Mercaptide
type: Concept
broader: organic molecular entity

N-(tetradecanoyl)sphing-4-enine
type: Concept
broader: organic molecular entity

3-Phosphoadenylylselenate(4-)
type: Concept
broader: organic molecular entity

Phenmetrazine hydrochloride
type: Concept
broader: organic molecular entity

N-(2,3-dihydroxybenzoyl)-L-serine trimer
type: Concept
broader: organic molecular entity

3-Alkylmalic acid
type: Concept
broader: organic molecular entity

Pirenoxine
type: Concept
broader: organic molecular entity

3-methyl-1-oxo-2-[3-oxo-3-(pyrrolidin-1-yl)propyl]-1,5-dihydrobenzo[4,5]imidazo[1,2-a]pyridine-4-carbonitrile
type: Concept
broader: organic molecular entity

bkas#20(1-)
type: Concept
broader: organic molecular entity

Pheniramine maleate
type: Concept
broader: organic molecular entity

Desmycocin
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
type: Concept
broader: organic molecular entity

1alpha,25-dihydroxy-2beta-(1,3-dihydroxypropoxy)vitamin D3
type: Concept
broader: organic molecular entity

4-Nitroanilide
type: Concept
broader: organic molecular entity

oxidized 2-acylglycerol
type: Concept
broader: organic molecular entity

bkos#24(1-)
type: Concept
broader: organic molecular entity

oxime
type: Concept
broader: organic molecular entity

KFP-JQCKDT9P-2
type: Concept
preferred label: beta-D-galactosyl-(1->4)-N-acetyl-beta-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(1-)
type: Concept
broader: organic molecular entity

bkas#14-CoA(4-)
type: Concept
broader: organic molecular entity

Magnesium peroxide
type: Concept
broader: organic molecular entity

bhas#18-CoA
type: Concept
broader: organic molecular entity

anticoagulant rodenticide
type: Concept
broader: organic molecular entity

KFP-LNWBK5MZ-Z
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
type: Concept
broader: organic molecular entity

TMC-151
type: Concept
broader: organic molecular entity

N-12R-hydroxymyristoyl-L-cysteine residue
type: Concept
broader: organic molecular entity

6-Methylpenicillin
type: Concept
broader: organic molecular entity

alpha-N-acetylneuraminosyl-(2->6)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

Insulin-like peptide 5
type: Concept
broader: organic molecular entity

gamma-L-Glutamyl-4-aminobutyryl-[acp]
type: Concept
broader: organic molecular entity

Z-Phe-Phe-CHN2
type: Concept
broader: organic molecular entity

Xaa-Lys
type: Concept
broader: organic molecular entity

KFP-GTQ0580J-1
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

N-(2,3-dihydroxybenzoyl)-L-seryl-[N-(C-5-[deoxy-beta-D-glucosyl]-2,3-dihydroxybenzoyl)-L-serine]2
type: Concept
broader: organic molecular entity

2-Hydroxy-beta-keto-L-tyrosyl-[pcp]
type: Concept
broader: organic molecular entity

KFP-Q6HLQJ5C-0
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

KFP-P1HQHFP4-8
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

beta-D-mannopyranosyl-(1->4)-alpha-L-rhamnopyranosyl-(1->3)-alpha-D-galactopyranosyl-diphospho-ditrans,octacis-undecaprenol(2-)
type: Concept
broader: organic molecular entity

alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

KFP-XC0K7DQG-C
type: Concept
preferred label: alpha-N-acetylneuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

Thiol-containing reductant
type: Concept
broader: organic molecular entity

Hexadecenoyl-[acyl-carrier protein]
type: Concept
broader: organic molecular entity

beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc6S-(1->3)-D-Galp
type: Concept
broader: organic molecular entity

Apo-[carboxylase]
type: Concept
broader: organic molecular entity

KFP-LKDW20SK-0
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(5-)
broader: organic molecular entity

Saccharated iron oxide
type: Concept
broader: organic molecular entity

huratoxin
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
type: Concept
broader: organic molecular entity

B-sitosterol
type: Concept
broader: organic molecular entity

Luzopeptin
type: Concept
broader: organic molecular entity

KFP-MP2Z87SM-H
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

KFP-D90RRTB8-C
type: Concept
preferred label: N-acetyl-alpha-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

Methsuximide
type: Concept
broader: organic molecular entity

KFP-GXLS2M6Q-Q
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

Monuron-TCA
type: Concept
broader: organic molecular entity

ascr#11-CoA
type: Concept
broader: organic molecular entity

Adenylylselenate(2-)
type: Concept
broader: organic molecular entity

Octaneuropeptide
type: Concept
broader: organic molecular entity

phosphorus-31(3-)
type: Concept
broader: organic molecular entity

Bentazone-sodium
type: Concept
broader: organic molecular entity

Anecortave acetate
type: Concept
broader: organic molecular entity

S-(12-hydroxyfarnesyl)-L-cysteine residue
type: Concept
broader: organic molecular entity

9-Hydroxy-3,5,7,11,13,15,17-octaoxo-nonadecanoyl-[acp]
type: Concept
broader: organic molecular entity

phosphorus-31(5+)
type: Concept
broader: organic molecular entity

KFP-CT54WX4F-K
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
broader: organic molecular entity

bhos#22(1-)
type: Concept
broader: organic molecular entity

CHEBI:55424-chloramide
type: Concept
broader: organic molecular entity

homatropine hydrobromide
type: Concept
broader: organic molecular entity

Haloalcohol
type: Concept
broader: organic molecular entity

Protein serine D-xyloside
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
type: Concept
broader: organic molecular entity

4-hydroxyatorvastatin lactone
type: Concept
broader: organic molecular entity

KFP-HV6LTD7L-7
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(3-)
broader: organic molecular entity

2-methyl-3-hydroxy indole
type: Concept
broader: organic molecular entity

N6-[1,1-(5-adenosylyl-alpha-D-ribose-1,2-di-O-yl)ethyl]-L-lysinium residue
type: Concept
broader: organic molecular entity

Reduced azurin
type: Concept
broader: organic molecular entity

catalpol
type: Concept
broader: organic molecular entity

13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE
type: Concept
broader: organic molecular entity

(2E)-3-(4-hydroxyphenyl)-2-isocyanoprop-2-enoate
type: Concept
broader: organic molecular entity

3-acetyl-4a,6,7,9,12a-pentahydroxy-4,5-dioxo-1,4,4a,5,12,12a-hexahydrotetracen-2-olate
type: Concept
broader: organic molecular entity

selenium-82(4+)
type: Concept
broader: organic molecular entity

KFP-D584PTQW-W
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

ascr#37(1-)
type: Concept
broader: organic molecular entity

3,5,7,11,13,15-Heptaoxo-9-hydroxy-heptadecanoyl-[acp]
type: Concept
broader: organic molecular entity

ascr#11-CoA(4-)
type: Concept
broader: organic molecular entity

KFP-LKRT4Q3P-Q
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

KFP-WCHQGD7C-C
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(4-)
broader: organic molecular entity

Angiotensin IV
type: Concept
broader: organic molecular entity

(+)-isomalbrancheamide C(1+)
type: Concept
broader: organic molecular entity

Rimantadine hydrochloride
type: Concept
broader: organic molecular entity

ascr#29(1-)
type: Concept
broader: organic molecular entity

betanidin quinone(2-)
type: Concept
broader: organic molecular entity

pochonin D
type: Concept
broader: organic molecular entity

KFP-SFW1RGFQ-1
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-galactosaminyl-(1->4)-[alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(3-)
broader: organic molecular entity

6-Benzyl-4-methyl-1-hydroxypyridin-2(1H)-one
type: Concept
broader: organic molecular entity

KFP-QG1JNCL4-P
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->8)-alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
broader: organic molecular entity

bkos#38-CoA
type: Concept
broader: organic molecular entity

3'-O-salicyl-AMP(2-)
type: Concept
broader: organic molecular entity

Metarhodopsin
type: Concept
broader: organic molecular entity

Bm3
type: Concept
broader: organic molecular entity

chlorobiocin-like antibiotic
type: Concept
broader: organic molecular entity

Pb1
type: Concept
broader: organic molecular entity

KFP-HFQWM1VJ-V
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

Esmeraldin A
type: Concept
broader: organic molecular entity

ascr#20-CoA(4-)
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0) (1-)
type: Concept
broader: organic molecular entity

ascr#34-CoA
type: Concept
broader: organic molecular entity

O-methyl-sterigmatocystin
type: Concept
broader: organic molecular entity

Aflatoxin B1 endo-cysteinyl-conjugate
type: Concept
broader: organic molecular entity

Kitasamycin tartrate
type: Concept
broader: organic molecular entity

Protein L-isoaspartate methyl ester
type: Concept
broader: organic molecular entity

beta-Lipotropin
type: Concept
broader: organic molecular entity

ascr#15(1-)
type: Concept
broader: organic molecular entity

ascr#22(1-)
type: Concept
broader: organic molecular entity

7,12-Decaketide intermediate 1
type: Concept
broader: organic molecular entity

ascr#24-CoA(4-)
type: Concept
broader: organic molecular entity

ferric enterobactin
type: Concept
broader: organic molecular entity

PE(0:0/14:0)
type: Concept
broader: organic molecular entity

1-O-acetylbulbisine Trifluoroacetic acid
type: Concept
broader: organic molecular entity

4-Substituted aniline
type: Concept
broader: organic molecular entity

KFP-BTB1C4L2-H
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

ascr#16-CoA(4-)
type: Concept
broader: organic molecular entity

3,5,7,9,11,13,15,17-Octaoxo-eicosanoyl-[acp]
type: Concept
broader: organic molecular entity

Palygorskite
type: Concept
broader: organic molecular entity

1,2-diacyl-sn-glycerolipid
type: Concept
broader: organic molecular entity

Olivanic acid
type: Concept
broader: organic molecular entity

ricinoleoyl-sn-glycero-3-phosphocholine
type: Concept
broader: organic molecular entity

KFP-L1J90H3F-M
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

beta-D-GalNAc-(1->3)alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1)-N-acylsphinganine
type: Concept
broader: organic molecular entity

ascr#9-CoA
type: Concept
broader: organic molecular entity

8-O-demethyloxomaritidine Trifluoroacetic acid
type: Concept
broader: organic molecular entity

Neuropeptide W-23
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

bhos#26(1-)
type: Concept
broader: organic molecular entity

ascr#29-CoA
type: Concept
broader: organic molecular entity

bkos#12-CoA(4-)
type: Concept
broader: organic molecular entity

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(1-)
type: Concept
broader: organic molecular entity

chaetocin
type: Concept
broader: organic molecular entity

KFP-QDDCD644-D
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(4-)
broader: organic molecular entity

7,9,12-Octaketide intermediate 3
type: Concept
broader: organic molecular entity

ascr#19(1-)
type: Concept
broader: organic molecular entity

Urocortin I
type: Concept
broader: organic molecular entity

purines 2'-deoxy-D-ribonucleoside
type: Concept
broader: organic molecular entity

KFP-T9FNW3BX-9
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

DISTAMYCIN A
type: Concept
broader: organic molecular entity

ascr#14-CoA(4-)
type: Concept
broader: organic molecular entity

MAGE-3 (271 - 279)
type: Concept
broader: organic molecular entity

Citric acid monohydrate
type: Concept
broader: organic molecular entity

pseudohalogen
type: Concept
broader: organic molecular entity

Cer(d16:0(15Me)/26:0)
type: Concept
broader: organic molecular entity

KFP-FBMJL7K9-W
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

ascr#35-CoA(4-)
type: Concept
broader: organic molecular entity

Cer(d16:1(4E)(1OH,3OH)(15Me)/30:0)
type: Concept
broader: organic molecular entity

bkas#30-CoA
type: Concept
broader: organic molecular entity

KFP-SPKFH10R-G
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

Sodium ortho-phenylphenate
type: Concept
broader: organic molecular entity

Ozagrel hydrochloride
type: Concept
broader: organic molecular entity

Acrinol
type: Concept
broader: organic molecular entity

bkas#12
type: Concept
broader: organic molecular entity

N6-monoubiquitinyl-[protein]-L-lysine
type: Concept
broader: organic molecular entity

Haloperidol decanoate
type: Concept
broader: organic molecular entity

N-(acyl)-sphingosyl-1,3-cyclicphosphate(1-)
type: Concept
broader: organic molecular entity

S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1<->1')-ceramide(d18:0) (1-)
type: Concept
broader: organic molecular entity

ascr#17-CoA
type: Concept
broader: organic molecular entity

beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
type: Concept
broader: organic molecular entity

bhos#12-CoA(4-)
type: Concept
broader: organic molecular entity

Cloxyfonac-sodium
type: Concept
broader: organic molecular entity

(3R,5R,7S,8E,10E,12E)-3-amino-5-hydroxy-7-methoxyoctadeca-8,10,12-trienoic acid
type: Concept
broader: organic molecular entity

Iofetamine hydrochloride I 123
type: Concept
broader: organic molecular entity

Cholecystokinin-33
type: Concept
broader: organic molecular entity

Cnidilide
type: Concept
broader: organic molecular entity

Docarpamine
type: Concept
broader: organic molecular entity

1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phospho-(1'-sn-glycerol)(1-)
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
type: Concept
broader: organic molecular entity

octadecenedioic acid
type: Concept
broader: organic molecular entity

Protein(N-Glu, Asp, Cystine)
type: Concept
broader: organic molecular entity

Spinetoram
type: Concept
broader: organic molecular entity

etanercept
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(1-)
type: Concept
broader: organic molecular entity

3-Oxohexanoyl-[acp]
type: Concept
broader: organic molecular entity

2-O-acetylcrinamabine Trifluoroacetic acid
type: Concept
broader: organic molecular entity

KFP-XV53H92W-J
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(2-)
broader: organic molecular entity

Stearyltrimethylammonium chloride
type: Concept
broader: organic molecular entity

Ibuprofen piconol
type: Concept
broader: organic molecular entity

KFP-SFDCVT4M-N
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
broader: organic molecular entity

alpha-D-Gal-(1->4)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

LL-37
type: Concept
broader: organic molecular entity

cis-11,12-methyleneoctadecanoyl-carnitine
type: Concept
broader: organic molecular entity

KFP-VVB05BGQ-K
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(5-)
broader: organic molecular entity

Myomodulin
type: Concept
broader: organic molecular entity

N-[1-(R,S)-carboxy-3-phenylpropyl]-Ala-Ala-Tyr-p-aminobenzoate
type: Concept
broader: organic molecular entity

KFP-JDG41W7Q-B
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

KFP-XF9S8ZJZ-H
type: Concept
preferred label: alpha-N-acetylneuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

ethylthiourea
type: Concept
broader: organic molecular entity

bkas#10(1-)
type: Concept
broader: organic molecular entity

ascr#27-CoA
type: Concept
broader: organic molecular entity

KFP-LF0KBLQ2-N
type: Concept
preferred label: beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(3-)
broader: organic molecular entity

bkas#18
type: Concept
broader: organic molecular entity

[beta-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)]n
type: Concept
broader: organic molecular entity

N-acetyl-beta-galactosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
type: Concept
broader: organic molecular entity

KFP-W65V5BD9-9
type: Concept
preferred label: alpha-N-acetyl-9-O-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

trans-Hexadec-2-enoyl-[acp]
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
type: Concept
broader: organic molecular entity

KFP-GJ003XJ1-M
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-)
broader: organic molecular entity

Pentagastrin
type: Concept
broader: organic molecular entity

3beta-(p-chlorophenyl)tropane-2beta-carboxylic acid, 4'-azido-3'-iodophenylethyl ester
type: Concept
broader: organic molecular entity

bhas#30(1-)
type: Concept
broader: organic molecular entity

bhos#24-CoA
type: Concept
broader: organic molecular entity

(S)-Hydroxynitrile
type: Concept
broader: organic molecular entity

6-chloro-5-methyl-N-[6-(2-methylpyridin-3-yl)oxypyridin-3-yl]-2,3-dihydroindole-1-carboxamide;dihydrochloride
type: Concept
broader: organic molecular entity

beta-glucosyl 6-beta-glucosyloxy-indole-3-carboxylate
type: Concept
broader: organic molecular entity

ascr#37-CoA
type: Concept
broader: organic molecular entity

N-12-oxomyristoyl-L-cysteine residue
type: Concept
broader: organic molecular entity

P55-TNFR
type: Concept
broader: organic molecular entity

bkas#16
type: Concept
broader: organic molecular entity

Agouti related protein (87-132)
type: Concept
broader: organic molecular entity

ascr#36-CoA
type: Concept
broader: organic molecular entity

CI Acid Orange 3
type: Concept
broader: organic molecular entity

Halcinonide
type: Concept
broader: organic molecular entity

Pyrrole-2-carboxyl-[pcp]
type: Concept
broader: organic molecular entity

N-palmitoyl-L-cysteine residue
type: Concept
broader: organic molecular entity

Galantide
type: Concept
broader: organic molecular entity

ascr#23-CoA
type: Concept
broader: organic molecular entity

DNA 5'-phosphate
type: Concept
broader: organic molecular entity

2-hydroxyatorvastatin lactone
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
type: Concept
broader: organic molecular entity

ascr#9-CoA(4-)
type: Concept
broader: organic molecular entity

20-dihydrochaetoglobosin A
type: Concept
broader: organic molecular entity

Vancomycin hydrochloride
type: Concept
broader: organic molecular entity

Duplicate chrysophanol
type: Concept
broader: organic molecular entity

2-{4-[(3,5-DIMETHYLANILINO)-CARBONYL-METHYL]-PHENOXY}-2-METHYLPROPIONIC ACID
type: Concept
broader: organic molecular entity

ascr#12-CoA
type: Concept
broader: organic molecular entity

4,5-dihydro-6beta-hydroxyprednisolone
type: Concept
broader: organic molecular entity

bkas#10-CoA
type: Concept
broader: organic molecular entity

Peptide(-Phe)
type: Concept
broader: organic molecular entity

Glycopeptidelipid
type: Concept
broader: organic molecular entity

3-hydroxyoct-3-enoylglycine
type: Concept
broader: organic molecular entity

Pro-Xaa
type: Concept
broader: organic molecular entity

iron tetraphenylporphyrin
type: Concept
broader: organic molecular entity

KFP-GTF0BRGV-W
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

Chorionic gonadotropin
type: Concept
broader: organic molecular entity

sialyl Lewis A antigen
type: Concept
broader: organic molecular entity

acylaminosugars
type: Concept
broader: organic molecular entity

KFP-THMH1M46-7
type: Concept
preferred label: alpha-N-acetylneuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

GS-nitroimidazole
type: Concept
broader: organic molecular entity

bkas#18-CoA
type: Concept
broader: organic molecular entity

Octaketide bicyclic intermediate
type: Concept
broader: organic molecular entity

Activin AB
type: Concept
broader: organic molecular entity

dotriacontahexaenoate
type: Concept
broader: organic molecular entity

Luteinizing hormone
type: Concept
broader: organic molecular entity

alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(3-)
type: Concept
broader: organic molecular entity

18-Carbamoyl-9-hydroxy-3,5,7,11,13,15,17-octaoxo-octadecanoyl-[acp]
type: Concept
broader: organic molecular entity

alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine
type: Concept
broader: organic molecular entity

Bacteriochlorophyll d
type: Concept
broader: organic molecular entity

KFP-TKMJKM09-1
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->8)-alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
broader: organic molecular entity

Met-enkephalin-Arg-Phe
type: Concept
broader: organic molecular entity

KFP-LRBTK0KL-2
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)
type: Concept
broader: organic molecular entity

KFP-R927JBNZ-K
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

Alkyldiaminoethylglycine hydrochloride
type: Concept
broader: organic molecular entity

sodium(E)-((1R,4aS,4bS,8aS,10aS)-4b,8,8,10a-tetramethyl-1-(2-(5-oxo-2,5-dihydrofuran-3-yl)ethyl)decahydrophenanthren-2(1H,3H,4bH)-ylidene)methyl sulfate
type: Concept
broader: organic molecular entity

(1S,8R,14S)-6-hydroxy-9-oxo-15,17-diazatetracyclo[12.2.2.1(3,7).1(8,12)]icosa-3(20),4,6,10,12(19)-pentaen-15-ium(1+)
type: Concept
broader: organic molecular entity

Neuropeptide W-30
type: Concept
broader: organic molecular entity

KFP-FWR16JBN-J
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

[Ribulose-1,5-bisphosphate-carboxylase]-lysine
type: Concept
broader: organic molecular entity

alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-[alpha-NeuAc-(2->6)]-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphingosine
type: Concept
broader: organic molecular entity

bkos#34
type: Concept
broader: organic molecular entity

Patent blue
type: Concept
broader: organic molecular entity

KFP-NZB0QDQT-G
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

SO3-3beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

(+)-malbrancheamide C(1+)
type: Concept
broader: organic molecular entity

KFP-VJH4ZJD0-S
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-Fuc-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

bhas#38(1-)
type: Concept
broader: organic molecular entity

hexadecenoate
type: Concept
broader: organic molecular entity

bkos#32-CoA
type: Concept
broader: organic molecular entity

4-Methoxy potassium salicylate
type: Concept
broader: organic molecular entity

KFP-F4JCQRBX-T
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

alpha-L-Fuc-(1->2)-alpha-D-Gal-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

Ferritin
type: Concept
broader: organic molecular entity

omega-hydroxy-ultra-long chain fatty acylceramide
type: Concept
broader: organic molecular entity

KFP-TQ8SX6TF-G
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->8)-alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-)
broader: organic molecular entity

KFP-PQ34CG8W-P
type: Concept
preferred label: beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

M3 acceptor complex
type: Concept
broader: organic molecular entity

S-Palmitoylprotein
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-[alpha-N-acetylneuraminosyl-(2->6)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
type: Concept
broader: organic molecular entity

1,2-alpha-D-Mannosylheteroglycan
type: Concept
broader: organic molecular entity

KFP-VM7NFQPT-M
type: Concept
preferred label: N-acetyl-alpha-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

Glycyl amino acid
type: Concept
broader: organic molecular entity

alpha-D-GalNAc-(1->3)-[alpha-L-Fuc-beta-(1->2)]-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

KFP-V417FDKZ-F
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
broader: organic molecular entity

3-Acetylenic fatty acyl thioesters
type: Concept
broader: organic molecular entity

Kassinin
type: Concept
broader: organic molecular entity

bkos#16-CoA(4-)
type: Concept
broader: organic molecular entity

Neocarzilin
type: Concept
broader: organic molecular entity

KFP-DSGZQDZP-P
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

R
type: Concept
broader: organic molecular entity

bkas#34-CoA(4-)
type: Concept
broader: organic molecular entity

N-carbamothioylacetamide
type: Concept
broader: organic molecular entity

6-(4-hydroxybenzyl)-4-methyl-1-hydroxypyridin-2(1H)-one
type: Concept
broader: organic molecular entity

iGb5Cer
type: Concept
broader: organic molecular entity

sodium(E)-((1R,4aS,4bS,8aS,10aS)-1-(2-((2S,3S,4R,5R)-3,4-dihydroxy-2,5-dimethoxytetrahydrofuran-3-yl)ethyl)-4b,8,8,10a-tetramethyldecahydrophenanthren-2(1H,3H,4bH)-ylidene)methyl sulfate
type: Concept
broader: organic molecular entity

PM26
type: Concept
broader: organic molecular entity

1-(11Z-icosenoyl)glycerol
type: Concept
broader: organic molecular entity

3beta,11beta-Diacetoxy-1alpha-hydroxykaura-16-ene-6,15-dione
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

phosphatidylethanolamine 20:4_22:2
type: Concept
broader: organic molecular entity

KFP-TK5PLLGX-L
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

KFP-GC22R7TT-D
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

2-[(L-alanin-3-ylcarbamoyl)methyl]-3-(2-aminoethylcarbamoyl)-2-hydroxypropanoate
type: Concept
broader: organic molecular entity

Nonylphenol
type: Concept
broader: organic molecular entity

PS3061
type: Concept
broader: organic molecular entity

oxidized glycerolipid
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

hbas#3(1-)
type: Concept
broader: organic molecular entity

alpha-L-Fuc-(1->2)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

5-hydroxymethyluridine-2'-deoxy-5'-phosphate(2-)
type: Concept
broader: organic molecular entity

KFP-KG4CXWP2-V
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(2-)
broader: organic molecular entity

3-O-sulfo-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(3-O-sulfo)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(2-)
type: Concept
broader: organic molecular entity

bhos#28-CoA(4-)
type: Concept
broader: organic molecular entity

Protein N6-(lipoyl)lysine
type: Concept
broader: organic molecular entity

KFP-WKDGWX4B-S
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

bkos#32-CoA(4-)
type: Concept
broader: organic molecular entity

alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
type: Concept
broader: organic molecular entity

KFP-L8J81L0V-H
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-)
broader: organic molecular entity

Copper gluconate
type: Concept
broader: organic molecular entity

KFP-KN52G8M8-5
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

Magainin 1
type: Concept
broader: organic molecular entity

glucuronate acceptor
type: Concept
broader: organic molecular entity

Bleomycin A
type: Concept
broader: organic molecular entity

Protein 5-hydroxylysine
type: Concept
broader: organic molecular entity

Prednisolone farnesylate
type: Concept
broader: organic molecular entity

KFP-RWS6CJ1X-H
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

xanthochymol
type: Concept
broader: organic molecular entity

Vinyl toluene
type: Concept
broader: organic molecular entity

(4aS,5R,10bR)-(+)-siculine Trifluoroacetic acid
type: Concept
broader: organic molecular entity

KFP-FBDT65QZ-H
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t20:0)(1-)
broader: organic molecular entity

Antimony trisulfide
type: Concept
broader: organic molecular entity

methylated enzyme bound TLM intermediate
type: Concept
broader: organic molecular entity

Isosorbide
type: Concept
broader: organic molecular entity

KFP-BSZRH04C-8
type: Concept
preferred label: alpha-L-fucosyl-(1->3)-[beta-D-galactosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

4-Aminobutyryl-[acp]
type: Concept
broader: organic molecular entity

R-H
type: Concept
broader: organic molecular entity

Doxylamine succinate
type: Concept
broader: organic molecular entity

KFP-TV9HGG35-M
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

KFP-Q6KSFF2S-N
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

KFP-DZ2K7555-G
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

(2E)-Octadecenoyl-[acp]
type: Concept
broader: organic molecular entity

KFP-G3L06SG8-N
type: Concept
preferred label: beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(3-)
broader: organic molecular entity

KFP-P4QPMV8F-N
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
broader: organic molecular entity

Astaxanthin diester
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
type: Concept
broader: organic molecular entity

N-(very-long-chain fatty acyl)-sphingoid base
type: Concept
broader: organic molecular entity

compound 78
type: Concept
broader: organic molecular entity

X-Trp
type: Concept
broader: organic molecular entity

Neurophysin II
type: Concept
broader: organic molecular entity

bkos#12-CoA
type: Concept
broader: organic molecular entity

Factor X
type: Concept
broader: organic molecular entity

alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)
type: Concept
broader: organic molecular entity

KFP-G747K6QQ-9
type: Concept
preferred label: beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
broader: organic molecular entity

CS-D
type: Concept
broader: organic molecular entity

mitochondrial ribosomes
type: Concept
broader: organic molecular entity

Adrenomedullin
type: Concept
broader: organic molecular entity

bkos#34-CoA(4-)
type: Concept
broader: organic molecular entity

Ethylendiamine dihydroiodide
type: Concept
broader: organic molecular entity

KFP-WG4PG52B-H
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

Novobiocin sodium
type: Concept
broader: organic molecular entity

bkas#30(1-)
type: Concept
broader: organic molecular entity

Endothelin-2
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
type: Concept
broader: organic molecular entity

alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1)-N-acylsphinganine
type: Concept
broader: organic molecular entity

bhos#32(1-)
type: Concept
broader: organic molecular entity

Prolactin
type: Concept
broader: organic molecular entity

bhos#14
type: Concept
broader: organic molecular entity

bulbisine Trifluoroacetic acid
type: Concept
broader: organic molecular entity

KFP-R870ZPLD-F
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

N-Acylmuramate
type: Concept
broader: organic molecular entity

5-Chloro-3,4-dihydroxy-L-phenylalanyl-[pcp]
type: Concept
broader: organic molecular entity

Glycerol monoester
type: Concept
broader: organic molecular entity

Hepronicate
type: Concept
broader: organic molecular entity

KFP-XP8WR8HW-V
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

Polyplatillen
type: Concept
broader: organic molecular entity

2-acylphloroglucinol 1-O-beta-D-glucoside
type: Concept
broader: organic molecular entity

ascr#33-CoA(4-)
type: Concept
broader: organic molecular entity

KFP-VP0MKQSX-3
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

KFP-CPS1S3NM-M
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(5-)
broader: organic molecular entity

methylated enzyme bound ZBM intermediate
type: Concept
broader: organic molecular entity

glycerophosphoinositol monophosphate
type: Concept
broader: organic molecular entity

m-Iodobenzylguanidine-123I
type: Concept
broader: organic molecular entity

1-stearoyl-2-(9,10-epoxyoctadecanoyl)-sn-glycero-3-phospho-L-serine(1-)
type: Concept
broader: organic molecular entity

bkas#24-CoA(4-)
type: Concept
broader: organic molecular entity

Faropenem sodium
type: Concept
broader: organic molecular entity

alpha-D-Gal-(1->3)-[alpha-L-Fuc-(1->2)]-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

KFP-G5VJNB8Z-G
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)
broader: organic molecular entity

SRK2
type: Concept
broader: organic molecular entity

N-hexadecanoyl-(2S)-hydroxyglycinate
type: Concept
broader: organic molecular entity

KFP-X7NSHQF4-L
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-)
broader: organic molecular entity

SO3-3-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
type: Concept
broader: organic molecular entity

3-((3R,5R,7S,8E,10E,12E)-3-amino-5-hydroxy-7-methoxyoctadeca-8,10,12-trienamido)propanoic acid
type: Concept
broader: organic molecular entity

Hexanoyl-[acp]
type: Concept
broader: organic molecular entity

Coagulation Factor Xa
type: Concept
broader: organic molecular entity

Sodium glucuronate
type: Concept
broader: organic molecular entity

atropine methonitrate
type: Concept
broader: organic molecular entity

KFP-WNFRR74G-H
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)
broader: organic molecular entity

iron-57(2+)
type: Concept
broader: organic molecular entity

bkos#24-CoA(4-)
type: Concept
broader: organic molecular entity

beta-Chloro-alpha-phenylbenzeneethanamine hydrochloride
type: Concept
broader: organic molecular entity

Ammonium sulfamate
type: Concept
broader: organic molecular entity

Non-structural protein V
type: Concept
broader: organic molecular entity

N,N'-BIS(4-AMINO-2-METHYLQUINOLIN-6-YL)UREA
type: Concept
broader: organic molecular entity

(8Z,11Z,14Z,17Z)-icosatetraenoyl-carnitine
type: Concept
broader: organic molecular entity

Glycolide
type: Concept
broader: organic molecular entity

Sodium folinate
type: Concept
broader: organic molecular entity

Ciclesonide
type: Concept
broader: organic molecular entity

Radium-228
type: Concept
broader: organic molecular entity

bkas#10
type: Concept
broader: organic molecular entity

Diosgenin glycoside
type: Concept
broader: organic molecular entity

N5-Alkylglutamine
type: Concept
broader: organic molecular entity

Dermaseptin
type: Concept
broader: organic molecular entity

MZ1
type: Concept
broader: organic molecular entity

KFP-ZD1SZHN0-K
type: Concept
preferred label: alpha-N-acetyl-9-O-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
broader: organic molecular entity

Monanchocidin C, rel-
type: Concept
broader: organic molecular entity

7-hydroxy-6-(3-oxobut-1-en-1-yl)-2H-chromen-2-one
type: Concept
broader: organic molecular entity

Glybuzole
type: Concept
broader: organic molecular entity

N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
type: Concept
broader: organic molecular entity

KFP-RBLBQLKZ-J
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

KFP-C399DZVB-6
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-)
broader: organic molecular entity

(2S,3R,4S)-2-[(1E)-buta-1,3-dienyl]-4-[(1E,3E)-penta-1,3-dienyl]tetrahydrofuran-3-ol
type: Concept
broader: organic molecular entity

Cys-Phe thioether
type: Concept
broader: organic molecular entity

bkas#12-CoA
type: Concept
broader: organic molecular entity

Long-chain carboxylate
type: Concept
broader: organic molecular entity

RFamide-related peptide 3
type: Concept
broader: organic molecular entity

bhas#34(1-)
type: Concept
broader: organic molecular entity

(5Z,8R,9Z,11Z,14Z)-8,9-epoxyicosatetraenoate
type: Concept
broader: organic molecular entity

1,2-diphytanoyl-sn-glycero-3-phosphocholine
type: Concept
broader: organic molecular entity

osas#10
type: Concept
broader: organic molecular entity

ascr#34-CoA(4-)
type: Concept
broader: organic molecular entity

KFP-VWVJ6N1P-7
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(1-)
broader: organic molecular entity

KFP-SN830RT0-R
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

bhos#10(1-)
type: Concept
broader: organic molecular entity

ascr#37-CoA(4-)
type: Concept
broader: organic molecular entity

Amaranth
type: Concept
broader: organic molecular entity

ascr#5(1-)
type: Concept
broader: organic molecular entity

(4E,8E)-10-(4,6-dihydroxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4,8-dimethyldeca-4,8-dienoate
type: Concept
broader: organic molecular entity

alpha-D-Gal-(1->3)-alpha-D-Gal-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

Protein N6-methyl-L-lysine
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
type: Concept
broader: organic molecular entity

KFP-HC2JPHZ5-5
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(5-)
broader: organic molecular entity

7-methyloctan-1-ol
type: Concept
broader: organic molecular entity

N-hexanoyl-sphingosine-1,3-cyclophosphate(1-)
type: Concept
broader: organic molecular entity

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N- glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
type: Concept
broader: organic molecular entity

N-Acetyl-alpha-D-glucosaminyl-(1->4)-beta-D-glucuronosylproteoglycan
type: Concept
broader: organic molecular entity

KFP-Q0V5PRWZ-4
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

KFP-RHD1QV2M-H
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(3-)
broader: organic molecular entity

metallocene
type: Concept
broader: organic molecular entity

C9-C9a linked PQQ
type: Concept
broader: organic molecular entity

butoxycaine
type: Concept
broader: organic molecular entity

bhas#12-CoA(4-)
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-[alpha-N-acetylneuraminosyl-(2->6)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

KFP-MW9VNHWH-F
type: Concept
preferred label: N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-alpha-D-galactosaminyl-(1->3)-(alpha-L-fucosyl-(1->2))-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

sodium(E)-((1R,4aS,4bS,8aS,10aS)-1-(2-((S)-2-hydroxy-5-oxo-2,5-dihydrofuran-3-yl)ethyl)-4b,8,8,10a-tetramethyldecahydrophenanthren-2(1H,3H,4bH)-ylidene)methyl sulfate
type: Concept
broader: organic molecular entity

bkos#20
type: Concept
broader: organic molecular entity

Oxazolam
type: Concept
broader: organic molecular entity

Oxidized azurin
type: Concept
broader: organic molecular entity

SO3-3-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
type: Concept
broader: organic molecular entity

7S(8)-epoxy-17(S)-hydroxydocosahexaenoic acid
type: Concept
broader: organic molecular entity

Panthenyl ethyl ether
type: Concept
broader: organic molecular entity

KFP-PX047NMD-W
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

Neuropeptide gamma
type: Concept
broader: organic molecular entity

Acyl-D-Ala-D-Ala
type: Concept
broader: organic molecular entity

Pemirolast potassium
type: Concept
broader: organic molecular entity

bkas#26
type: Concept
broader: organic molecular entity

alpha-NeuAc-(2->8)-alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphingosine
type: Concept
broader: organic molecular entity

alpha-Neoendorphin
type: Concept
broader: organic molecular entity

KFP-G290HX1C-R
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
broader: organic molecular entity

Glycoside of aldohexose
type: Concept
broader: organic molecular entity

6-Thioxanthine 5'-monophosphate(2-)
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
type: Concept
broader: organic molecular entity

Angiotensin (1-5)
type: Concept
broader: organic molecular entity

3,5-dimethyl-1-oxo-2-[3-oxo-3-(pyrrolidin-1-yl)propyl]-1,5-dihydrobenzo[4,5]imidazo[1,2-a]pyridine-4-carbonitrile
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

Glyphosate-monoammonium
type: Concept
broader: organic molecular entity

capnoidine
type: Concept
broader: organic molecular entity

KFP-Q4XL7LJ4-R
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

SO3-3beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E))
type: Concept
broader: organic molecular entity

sodium-23(1+)
type: Concept
broader: organic molecular entity

microcystin RR
type: Concept
broader: organic molecular entity

ap-NADH
type: Concept
broader: organic molecular entity

bhos#36(1-)
type: Concept
broader: organic molecular entity

KFP-R2KR1ZLZ-K
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
broader: organic molecular entity

bkas#1
type: Concept
broader: organic molecular entity

Exendin-2
type: Concept
broader: organic molecular entity

bhas#9-CoA(4-)
type: Concept
broader: organic molecular entity

ascr#23(1-)
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
type: Concept
broader: organic molecular entity

CMN 131
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
type: Concept
broader: organic molecular entity

Tri-2,5-cyclohexadien-1-ylsilane
type: Concept
broader: organic molecular entity

sialyl-Lewis X antigen
type: Concept
broader: organic molecular entity

staphyloferrin A(5-)
type: Concept
broader: organic molecular entity

Monoammonium glycyrrhizinate
type: Concept
broader: organic molecular entity

KFP-QK70M91L-K
type: Concept
preferred label: alpha-N-acetylneuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

Thyroglobulin triiodothyronine
type: Concept
broader: organic molecular entity

bkos#12
type: Concept
broader: organic molecular entity

KFP-MQS4NM7K-B
type: Concept
preferred label: D-mannose-(alpha1->2)-D-mannose-(alpha1->2)-D-mannose-(alpha1->6)-2-phosphoethanolamine-D-mannose-(alpha1->4)-D-glucosaminyl-(alpha1->6)-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-2-acyl-inositol zwitterion
broader: organic molecular entity

KFP-WQ4QL947-9
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->8)-alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-)
broader: organic molecular entity

KFP-FL4DMG8D-N
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

Maxacalcitol
type: Concept
broader: organic molecular entity

Xaa-His
type: Concept
broader: organic molecular entity

bhos#22-CoA(4-)
type: Concept
broader: organic molecular entity

ascr#38(1-)
type: Concept
broader: organic molecular entity

KFP-C9W9L9SW-G
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

Gestonorone caproate
type: Concept
broader: organic molecular entity

chaetomanone
type: Concept
broader: organic molecular entity

beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

Acetylpheneturide
type: Concept
broader: organic molecular entity

alpha-D-Gal-(1->3)-(alpha-L-Fuc-(1->2))-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

2-[(L-alanin-3-ylcarbamoyl)methyl]-2-hydroxybutanedioate(2-)
type: Concept
broader: organic molecular entity

KFP-BL5R77Q9-6
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-)
broader: organic molecular entity

2-amino-5-chloro-cis,cis-muconate 6-semialdehyde zwitterion
type: Concept
broader: organic molecular entity

Alexa Fluor 633
type: Concept
broader: organic molecular entity

bkos#18(1-)
type: Concept
broader: organic molecular entity

KFP-K28L9F9X-K
type: Concept
preferred label: alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-[alpha-N-acetylneuraminosyl-(2->6)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

KFP-HPCN4S0N-G
type: Concept
preferred label: N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

CANBEF-13
type: Concept
broader: organic molecular entity

bhos#12-CoA
type: Concept
broader: organic molecular entity

osas#1(1-)
type: Concept
broader: organic molecular entity

beta-D-Gal-(1->3)-[beta-D-GlcNAc-(1->6)]-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

n-[4-(3-iodo-4-azidophenyl)butyl]-2beta-carbomethoxy-3beta-(4-chlorophenyl)tropane
type: Concept
broader: organic molecular entity

LPS O antigen repeat from P. aeruginosa serotype 10
type: Concept
broader: organic molecular entity

cis-11,12-methyleneoctadecanoate
type: Concept
broader: organic molecular entity

KFP-PG68CK24-2
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

Cys-Glu thioether
type: Concept
broader: organic molecular entity

Flopropione
type: Concept
broader: organic molecular entity

KFP-FQKH9S9Z-Q
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)
broader: organic molecular entity

Nonaketamide monocyclic intermediate
type: Concept
broader: organic molecular entity

ascr#13(1-)
type: Concept
broader: organic molecular entity

Pancreatic polypeptide
type: Concept
broader: organic molecular entity

6beta-hydroxy-20beta-dihydro-prednisolone
type: Concept
broader: organic molecular entity

alpha-NeuAc-(2->8)-alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

bkas#22
type: Concept
broader: organic molecular entity

Obscurin
type: Concept
broader: organic molecular entity

Cer(d16:1(4E)(1OH,3OH)(15Me)/24:0(2OH[R]))
type: Concept
broader: organic molecular entity

2-Pyrroline-2-carboxyl-[pcp]
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
type: Concept
broader: organic molecular entity

KFP-LSR2TSDM-L
type: Concept
preferred label: alpha-L-fucosyl-(1->3)-[beta-D-galactosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(1-)
broader: organic molecular entity

A54145
type: Concept
broader: organic molecular entity

SMS 201-995
type: Concept
broader: organic molecular entity

ascr#9(1-)
type: Concept
broader: organic molecular entity

Reduced cytochrome cL
type: Concept
broader: organic molecular entity

KFP-WBVZW70D-4
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
broader: organic molecular entity

beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

bkas#10-CoA(4-)
type: Concept
broader: organic molecular entity

11a-hydroxy-oxytetracycline zwitterion
type: Concept
broader: organic molecular entity

prostaglandin B1(1-)
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-D-galactosamine(2-)
type: Concept
broader: organic molecular entity

Neuropeptide AF
type: Concept
broader: organic molecular entity

2-O-acetylbulbisine Trifluoroacetic acid
type: Concept
broader: organic molecular entity

Carpipramine maleate
type: Concept
broader: organic molecular entity

Core protein
type: Concept
broader: organic molecular entity

KFP-B1RR8K4G-5
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)
broader: organic molecular entity

Bucetin
type: Concept
broader: organic molecular entity

KFP-TLX6H0FZ-W
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

KFP-XLN3FKGC-9
type: Concept
preferred label: beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
type: Concept
broader: organic molecular entity

bkas#9-CoA
type: Concept
broader: organic molecular entity

KFP-X7PR3RLR-0
type: Concept
preferred label: beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(3-)
broader: organic molecular entity

Monanchocidin D, rel-
type: Concept
broader: organic molecular entity

Bromazepam
type: Concept
broader: organic molecular entity

Porphyropsin
type: Concept
broader: organic molecular entity

15-oxo-EDE(1-)
type: Concept
broader: organic molecular entity

alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-(beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4))-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

Katacalcin
type: Concept
broader: organic molecular entity

potassium-39(1+)
type: Concept
broader: organic molecular entity

N-lauroyl-sphingosine-1,3-cyclophosphate(1-)
type: Concept
broader: organic molecular entity

trichodion
type: Concept
broader: organic molecular entity

bhas#36-CoA(4-)
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
type: Concept
broader: organic molecular entity

alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d16:1)(1-)
type: Concept
broader: organic molecular entity

cis-9,10-methylenehexadecanoyl carnitine
type: Concept
broader: organic molecular entity

C5a anaphylatoxin
type: Concept
broader: organic molecular entity

levothyroxine sodium hydrate
type: Concept
broader: organic molecular entity

KFP-BKSQKP29-P
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

1-epijosephinine Trifluoroacetic acid
type: Concept
broader: organic molecular entity

monogalactosylglycerol
type: Concept
broader: organic molecular entity

beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-(1->6)-[beta-D-Gal-(1->3)]-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphingosine
type: Concept
broader: organic molecular entity

KFP-Q3R761MW-0
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
broader: organic molecular entity

bkas#38
type: Concept
broader: organic molecular entity

Tulobuterol hydrochloride
type: Concept
broader: organic molecular entity

Imipenem-cilastatin
type: Concept
broader: organic molecular entity

alpha-NeuAc-(2->8)-alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine
type: Concept
broader: organic molecular entity

Evadol hydrochloride
type: Concept
broader: organic molecular entity

epoxybetaenone
type: Concept
broader: organic molecular entity

6-FAM-mAmArCmAmA-Dabcyl
type: Concept
broader: organic molecular entity

Dialicor
type: Concept
broader: organic molecular entity

KFP-JHJSVZ33-Z
type: Concept
preferred label: rel-sodium 2-((1S,4R,5aS,5bR,7aS,11aS,11bR,13R,13aS)-13-acetoxy-1,4-dimethoxy-5b,8,8,11a,13a-pentamethyl-3-oxo-5,5a,6,7,7a,8,9,10,11,11a,11b,12,13,13a-tetradecahydro-1H-phenanthro[2,1-e]isoindol-2(3H,4H,5bH)-yl)acetate
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
type: Concept
broader: organic molecular entity

KFP-MXZ7Q44W-X
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
broader: organic molecular entity

CU-O LINKAGE
type: Concept
broader: organic molecular entity

KFP-B02HN5Z7-H
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

Hydroxypro-Xaa
type: Concept
broader: organic molecular entity

alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1)-N-acylsphinganine
type: Concept
broader: organic molecular entity

Oxytetracycline hydrochloride
type: Concept
broader: organic molecular entity

KFP-HKJ6KR4B-2
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(5-)
broader: organic molecular entity

bhas#14-CoA(4-)
type: Concept
broader: organic molecular entity

KFP-KWH930S2-P
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1<->1')-ceramide(d18:1(4E))
type: Concept
broader: organic molecular entity

pentaglutamyl folate(6-)
type: Concept
broader: organic molecular entity

9-Hydroxy-3,5,7,11,13,15,17-octaoxo-eicosanoyl-[acp]
type: Concept
broader: organic molecular entity

bkos#14-CoA
type: Concept
broader: organic molecular entity

bhos#36-CoA
type: Concept
broader: organic molecular entity

Efloxate
type: Concept
broader: organic molecular entity

Phenoxybenzamine hydrochloride
type: Concept
broader: organic molecular entity

bkas#30
type: Concept
broader: organic molecular entity

KFP-XB0XBDXX-D
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

KFP-RS0LX372-6
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

Cinnavalininate(2-)
type: Concept
broader: organic molecular entity

dihydrovittatine Trifluoroacetic acid
type: Concept
broader: organic molecular entity

Lumirhodopsin
type: Concept
broader: organic molecular entity

Glycino 3beta-cholesterol ester group
type: Concept
broader: organic molecular entity

Bufencarb
type: Concept
broader: organic molecular entity

Shale oils
type: Concept
broader: organic molecular entity

[(ppy)2Ir(dmn)]Cl
type: Concept
broader: organic molecular entity

KFP-JP12NKHQ-D
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

bkos#10-CoA
type: Concept
broader: organic molecular entity

3-hydroxypropenoate(1-)
type: Concept
broader: organic molecular entity

alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

ascr#31(1-)
type: Concept
broader: organic molecular entity

yersinopine(1-)
type: Concept
broader: organic molecular entity

alpha-D-Gal-(1->3)-(alpha-L-Fuc-(1->2))-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine
type: Concept
broader: organic molecular entity

[Dihydrolipoyllysine-residue acetyltransferase] S-acetyldihydrolipoyllysine
type: Concept
broader: organic molecular entity

ascr#20(1-)
type: Concept
broader: organic molecular entity

IdoA2S-GlcNS6S tetrasaccharide
type: Concept
broader: organic molecular entity

Holo-Lys2
type: Concept
broader: organic molecular entity

(R)-Chiral alcohol
type: Concept
broader: organic molecular entity

azodicarbonamide
type: Concept
broader: organic molecular entity

dinapinone A
type: Concept
broader: organic molecular entity

Histone L-arginine
type: Concept
broader: organic molecular entity

8-[(3R)-3-Aminopiperidin-1-yl]-7-but-2-yn-1-yl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione
type: Concept
broader: organic molecular entity

cis-9,10-methylenehexadecanoate
type: Concept
broader: organic molecular entity

Pelubiprofen
type: Concept
broader: organic molecular entity

Gonadotropin-releasing hormone II
type: Concept
broader: organic molecular entity

bkas#28
type: Concept
broader: organic molecular entity

beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine
type: Concept
broader: organic molecular entity

Oxypertine
type: Concept
broader: organic molecular entity

Insulin-like growth factor II
type: Concept
broader: organic molecular entity

bkos#18
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

bkos#26-CoA
type: Concept
broader: organic molecular entity

N-Acetyldemethylphosphinothricinate (2-)
type: Concept
broader: organic molecular entity

bhas#10(1-)
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1<->1')-ceramide(t18:0) (1-)
type: Concept
broader: organic molecular entity

KFP-MQQ8S4M5-X
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(3-)
broader: organic molecular entity

beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine
type: Concept
broader: organic molecular entity

bkas#38-CoA
type: Concept
broader: organic molecular entity

Cer(d16:1(4E)(1OH,3OH)(15Me)/21:0(2OH[R]))
type: Concept
broader: organic molecular entity

alpha-D-glucosaminyl-(1->6)-(phosphatidyl)-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion
type: Concept
broader: organic molecular entity

Liver-expressed antimicrobial peptide 2
type: Concept
broader: organic molecular entity

Tungsten carbide
type: Concept
broader: organic molecular entity

KFP-W5X7GNZR-6
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

bhos#9(1-)
type: Concept
broader: organic molecular entity

12a-hydroxyrotenone
type: Concept
broader: organic molecular entity

Octotiamine
type: Concept
broader: organic molecular entity

HexCer(d16:1(4E,15Me)/26:0(OH))
type: Concept
broader: organic molecular entity

alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(3-)
type: Concept
broader: organic molecular entity

iron-57(3+)
type: Concept
broader: organic molecular entity

xueguang1024
type: Concept
broader: organic molecular entity

one-carbon compound
type: Concept
broader: organic molecular entity

SO3-3-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E))
type: Concept
broader: organic molecular entity

bkos#36
type: Concept
broader: organic molecular entity

bkas#28(1-)
type: Concept
broader: organic molecular entity

Follicle stimulating hormone
type: Concept
broader: organic molecular entity

Bismuth subnitrate
type: Concept
broader: organic molecular entity

ascr#33(1-)
type: Concept
broader: organic molecular entity

3-O-sulfo-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(3-O-sulfo)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
type: Concept
broader: organic molecular entity

Relaxin-2
type: Concept
broader: organic molecular entity

CIS-N-TERT-BUTYL-DECAHYDRO-2-[2(R)-HYDROXY-4-PHENYL-3(S)-[[N-2-QUINOLYLCARBONYL-L-ASPARAGINYL]AMINO]BUTYL]-(4AS)-ISOQUINOLINE-3(S)-CARBOXAMIDE
type: Concept
broader: organic molecular entity

Protein-omega-N-(ADP-D-ribosyl)-L-arginine
type: Concept
broader: organic molecular entity

modified amino acid anion
type: Concept
broader: organic molecular entity

ascr#19-CoA(4-)
type: Concept
broader: organic molecular entity

KFP-GQ2SPRGP-9
type: Concept
preferred label: beta-D-galactosyl-(1->4)-N-acetyl-beta-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

KFP-GWNSF3FD-G
type: Concept
preferred label: beta-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

Thyroglobulin L-thyroxine
type: Concept
broader: organic molecular entity

Dipeptide (Xaa-Pro)
type: Concept
broader: organic molecular entity

KFP-N3XWXTZ8-T
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

KFP-PTBTBV2G-R
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

Repirinast
type: Concept
broader: organic molecular entity

bkas#14
type: Concept
broader: organic molecular entity

KFP-L61RP2FT-R
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

isoaspartate
type: Concept
broader: organic molecular entity

4a-dehydroxycrinamabine Trifluoroacetic acid
type: Concept
broader: organic molecular entity

Flutazolam
type: Concept
broader: organic molecular entity

Amino acid(Tyr-, Trp-, Phe-, Leu-)
type: Concept
broader: organic molecular entity

C-Type natriuretic peptide
type: Concept
broader: organic molecular entity

KFP-QT72G06C-1
type: Concept
preferred label: beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

Cer(d16:1(4E)(1OH,3OH)(15Me)/22:0(2OH[R]))
type: Concept
broader: organic molecular entity

simplexin
type: Concept
broader: organic molecular entity

glyphosate-isopropylammonium
type: Concept
broader: organic molecular entity

alpha-NeuGc-(2->8)-alpha-NeuGc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

KFP-C8XML0L4-H
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->8)-alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(2-)
broader: organic molecular entity

dysidenin
type: Concept
broader: organic molecular entity

KFP-BQRDD3VW-K
type: Concept
preferred label: beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

KFP-SX03GC5S-5
type: Concept
preferred label: N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

Ethyl tellurac
type: Concept
broader: organic molecular entity

icosadienoate
type: Concept
broader: organic molecular entity

(3-((3R,5R,7S,8E,10E,12E)-3-amino-5-hydroxy-7-methoxyoctadeca-8,10,12-trienamido)propanoyl)-D-asparagine
type: Concept
broader: organic molecular entity

4-Imidazolone-5-propanoate(1-)
type: Concept
broader: organic molecular entity

bifonsecin B
type: Concept
broader: organic molecular entity

chaetochalasin A
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
type: Concept
broader: organic molecular entity

nitrofen
type: Concept
broader: organic molecular entity

1-palmitoyl-2-(5-hydroxyvaleroyl)-sn-glycero-3-phosphoethanolamine
type: Concept
broader: organic molecular entity

Thymosin alpha-1
type: Concept
broader: organic molecular entity

KFP-S0XBVWCG-Z
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(3-)
broader: organic molecular entity

bkos#34-CoA
type: Concept
broader: organic molecular entity

cytidine 5'-{[hydroxy(2-hydroxypropyl)phosphonoyl]phosphate}(2-)
type: Concept
broader: organic molecular entity

R-CHOH-CO-CH2OH
type: Concept
broader: organic molecular entity

KFP-ZFS69S0K-V
type: Concept
preferred label: beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(1-)
broader: organic molecular entity

3,5,7,9,11,13,15,17-Octaoxo-octadecanoyl-[acp]
type: Concept
broader: organic molecular entity

KFP-PPF9RP4D-R
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
broader: organic molecular entity

KFP-B3RDJ1ZF-J
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

KFP-N8WMV480-F
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

Protein alanine
type: Concept
broader: organic molecular entity

7-methoxycrinamabine Trifluoroacetic acid
type: Concept
broader: organic molecular entity

AK-toxin I
type: Concept
broader: organic molecular entity

Cer(d16:1(4E)(1OH,3OH)(15Me)/30:0(2OH[R]))
type: Concept
broader: organic molecular entity

calcium-43(2+)
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

3,5,7,9,11,13,15-Heptaoxo-heptadecanoyl-[acp]
type: Concept
broader: organic molecular entity

4-(5-PYRIDIN-4-YL-1H-1,2,4-TRIAZOL-3-YL)PYRIDINE-2-CARBONITRILE
type: Concept
broader: organic molecular entity

powelline Trifluoroacetic acid
type: Concept
broader: organic molecular entity

Protein N6,N6-dimethyl-L-lysine
type: Concept
broader: organic molecular entity

6-Thioguanosine monophosphate(2-)
type: Concept
broader: organic molecular entity

ascr#34(1-)
type: Concept
broader: organic molecular entity

bkas#24
type: Concept
broader: organic molecular entity

9-Hydroxy-3,5,7,11,13,15,17-octaoxo-octadecanoyl-[acp]
type: Concept
broader: organic molecular entity

KFP-BSBLQFH1-C
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

Zaltoprofen
type: Concept
broader: organic molecular entity

2'-Hydroxy caffeic acid
type: Concept
broader: organic molecular entity

Chlorpheniramine maleate
type: Concept
broader: organic molecular entity

KFP-VQPZBC69-Z
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-Fuc-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

ascr#20-CoA
type: Concept
broader: organic molecular entity

KFP-C4Q7XL2N-T
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-)
broader: organic molecular entity

TCA-sodium
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

cobalt-59(2+)
type: Concept
broader: organic molecular entity

Syringopeptin
type: Concept
broader: organic molecular entity

KFP-WV78W12G-9
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

cis-9,10-methylenehexadecanoyl-CoA
type: Concept
broader: organic molecular entity

bkos#28(1-)
type: Concept
broader: organic molecular entity

3-Oxododecanoyl-[acp]
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

Cefovecin sodium
type: Concept
broader: organic molecular entity

Lactenosin
type: Concept
broader: organic molecular entity

KFP-GX62JHVT-L
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

ascr#29-CoA(4-)
type: Concept
broader: organic molecular entity

2-(alpha-D-Glucosyl)-sn-glycerol
type: Concept
broader: organic molecular entity

Leucokinin VIII
type: Concept
broader: organic molecular entity

Galanin-like peptide
type: Concept
broader: organic molecular entity

alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

N-[2-(BENZHYDRYLOXY)ETHYL]-N,N-DIMETHYLAMINE
type: Concept
broader: organic molecular entity

KFP-XHW51HX2-J
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(5-)
broader: organic molecular entity

3-Hydroxyoctadecanoyl-[acp]
type: Concept
broader: organic molecular entity

6alpha-hydroxy-20beta-dihydro-prednisolone
type: Concept
broader: organic molecular entity

Duplicate sterigmatocystin
type: Concept
broader: organic molecular entity

Sodium thiosalicylate
type: Concept
broader: organic molecular entity

HexCer(d16:1(4E,15Me)/23:0(OH))
type: Concept
broader: organic molecular entity

trans-Geranyl-CoA
type: Concept
broader: organic molecular entity

Type 2 monosialylgalactosylgloboside
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
type: Concept
broader: organic molecular entity

KFP-T62744PJ-0
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
broader: organic molecular entity

bkas#26-CoA
type: Concept
broader: organic molecular entity

bhos#1-CoA
type: Concept
broader: organic molecular entity

Aflatoxin B1 exo-cysteinyl-conjugate
type: Concept
broader: organic molecular entity

siccayne
type: Concept
broader: organic molecular entity

Duplicate chrysazin
type: Concept
broader: organic molecular entity

Pentobarbital sodium
type: Concept
broader: organic molecular entity

alpha-NeuGc-(2->8)-alpha-NeuGc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

KFP-WHNGSNVX-9
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

KFP-NTHN5SFJ-F
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

KFP-P2NFDNW3-N
type: Concept
preferred label: N-acetyl-alpha-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-alpha-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
type: Concept
broader: organic molecular entity

Osalmid
type: Concept
broader: organic molecular entity

Etomidoline
type: Concept
broader: organic molecular entity

KFP-TTWLH394-V
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

P75-TNFR
type: Concept
broader: organic molecular entity

bkos#1-CoA
type: Concept
broader: organic molecular entity

ascr#28(1-)
type: Concept
broader: organic molecular entity

bhos#18(1-)
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

bkas#38(1-)
type: Concept
broader: organic molecular entity

Chlorphonium chloride
type: Concept
broader: organic molecular entity

KFP-C43GZZBZ-H
type: Concept
preferred label: D-mannose-(alpha1->2)-6-phosphoethanolamine-D-mannose-(alpha1->2)-6-phosphoethanolamine-D-mannose-(alpha1->6)-2-phosphoethanolamine-D-mannose-(alpha1->4)-D-glucosaminyl-(alpha1->6)-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-2-acyl-inositol zwitterion
broader: organic molecular entity

bhos#16-CoA(4-)
type: Concept
broader: organic molecular entity

ascr#31-CoA(4-)
type: Concept
broader: organic molecular entity

Bisoxatin acetate
type: Concept
broader: organic molecular entity

3-O-sulfo-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
type: Concept
broader: organic molecular entity

Brotizolam
type: Concept
broader: organic molecular entity

KFP-DF9MRH74-7
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

2-PEtn-alpha-D-Man-(1->4)-alpha-D-GlcN-(1->6)-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-2-acyl-inositol zwitterion
type: Concept
broader: organic molecular entity

KFP-M0FQZ51X-D
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)
broader: organic molecular entity

bkas#18(1-)
type: Concept
broader: organic molecular entity

chetoseminudin B
type: Concept
broader: organic molecular entity

KFP-C3HNKWKD-4
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
broader: organic molecular entity

2',4'-Dihydroxycinnamic acid
type: Concept
broader: organic molecular entity

Oxymetebanol
type: Concept
broader: organic molecular entity

7,9,12-Decaketide intermediate 6
type: Concept
broader: organic molecular entity

falcarindiol
type: Concept
broader: organic molecular entity

KFP-S426VDZZ-9
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

Clorexolone
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

Atractyloside
type: Concept
broader: organic molecular entity

KFP-SWZ75XP8-W
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

Tesaglitazar
type: Concept
broader: organic molecular entity

S. pneumoniae serotype 6B CPS
type: Concept
broader: organic molecular entity

Menfegol
type: Concept
broader: organic molecular entity

2'-deoxyribose 5'-monophosphate residue
type: Concept
broader: organic molecular entity

3,5,7,9,11,13,15-Heptaoxo-octadecanoyl-[acp]
type: Concept
broader: organic molecular entity

KFP-G461RHND-5
type: Concept
preferred label: alpha-N-acetyl-9-O-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)
broader: organic molecular entity

KFP-WSBN3W7R-T
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

Fosfomycin calcium
type: Concept
broader: organic molecular entity

[Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(2-methylbutanoyl)dihydrolipoyllysine
type: Concept
broader: organic molecular entity

2-Hydroxy-3-methyl-beta-keto-L-tyrosyl-[pcp]
type: Concept
broader: organic molecular entity

1,2-di-[(9Z)-hexadecenoyl]-sn-glycero-3-phosphoethanolamine zwitterion
type: Concept
broader: organic molecular entity

Glucagon-like peptide 2
type: Concept
broader: organic molecular entity

kabiramide C
type: Concept
broader: organic molecular entity

4-[(E)-2-isocyanoethenyl]phenol
type: Concept
broader: organic molecular entity

1-palmitoyl-2-(5-hydroxyvaleroyl)-sn-glycero-3-phospho-(1'-sn-glycerol)(1-)
type: Concept
broader: organic molecular entity

KFP-JVSN4RFN-Z
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-(N-acetyl-alpha-D-galactosaminyl-(1->3))-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

N-omega-(L-glutamyl)-O-acylsphingosine residue
type: Concept
broader: organic molecular entity

bacterial virulence gene B
type: Concept
broader: organic molecular entity

KFP-WCZMF61F-4
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

bhas#34-CoA
type: Concept
broader: organic molecular entity

bhos#38-CoA(4-)
type: Concept
broader: organic molecular entity

Cefetamet pivoxil hydrochloride
type: Concept
broader: organic molecular entity

Peptide-L-methionine (R)-S-oxide
type: Concept
broader: organic molecular entity

Prothrombin
type: Concept
broader: organic molecular entity

KFP-DP9DM82Q-D
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

[Cytochrome c]-N(omega)-methylarginine
type: Concept
broader: organic molecular entity

1-acyl-2-decanoyl-sn-glycero-3-phosphate(2-)
type: Concept
broader: organic molecular entity

enzyme bound TLM intermediate
type: Concept
broader: organic molecular entity

Sodium oleate
type: Concept
broader: organic molecular entity

Ethyl loflazepate
type: Concept
broader: organic molecular entity

Tetramisole hydrochloride
type: Concept
broader: organic molecular entity

Mepitiostane
type: Concept
broader: organic molecular entity

Litorin
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
type: Concept
broader: organic molecular entity

bhas#36-CoA
type: Concept
broader: organic molecular entity

KFP-ZDFDPKSC-3
type: Concept
preferred label: alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

N(8),N'(8)-citryl-bis(spermidine) (+3)
type: Concept
broader: organic molecular entity

Enzyme N6-(lipoyl)lysine
type: Concept
broader: organic molecular entity

3-O-sulfo-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)
type: Concept
broader: organic molecular entity

Sobuzoxane
type: Concept
broader: organic molecular entity

KFP-JBSVR4Q7-P
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-)
broader: organic molecular entity

Cys-Thr thioether
type: Concept
broader: organic molecular entity

bkas#32(1-)
type: Concept
broader: organic molecular entity

bhas#14(1-)
type: Concept
broader: organic molecular entity

ascr#27(1-)
type: Concept
broader: organic molecular entity

KFP-NMR9H1TQ-T
type: Concept
preferred label: beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(3-)
broader: organic molecular entity

Lewis Y antigen
type: Concept
broader: organic molecular entity

beta-glycerylphosphocholine
type: Concept
broader: organic molecular entity

Pyranose
type: Concept
broader: organic molecular entity

KFP-SJZ6FJF0-Z
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)
broader: organic molecular entity

[beta-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)]n (1-)
type: Concept
broader: organic molecular entity

beta-Keto-L-tyrosyl-[pcp]
type: Concept
broader: organic molecular entity

4-Substituted phenylacetate
type: Concept
broader: organic molecular entity

alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-(beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4))-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

KFP-CRQ8P1TS-3
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-glucosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

KFP-DS9TTD7C-C
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

KFP-HM9K4HPF-Z
type: Concept
preferred label: N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-alpha-D-galactosaminyl-(1->3)-(alpha-L-fucosyl-(1->2))-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphate(2-)
type: Concept
broader: organic molecular entity

(alpha-D-glucosyl)3-(alpha-D-mannosyl)8-beta-D-mannosyldiacetylchitobiosyldiphosphodolichol
type: Concept
broader: organic molecular entity

7,9,12-Decaketide intermediate 2
type: Concept
broader: organic molecular entity

Pahutoxin
type: Concept
broader: organic molecular entity

bhos#24-CoA(4-)
type: Concept
broader: organic molecular entity

bhas#18-CoA(4-)
type: Concept
broader: organic molecular entity

Endokinin A/B
type: Concept
broader: organic molecular entity

(2S)-2-ammonio-4-{[(1R)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]ammonio}butanoate
type: Concept
broader: organic molecular entity

alpha-D-Gal-(1->4)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

bkos#12(1-)
type: Concept
broader: organic molecular entity

2-[(2-aminoethylcarbamoyl)methyl]-2-hydroxybutanedioate
type: Concept
broader: organic molecular entity

5-L-Glutamyl-D-glutamyl-peptide
type: Concept
broader: organic molecular entity

staphylopine(1-)
type: Concept
broader: organic molecular entity

bhas#16-CoA(4-)
type: Concept
broader: organic molecular entity

1-octadecanoyl-2-(15-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine zwitterion
type: Concept
broader: organic molecular entity

alpha-D-Gal-(1->3)-alpha-D-Gal-(1->3)-alpha-D-Gal-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

ascr#32-CoA(4-)
type: Concept
broader: organic molecular entity

Hydrocortisone Sodium Succinate
type: Concept
broader: organic molecular entity

Haloaromatic compound
type: Concept
broader: organic molecular entity

ascr#38-CoA
type: Concept
broader: organic molecular entity

Holothurin
type: Concept
broader: organic molecular entity

KFP-X3G3LQC0-W
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

osas#9(1-)
type: Concept
broader: organic molecular entity

(R)-3-Hydroxydodecanoyl-[acp]
type: Concept
broader: organic molecular entity

3'SLN
type: Concept
broader: organic molecular entity

Glycoprotein with the oligosaccharide chain attached by N-glycosyllinkage to protein L-asparagine
type: Concept
broader: organic molecular entity

iglu#2
type: Concept
broader: organic molecular entity

KFP-FCC705XF-6
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

SO3-3-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
type: Concept
broader: organic molecular entity

Dehydropeptide
type: Concept
broader: organic molecular entity

Neuropeptide EI
type: Concept
broader: organic molecular entity

organophosphorus herbicide
type: Concept
broader: organic molecular entity

beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphingosine
type: Concept
broader: organic molecular entity

KFP-MV2FPG05-X
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(5-)
broader: organic molecular entity

C15810
type: Concept
broader: organic molecular entity

RFamide-related peptide 2
type: Concept
broader: organic molecular entity

juglanin B
type: Concept
broader: organic molecular entity

Coagulation Factor VIIa
type: Concept
broader: organic molecular entity

KFP-N66BG8CB-5
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
broader: organic molecular entity

icas#7(1-)
type: Concept
broader: organic molecular entity

(S)-carazolol(1+)
type: Concept
broader: organic molecular entity

Emorfazone
type: Concept
broader: organic molecular entity

bhos#34-CoA
type: Concept
broader: organic molecular entity

bkas#38-CoA(4-)
type: Concept
broader: organic molecular entity

Interferon beta-1b
type: Concept
broader: organic molecular entity

Methylmethionine sulfonium salt
type: Concept
broader: organic molecular entity

KFP-LL2ZLCQG-X
type: Concept
preferred label: alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

Indium phosphide
type: Concept
broader: organic molecular entity

(GlcNAc)2 (Man)8
type: Concept
broader: organic molecular entity

(omega-1)-methyl-branched lipid
type: Concept
broader: organic molecular entity

cyclo(L-Phe-L-Pro)
type: Concept
broader: organic molecular entity

bkos#10
type: Concept
broader: organic molecular entity

beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
type: Concept
broader: organic molecular entity

KFP-Q1SF7MLC-1
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

D-glucosaminyl-(alpha1->6)-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-2-acyl-inositol zwitterion
type: Concept
broader: organic molecular entity

SO3-6-O-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
type: Concept
broader: organic molecular entity

bhos#32-CoA
type: Concept
broader: organic molecular entity

Calcium levulinate anhydrous
type: Concept
broader: organic molecular entity

Chivosazole C
type: Concept
broader: organic molecular entity

sesterbrasiliatriene
type: Concept
broader: organic molecular entity

bkos#1-CoA(4-)
type: Concept
broader: organic molecular entity

Cefoperazone sodium
type: Concept
broader: organic molecular entity

9-Hydroxy-3,5,7,11,13,15,17,19-nonaoxo-henicosanoyl-[acp]
type: Concept
broader: organic molecular entity

bhos#24(1-)
type: Concept
broader: organic molecular entity

Metharbital
type: Concept
broader: organic molecular entity

Thymosin beta-10
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
type: Concept
broader: organic molecular entity

N-acetyl-alpha-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

KFP-C0J82QC4-D
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(1-)
broader: organic molecular entity

KFP-PVZFVBSS-D
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

4S(5)-epoxy-17(S)-hydroxydocosahexaenoic acid
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(2-)
type: Concept
broader: organic molecular entity

phosphorus-31(3+)
type: Concept
broader: organic molecular entity

Mirabamide F
type: Concept
broader: organic molecular entity

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
type: Concept
broader: organic molecular entity

Linoleoyl-[acyl-carrier protein]
type: Concept
broader: organic molecular entity

organometalloidal compound
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(1-)
type: Concept
broader: organic molecular entity

KFP-VJ0LXBK5-9
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

ascr#17-CoA(4-)
type: Concept
broader: organic molecular entity

bhos#20-CoA(4-)
type: Concept
broader: organic molecular entity

KFP-JFNWVW22-Q
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)(2-)
broader: organic molecular entity

an alpha-mycolate
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0)
type: Concept
broader: organic molecular entity

Melanin-concentrating hormone
type: Concept
broader: organic molecular entity

elemental carbon
type: Concept
broader: organic molecular entity

Niceritrol
type: Concept
broader: organic molecular entity

KFP-QQ5T555K-K
type: Concept
preferred label: beta-D-galactosyl-(1->4)-N-acetyl-beta-glucosaminyl-(1->3)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
broader: organic molecular entity

KFP-HL931QZD-J
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(2-)
broader: organic molecular entity

Hydroxypropylmethylcellulose phthalate
type: Concept
broader: organic molecular entity

Elastin
type: Concept
broader: organic molecular entity

Quinupristin-dalfopristin
type: Concept
broader: organic molecular entity

Carbidopa-levodopa
type: Concept
broader: organic molecular entity

beta-Melanotropin
type: Concept
broader: organic molecular entity

2,5-dihydroxybenzoic acid-5-O-glucoside
type: Concept
broader: organic molecular entity

Mas7
type: Concept
broader: organic molecular entity

bhos#1(1-)
type: Concept
broader: organic molecular entity

3,5-Dioxo acid
type: Concept
broader: organic molecular entity

gamma-L-Glutamyl-[acp]
type: Concept
broader: organic molecular entity

C-terminal amino acid-glycine residue(1-)
type: Concept
broader: organic molecular entity

3'-hydro-2'-hydroxy-beta-oxodihydrochalcone
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
type: Concept
broader: organic molecular entity

opacaline C
type: Concept
broader: organic molecular entity

KFP-NH9B5Q91-H
type: Concept
preferred label: N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
broader: organic molecular entity

Ramatroban
type: Concept
broader: organic molecular entity

Neurophysin I
type: Concept
broader: organic molecular entity

alpha-D-Man-(1->2)-alpha-D-Man-(1->6)-2-PEtn-alpha-D-Man-(1->4)-alpha-D-GlcN-(1->6)-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-2-acyl-inositol zwitterion
type: Concept
broader: organic molecular entity

KFP-LGZHJFCG-0
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

1-stearoyl,2-(10-hydroxyoctadecanoyl)-sn-glycero-3-phospho-L-serine(1-)
type: Concept
broader: organic molecular entity

Cytochrome c-552
type: Concept
broader: organic molecular entity

1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphoethanolamine
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
type: Concept
broader: organic molecular entity

Gsh-prostaglandin A1
type: Concept
broader: organic molecular entity

KFP-GZS6GX1P-C
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->8)-alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
broader: organic molecular entity

2-trans,4-cis-decadienoylcarnitine
type: Concept
broader: organic molecular entity

icosatrienoate
type: Concept
broader: organic molecular entity

2,3-Ene acid
type: Concept
broader: organic molecular entity

(ADP-D-ribosyl)(n+1)-acceptor
type: Concept
broader: organic molecular entity

2'-Hydroxyferulic acid
type: Concept
broader: organic molecular entity

10(S),17(S)-dihydroxy-omega 6-docosapentaenoic acid
type: Concept
broader: organic molecular entity

N,N,N-Trimethylmethanaminium chloride
type: Concept
broader: organic molecular entity

Procaterol hydrochloride
type: Concept
broader: organic molecular entity

6a,7-didehydro-1,9,10-trihydroxy-2-methoxy-6-methylaporphinium trifluoroacetate
type: Concept
broader: organic molecular entity

ascr#25-CoA(4-)
type: Concept
broader: organic molecular entity

C-terminal amino acid- phosphatidylethanolamine amidated glycine residue(1-)
type: Concept
broader: organic molecular entity

amicoumacin A(1+)
type: Concept
broader: organic molecular entity

Brain natriuretic peptide
type: Concept
broader: organic molecular entity

KFP-BF4WRTB5-P
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

Urodilatin
type: Concept
broader: organic molecular entity

KFP-SBSCFZW8-Q
type: Concept
preferred label: alpha-N-acetylneuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-)
broader: organic molecular entity

beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
type: Concept
broader: organic molecular entity

salicylic acid-2-O-glucoside
type: Concept
broader: organic molecular entity

Bathorhodopsin
type: Concept
broader: organic molecular entity

KFP-HSN8SD83-7
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

Midecamycin
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
type: Concept
broader: organic molecular entity

11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE
type: Concept
broader: organic molecular entity

bhas#32-CoA
type: Concept
broader: organic molecular entity

KFP-HJK8S1B0-V
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(2-)
broader: organic molecular entity

(2S)-3-(4-hydroxyphenyl)-2-isocyanopropanoate
type: Concept
broader: organic molecular entity

Iotrolan
type: Concept
broader: organic molecular entity

KFP-DFHFX26N-9
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

1,1'-(OXYDIMETHYLENE)BIS(4-FORMYLPYRIDINIUM)DIOXIME
type: Concept
broader: organic molecular entity

N-Acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosylproteoglycan
type: Concept
broader: organic molecular entity

sulfur-34(2+)
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
type: Concept
broader: organic molecular entity

Angiotensinogen
type: Concept
broader: organic molecular entity

Bis(3-azidopyridinium)-1,10-decane perchlorate
type: Concept
broader: organic molecular entity

3-O-sulfo-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(2-)
type: Concept
broader: organic molecular entity

bkas#32-CoA(4-)
type: Concept
broader: organic molecular entity

Endothelin-3
type: Concept
broader: organic molecular entity

bkas#36-CoA(4-)
type: Concept
broader: organic molecular entity

N-lauroyl-heptadecasphingosine-1,3-cyclophosphate(1-)
type: Concept
broader: organic molecular entity

Methandrostenolone
type: Concept
broader: organic molecular entity

KFP-N8VX8NDS-2
type: Concept
preferred label: alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
broader: organic molecular entity

ascr#15-CoA(4-)
type: Concept
broader: organic molecular entity

bkas#36
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
type: Concept
broader: organic molecular entity

myristicin
type: Concept
broader: organic molecular entity

bkos#10-CoA(4-)
type: Concept
broader: organic molecular entity

Protein C
type: Concept
broader: organic molecular entity

N-acetyl-beta-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
type: Concept
broader: organic molecular entity

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N- glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-)
type: Concept
broader: organic molecular entity

N-acyl-1-O-galactosyl-15-methylhexadecasphing-4-enine
type: Concept
broader: organic molecular entity

Alkylamide
type: Concept
broader: organic molecular entity

Voglibose
type: Concept
broader: organic molecular entity

N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

betaenone C
type: Concept
broader: organic molecular entity

4-amino-3-all-trans-hexaprenylbenzoate
type: Concept
broader: organic molecular entity

Arylamide
type: Concept
broader: organic molecular entity

Halopredone acetate
type: Concept
broader: organic molecular entity

KFP-WW4M9DLF-6
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

Monanchocidin A, rel-
type: Concept
broader: organic molecular entity

Mafoprazine mesylate
type: Concept
broader: organic molecular entity

Cer(d16:1(4E)(1OH,3OH)(15Me)/29:0)
type: Concept
broader: organic molecular entity

Cer(d16:1(4E)(1OH,3OH)(15Me)/26:0(2OH[R]))
type: Concept
broader: organic molecular entity

Lower primary alcohol
type: Concept
broader: organic molecular entity

3-O-acetyl-8-O-demethylmaritidine Trifluoroacetic acid
type: Concept
broader: organic molecular entity

molybdenum-98(3+)
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:0) (1-)
type: Concept
broader: organic molecular entity

3-dehydrolevoglucosan
type: Concept
broader: organic molecular entity

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
type: Concept
broader: organic molecular entity

gamma-L-Glutamyl-4-amino-2-hydroxybutyryl-[acp]
type: Concept
broader: organic molecular entity

CI Basic red 9
type: Concept
broader: organic molecular entity

alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
type: Concept
broader: organic molecular entity

bhos#14-CoA
type: Concept
broader: organic molecular entity

Envelope glycoprotein E2
type: Concept
broader: organic molecular entity

icas#1(1-)
type: Concept
broader: organic molecular entity

Aflatoxin B1 exo glutathione conjugate
type: Concept
broader: organic molecular entity

alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E))
type: Concept
broader: organic molecular entity

manganese-55(4+)
type: Concept
broader: organic molecular entity

Antibiotic K41
type: Concept
broader: organic molecular entity

KFP-W90NKFJS-Q
type: Concept
preferred label: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
broader: organic molecular entity

icosenoate
type: Concept
broader: organic molecular entity

KFP-LMF1CN1Z-3
type: Concept
preferred label: N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-alpha-D-galactosaminyl-(1->3)-(alpha-L-fucosyl-(1->2))-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))
broader: organic molecular entity

beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
type: Concept
broader: organic molecular entity

N-Acetyl-alpha-D-glucosaminyl-(1->4)-beta-D-glucuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminylproteoglycan
type: Concept
broader: organic molecular entity

4-{[(2S,5S)-5-[(4-hydroxyphenyl)methyl]-2,5-dihydropyrazin-2-yl]methyl}phenol(1+)
type: Concept
broader: organic molecular entity

[2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY]METHYLPHOSPHONIC ACID
type: Concept
broader: organic molecular entity

bkas#34-CoA
type: Concept
broader: organic molecular entity

2-O-[alpha-D-glucopyranosyl-(1->6)-alpha-D-glucopyranosyl]-D-glycerate
type: Concept
broader: organic molecular entity

osas#9
type: Concept
broader: organic molecular entity

organic amino compound
type: Concept
broader: organic molecular entity

KFP-D6DLBVWG-9
type: Concept
preferred label: N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
broader: organic molecular entity

KFP-X6DPKLLC-W
type: Concept
preferred label: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)
broader: organic molecular entity

4-O-feruloylquinic acid
type: Concept
broader: organic molecular entity

Ponceau 3R
type: Concept
broader: organic molecular entity

19-O-acetylchaetoglobosin D
type: Concept
broader: organic molecular entity

alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))
type: Concept
broader: organic molecular entity

Xaa-Arg
type: Concept
broader: organic molecular entity

N-arachidonoyl-1,2-diacyl-sn-glycero-3-phosphoethanolamine(1-)
type: Concept
broader: organic molecular entity

3',3'-cUAMP(2-)
type: Concept
broader: organic molecular entity

Succinate_d4
type: Concept
broader: organic molecular entity

Seratrodast
type: Concept
broader: organic molecular entity

Gimeracil
type: Concept
broader: organic molecular entity

Pinacidil
type: Concept
broader: organic molecular entity

fusicocccadiene
type: Concept
broader: organic molecular entity

alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(3-)
type: Concept
broader: organic molecular entity

(ADP-D-ribosyl)(n)-acceptor
type: Concept
broader: organic molecular entity

Mirabamide E
type: Concept
broader: organic molecular entity

an alpha-mycolic acid
type: Concept
broader: organic molecular entity

KFP-R60H8BXV-Z
type: Concept
preferred label: alpha-L-fucosyl-(1->3)-[beta-D-galactosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)
broader: organic molecular entity

TAXOTERE
type: Concept
broader: organic molecular entity

Saquinavir mesylate
type: Concept
broader: organic molecular entity

Botulinum toxin type A
type: Concept
broader: organic molecular entity

KFP-ZH1BKQCL-0
type: Concept
preferred label: alpha-N-glycoloylneuraminosyl-(2->8)-alpha-N-glycoloylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(2-)
broader: organic molecular entity

cis-11,12-methyleneoctadecanoyl-CoA(4-)
type: Concept
broader: organic molecular entity

bkas#32
type: Concept
broader: organic molecular entity

methylphosphotriester-DNA
type: Concept
broader: organic molecular entity

13-cis-4-oxoretinoate
type: Concept
broader: organic molecular entity

Iturin A
type: Concept
broader: organic molecular entity

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-N-glycoloylneuraminosyl-(2->3)]-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
type: Concept
broader: organic molecular entity

Thyroglobulin dehydroalanine
type: Concept
broader: organic molecular entity

bhos#28-CoA
type: Concept
broader: organic molecular entity

Fe(III)-[N-(C-5-[deoxy-beta-D-glucosyl]-2,3-dihydroxybenzoyl)-L-serine]2(2-)
type: Concept
broader: organic molecular entity

N-acetyl-alpha-neuraminosyl-(2->8)-N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(2-)
type: Concept
broader: organic molecular entity

Histatin 5
type: Concept
broader: organic molecular entity

C15814
type: Concept
broader: organic molecular entity

3_STAR
type: ConceptGroup
member: organic molecular entity